0001493152-23-040055.txt : 20231109 0001493152-23-040055.hdr.sgml : 20231109 20231109160810 ACCESSION NUMBER: 0001493152-23-040055 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FG Financial Group, Inc. CENTRAL INDEX KEY: 0001591890 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] IRS NUMBER: 461119100 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36366 FILM NUMBER: 231392401 BUSINESS ADDRESS: STREET 1: 104 S. WALNUT STREET STREET 2: UNIT 1A CITY: ITASCA STATE: IL ZIP: 60143 BUSINESS PHONE: (847)-773-1665 MAIL ADDRESS: STREET 1: 104 S. WALNUT STREET STREET 2: UNIT 1A CITY: ITASCA STATE: IL ZIP: 60143 FORMER COMPANY: FORMER CONFORMED NAME: 1347 Property Insurance Holdings, Inc. DATE OF NAME CHANGE: 20131113 10-Q 1 form10-q.htm
false --12-31 Q3 0001591890 0001591890 2023-01-01 2023-09-30 0001591890 FGF:CommonStock0.001ParValuePerShareMember 2023-01-01 2023-09-30 0001591890 FGF:Sec8.00CumulativePreferredStockSeries25.00ParValuePerShareMember 2023-01-01 2023-09-30 0001591890 2023-11-09 0001591890 2023-09-30 0001591890 2022-12-31 0001591890 2023-07-01 2023-09-30 0001591890 2022-07-01 2022-09-30 0001591890 2022-01-01 2022-09-30 0001591890 us-gaap:PreferredStockMember 2021-12-31 0001591890 us-gaap:CommonStockMember 2021-12-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591890 us-gaap:RetainedEarningsMember 2021-12-31 0001591890 2021-12-31 0001591890 us-gaap:PreferredStockMember 2022-03-31 0001591890 us-gaap:CommonStockMember 2022-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591890 us-gaap:RetainedEarningsMember 2022-03-31 0001591890 2022-03-31 0001591890 us-gaap:PreferredStockMember 2022-06-30 0001591890 us-gaap:CommonStockMember 2022-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001591890 us-gaap:RetainedEarningsMember 2022-06-30 0001591890 2022-06-30 0001591890 us-gaap:PreferredStockMember 2022-12-31 0001591890 us-gaap:CommonStockMember 2022-12-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591890 us-gaap:RetainedEarningsMember 2022-12-31 0001591890 us-gaap:PreferredStockMember 2023-03-31 0001591890 us-gaap:CommonStockMember 2023-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591890 us-gaap:RetainedEarningsMember 2023-03-31 0001591890 2023-03-31 0001591890 us-gaap:PreferredStockMember 2023-06-30 0001591890 us-gaap:CommonStockMember 2023-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001591890 us-gaap:RetainedEarningsMember 2023-06-30 0001591890 2023-06-30 0001591890 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591890 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591890 2022-01-01 2022-03-31 0001591890 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001591890 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001591890 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001591890 2022-04-01 2022-06-30 0001591890 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001591890 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001591890 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001591890 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591890 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591890 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591890 2023-01-01 2023-03-31 0001591890 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001591890 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001591890 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001591890 2023-04-01 2023-06-30 0001591890 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001591890 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001591890 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001591890 us-gaap:PreferredStockMember 2022-09-30 0001591890 us-gaap:CommonStockMember 2022-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001591890 us-gaap:RetainedEarningsMember 2022-09-30 0001591890 2022-09-30 0001591890 us-gaap:PreferredStockMember 2023-09-30 0001591890 us-gaap:CommonStockMember 2023-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001591890 us-gaap:RetainedEarningsMember 2023-09-30 0001591890 FGF:FundamentalGlobalInvestorMember us-gaap:CommonStockMember 2023-09-30 0001591890 FGF:FGCommunitiesIncMember 2022-12-31 0001591890 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember FGF:FundamentalGlobalAssetManagementLLCMember 2020-09-30 0001591890 FGF:FGACInvestorsLLCMember 2023-06-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-06-30 0001591890 FGF:GreenfirstForestProductsLLCMember 2023-06-30 0001591890 FGF:FGACInvestorsLLCMember 2023-06-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-06-30 0001591890 FGF:GreenfirstForestProductsHoldingsLLCMember 2023-06-30 0001591890 FGF:OppFiMember 2023-06-30 0001591890 FGF:FGCommunitiesIncMember 2022-10-31 0001591890 FGF:VariableInterestEntityMember 2023-09-30 0001591890 FGF:VariableInterestEntityMember 2022-12-31 0001591890 2023-01-01 0001591890 FGF:FGCommunitiesIncMember 2023-03-31 0001591890 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001591890 FGF:OppFiCommonStockAndWarrantsMember 2023-09-30 0001591890 FGF:OppFiCommonStockAndWarrantsMember 2023-01-01 2023-09-30 0001591890 FGF:HagertyCommonStockMember 2022-12-31 0001591890 FGF:HagertyCommonStockMember 2022-01-01 2022-12-31 0001591890 2022-01-01 2022-12-31 0001591890 FGF:OppFiCommonStockMember 2023-01-01 2023-09-30 0001591890 FGF:HagertyCommonStockMember 2022-12-14 2022-12-15 0001591890 FGF:FGSPACPartnersLPMember 2021-01-04 0001591890 FGF:FGMPMember 2023-07-01 2023-09-30 0001591890 FGF:FGMPMember 2023-01-01 2023-09-30 0001591890 FGF:FGMPMember 2022-01-01 2022-12-31 0001591890 FGF:FGMPMember 2023-09-30 0001591890 FGF:FGMPMember srt:MaximumMember 2023-09-30 0001591890 FGF:FGACInvestorsLLCMember 2023-09-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-09-30 0001591890 FGF:GreenfirstForestProductsLLCMember 2023-09-30 0001591890 FGF:InvestmentFundMember 2023-06-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-07-01 2023-09-30 0001591890 FGF:FGACInvestorsLLCMember 2023-07-01 2023-09-30 0001591890 FGF:FGMergerInvestorsMember 2023-07-01 2023-09-30 0001591890 FGF:GreenfirstForestProductsHoldingsLLCMember 2023-07-01 2023-09-30 0001591890 FGF:InvestmentFundMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsNonrecurringMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001591890 FGF:ThinkMarketsMember 2023-09-29 0001591890 FGF:ThinkMarketsMember 2023-09-29 2023-09-29 0001591890 FGF:ThinkMarketsMember 2023-09-30 0001591890 FGF:CraveworthyMember 2023-03-16 0001591890 FGF:CraveworthyMember 2023-03-16 2023-03-16 0001591890 FGF:CraveworthyMember 2023-09-30 0001591890 FGF:ICoreConnectIncMember 2023-03-15 0001591890 FGF:ICoreConnectIncMember 2023-01-01 2023-09-30 0001591890 FGF:ConvertiblePromissoryNoteMember 2023-09-29 0001591890 FGF:EquityMethodInvestmentMember 2023-09-30 0001591890 FGF:EquityMethodInvestmentMember 2022-12-31 0001591890 FGF:EquityMethodInvestmentMember 2023-01-01 2023-09-30 0001591890 FGF:EquityMethodInvestmentMember 2022-01-01 2022-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2023-07-01 2023-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2022-07-01 2022-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2023-01-01 2023-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2022-01-01 2022-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2023-07-01 2023-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2022-07-01 2022-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2023-01-01 2023-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2022-01-01 2022-09-30 0001591890 FGF:EquityMethodEarningsMember 2023-07-01 2023-09-30 0001591890 FGF:EquityMethodEarningsMember 2022-07-01 2022-09-30 0001591890 FGF:EquityMethodEarningsMember 2023-01-01 2023-09-30 0001591890 FGF:EquityMethodEarningsMember 2022-01-01 2022-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2023-07-01 2023-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2022-07-01 2022-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2023-01-01 2023-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2022-01-01 2022-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2023-07-01 2023-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2022-07-01 2022-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2023-01-01 2023-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2022-01-01 2022-09-30 0001591890 FGF:OtherMember 2023-07-01 2023-09-30 0001591890 FGF:OtherMember 2022-07-01 2022-09-30 0001591890 FGF:OtherMember 2023-01-01 2023-09-30 0001591890 FGF:OtherMember 2022-01-01 2022-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001591890 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001591890 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001591890 us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndThirtyNineMember 2023-09-30 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndFourtyMember 2023-09-30 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndFourtyOneMember 2023-09-30 0001591890 FGF:NotExpireUnderCurrentTaxLawMember 2023-09-30 0001591890 FGF:ExpireOnDecemberTwoThousandAndTwentySixMember 2023-09-30 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember srt:MaximumMember 2021-12-15 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember 2023-03-24 0001591890 FGF:AmendmentTwoThousandAndTwentyOneIncentivePlanMember 2023-03-24 0001591890 2023-03-24 0001591890 FGF:NonEmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-08-18 2022-08-19 0001591890 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember 2023-02-16 2023-02-17 0001591890 us-gaap:RestrictedStockUnitsRSUMember FGF:NonExecutiveMembersMember 2023-07-01 2023-09-30 0001591890 FGF:LarryGSwetsJrMember FGF:EquityAwardLetterAgreementMember 2021-01-17 2021-01-18 0001591890 FGF:MrSwetsMember us-gaap:RestrictedStockUnitsRSUMember 2023-02-16 2023-02-17 0001591890 FGF:EmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember FGF:TwentyTwentyOneEquityIncentivePlanMember 2022-07-31 2022-07-31 0001591890 FGF:LarryGSwetsJrMember FGF:StockOptionAgreementMember 2021-01-12 2021-01-12 0001591890 FGF:StockOptionAgreementMember FGF:LarryGSwetsJrMember 2023-01-01 2023-09-30 0001591890 us-gaap:WarrantMember 2022-02-24 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-12-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2023-01-01 2023-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2023-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2021-12-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-01-01 2022-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-09-30 0001591890 FGF:JointVentureAgreementMember FGF:FundamentalGlobalAssetManagementMember 2020-03-31 0001591890 FGF:ThinkMaketsMember 2023-09-29 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2020-03-31 2020-03-31 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2023-01-01 2023-09-30 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2022-01-01 2022-09-30 0001591890 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001591890 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001591890 FGF:LeaseAgreementMember 2021-07-31 0001591890 FGF:LeaseAgreementMember 2023-01-01 2023-09-30 0001591890 FGF:LeaseAgreementMember 2022-01-01 2022-09-30 0001591890 FGF:LeaseAgreementMember 2022-04-30 0001591890 FGF:UnrestrictedCashMember 2023-09-30 0001591890 FGF:UnrestrictedCashMember 2022-09-30 0001591890 FGF:InsuranceMember 2023-07-01 2023-09-30 0001591890 FGF:AssetManagementMember 2023-07-01 2023-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001591890 FGF:InsuranceMember 2023-01-01 2023-09-30 0001591890 FGF:AssetManagementMember 2023-01-01 2023-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001591890 FGF:InsuranceMember 2023-09-30 0001591890 FGF:AssetManagementMember 2023-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2023-09-30 0001591890 FGF:InsuranceMember 2022-07-01 2022-09-30 0001591890 FGF:AssetManagementMember 2022-07-01 2022-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001591890 FGF:InsuranceMember 2022-01-01 2022-09-30 0001591890 FGF:AssetManagementMember 2022-01-01 2022-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001591890 FGF:InsuranceMember 2022-09-30 0001591890 FGF:AssetManagementMember 2022-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure FGF:Integer FGF:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended September 30, 2023

 

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-36366

 

FG Financial Group, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   46-1119100

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

104 S. Walnut Street, Unit 1A, Itasca, IL 60143

(Address of principal executive offices and zip code)

 

(847) 773-1665

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   FGF   The Nasdaq Stock Market LLC
8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share   FGFPP   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer Smaller Reporting Company Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of shares outstanding of the registrant’s common stock as of November 9, 2023 was 10,558,930.

 

 

 

 
 

 

Table of Contents

 

PART I. FINANCIAL INFORMATION 3
   
ITEM 1. FINANCIAL STATEMENTS 3
   
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 27
   
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 35
   
ITEM 4. CONTROLS AND PROCEDURES 35
   
PART II. OTHER INFORMATION 35
   
ITEM 1. LEGAL PROCEEDINGS 35
   
ITEM 1A. RISK FACTORS 36
   
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 36
   
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 36
   
ITEM 4. MINE SAFETY DISCLOSURES 36
   
ITEM 5. OTHER INFORMATION 36
   
ITEM 6. EXHIBITS 36
   
SIGNATURES 37

 

2
 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

FG FINANCIAL GROUP, INC.

Consolidated Balance Sheets

($ in thousands, except per share data)

 

 

  

September 30, 2023

(unaudited)

  

December 31, 2022

 
ASSETS          
Equity securities, at fair value (cost basis of $1,916 and $889, respectively)  $2,187   $841 
Other investments   27,365    24,839 
Cash and cash equivalents   5,525    3,010 
Deferred policy acquisition costs   1,480    1,527 
Reinsurance balances receivable (net of current expected losses allowance of $84 and zero, respectively)   14,469    9,269 
Funds deposited with reinsured companies   7,075    9,277 
Other assets   727    712 
Total assets  $58,828   $49,475 
           
LIABILITIES          
Loss and loss adjustment expense reserves  $5,912   $4,409 
Unearned premium reserves   9,394    6,823 
Accounts payable and accrued expenses   720    723 
Other liabilities   135    225 
Total liabilities  $16,161   $12,180 
           
Commitments and contingencies (Note 10)   -    - 
           
SHAREHOLDERS’ EQUITY          
Series A Preferred Shares, $25.00 par and liquidation value, 1,000,000 shares authorized; 894,580 shares issued and outstanding as of September 30, 2023 and December 31, 2022  $22,365   $22,365 
Common stock, $0.001 par value; 100,000,000 shares authorized; 10,303,739 and 9,410,473 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively   10    9 
Additional paid-in capital   52,781    50,021 
Accumulated deficit   (32,489)   (35,100)
Total shareholders’ equity   42,667    37,295 
Total liabilities and shareholders’ equity  $58,828   $49,475 

 

See accompanying notes to consolidated financial statements.

 

3
 

 

FG FINANCIAL GROUP, INC.

Consolidated Statements of Operations

($ in thousands, except per share data)

(Unaudited)

 

 

   2023   2022   2023   2022 
  

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Revenue:                
Net premiums earned  $4,192   $4,383   $11,534   $9,809 
Net investment income   6,961    11,174    8,272    5,114 
Other income   24    214    84    266 
Total revenue   11,177    15,771    19,890    15,189 
                     
Expenses:                    
Net losses and loss adjustment expenses   2,205    2,406    6,081    5,798 
Amortization of deferred policy acquisition costs   1,003    1,109    2,533    2,427 
General and administrative expenses   2,341    2,001    7,221    6,009 
Total expenses   5,549    5,516    15,835    14,234 
                     
Net income  $5,628   $10,255   $4,055   $955 
Dividends declared on Series A Preferred Shares   447    447    1,339    1,342 
Income (loss) attributable to FG Financial Group, Inc. common shareholders  $5,181   $9,808   $2,716   $(387)
                     
Basic and diluted net income (loss) per common share  $0.50   $1.05   $0.28   $(0.05)
                     
Weighted average common shares outstanding:                    
Basic and diluted   10,303,739    9,333,709    9,813,438    7,564,017 

 

See accompanying notes to consolidated financial statements.

 

4
 

 

FG FINANCIAL GROUP, INC.

Consolidated Statements of Shareholders’ Equity

(Unaudited)

($ in thousands)

 

   Shares
Out-standing
   Amount   Shares
Out-standing
   Amount    Paid-in Capital   Accumulated Deficit   FG Financial Group, Inc. 
   Preferred Stock   Common Stock            Total
Shareholders’
Equity
attributable to
 
   Shares
Out-standing
   Amount   Shares
Out-standing
   Amount    Paid-in Capital   Accumulated Deficit   FG Financial Group, Inc. 
                              
Balance, January 1, 2022               894,580   $22,365                6,497,205   $6    $46,037   $(34,399)  $34,009 
Stock based compensation           30,796    1     62        63 
Dividends declared on Series A Preferred Shares ($0.50 per share)                        (447)   (447)
Net loss                        (3,823)   (3,823)
Balance, March 31, 2022   894,580   $22,365    6,528,001   $7    $46,099   $(38,669)  $            29,802 
                                     
Common stock issuance           2,750,000    2     3,781        3,784 
Stock based compensation                            53        52 
Dividends declared on Series A Preferred Shares ($0.50 per share)                        (447)   (447)
Net loss                        (5,478)   (5,478)
Balance, June 30, 2022   894,580   $22,365    9,278,001   $9    $49,933   $(44,594)  $27,713 
                                     
Common stock issuance           71,770         106        106 
Stock based compensation           44,269         65        65 
Dividends declared on Series A Preferred Shares ($0.50 per share)                        (447)   (447)
Net income                        10,255    10,255 
Balance, September 30, 2022   894,580   $22,365    9,394,040   $9    $50,104   $(34,786)  $37,692 
                                     
Balance, January 1, 2023   894,580   $22,365    9,410,473   $9   $50,021   $(35,100)  $37,295 
Common stock issuance             27,186         74         74 
Stock based compensation           1,080    -    641        641 
Dividends declared on Series A Preferred Shares ($0.50 per share)                       (447)   (447)
Net income                       1,350    1,350 
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023                            (106)   (106)
Balance, March 31, 2023   894,580   $22,365    9,438,739   $9   $50,736   $(34,303)  $38,807 
                                    
Common stock issuance   -    -    865,000    1    1,205    -    1,206 
Stock based compensation           -    -    361        361 
Dividends declared on Series A Preferred Shares ($0.50 per share)                       (444)   (444)
Net loss                       (2,923)   (2,923)
Balance, June 30, 2023   894,580   $22,365    10,303,739   $10   $52,302   $(37,670)  $37,007 
Stock based compensation           -    -    479        479 
Dividends declared on Series A Preferred Shares ($0.50 per share)                       (447)   (447)
Net income                       5,628    5,628 
Balance, September 30, 2023   894,580   $22,365    10,303,739   $10   $52,781   $(32,489)  $42,667 

 

See accompanying notes to consolidated financial statements.

 

5
 

 

FG FINANCIAL GROUP, INC.

Consolidated Statement of Cash Flows

(Unaudited)

(in thousands)

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
Cash flows from operating activities:          
Net income  $4,055   $955 
Adjustments to reconcile net loss to net cash used by operating activities:          
Net unrealized holding (gain) on equity investments   (319)   (10,521)
(Income) from equity method investments, net of distributions received   (4,192)   (2,880)
(Increase) in investment without a readily determinable fair value   (250)   - 
(Increase) in fair value of convertible note   (125)   - 
Net realized (gain) loss on sale of equity investments   (3,062)   11,263 
Stock compensation expense   1,481    180 
Changes in operating assets and liabilities:        - 
Reinsurance balances receivable   (5,307)   (3,857)
Funds deposited with reinsured companies   2,202    (2,237)
Deferred policy acquisition costs   47    (1,134)
Other assets   (42)   (121)
Loss and loss adjustment expense reserves   1,503    2,000 
Unearned premium reserves   2,571    2,955 
Accounts payable, accrued expenses and other liabilities   (92)   (544)
Net cash used by operating activities   (1,530)   (3,941)
           
Cash flows from investing activities:          
Purchases of furniture and equipment   -    (77)
Purchases of equity method investments   (495)   (6,795)
Purchases of other investments   (950)   - 
Distribution from equity method investments   761    1,521 
Proceeds from sales of equity securities   4,604    664 
Return of capital – other investments   184    185 
Net cash provided (used) by investing activities   4,104    (4,502)
           
Cash flows from financing activities:          
Payment of dividends on preferred shares   (1,339)   (1,341)
Proceeds from issuance of common stock, net   1,280    3,889 
Net cash (used) provided by financing activities   (59)   2,548 
           
Net increase (decrease) in cash and cash equivalents   2,515    (5,895)
Cash and cash equivalents at beginning of period   3,010    15,542 
Cash and cash equivalents at end of period  $5,525   $9,647 
Non-Cash Investing Transactions:          

Equity securities in OppFi received in connection with FG Special Situations Fund unwind

  $1,916   $- 

 

See accompanying notes to consolidated financial statements.

 

6
 

 

FG FINANCIAL GROUP, INC.

Notes to Consolidated Financial Statements

 

Note 1. Nature of Business

 

FG Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss-capped reinsurance, while allocating capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also provides asset management services.

 

From our inception in October 2012 through December 2019, we operated as an insurance holding company, writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three former insurance subsidiaries to FedNat Holding Company (“FedNat”) for a combination of cash and FedNat common stock, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.

 

As of September 30, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity, collectively beneficially owned approximately 55% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.

 

Reincorporation

 

Effective at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the “Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws. The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.

 

Other than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management, assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management.

 

The Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00% Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”

 

Current Business

 

Our strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking activities with asymmetrical risk/reward opportunities. As part of our refined focus, we have adopted the following capital allocation philosophy:

 

Grow intrinsic value per share with a long-term focus using fundamental research, allocating capital to asymmetric risk/reward opportunities.”

 

Currently, the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special Purpose Acquisition Corporation “SPAC” Platform businesses, and our merchant banking division.

 

7
 

 

Insurance

 

Sponsor Protection Coverage and Risk, Inc. has been formed as a special purpose captive in South Carolina to provide reinsurance coverage for Sides A, B, & C Directors and Officers Liability insurance coverage for related and unrelated entities of FG Reinsurance Ltd (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as small cap businesses performing an initial public offering. Sponsor Protection Coverage and Risk, Inc. has yet to write any business.

 

Reinsurance

 

The Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised) of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”). The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which are not fully collateralized.

 

As of September 30, 2023, the Company had seven active reinsurance contracts, including participating in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate during the 2021, 2022 and 2023 calendar years.

 

Asset Management

 

FG Strategic Consulting, LLC, (“FGSC”) a wholly owned subsidiary of the Company, looks to provide investment advisory services, including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization, recommending investment dispositions, and providing advice regarding macro-economic conditions.

 

SPAC Platform and Merchant Banking

 

On December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company, to facilitate the launch of our “SPAC Platform.” Under the SPAC Platform, we provide various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs.

 

In the third quarter of 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division.

 

8
 

 

In the fourth quarter of 2022, the Company invested $2.0 million into its first merchant banking project, FG Communities, Inc. (“FGC”). FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC.

 

Note 2. Significant Accounting Policies

 

Basis of Presentation

 

These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Consolidation Policies

 

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

The consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that could potentially be significant to the legal entity.

 

The determination of whether a legal entity is consolidated under either model is reassessed where there is a substantive change in the governing documents or contractual arrangements of the entity, to the capital structure of the entity or in the activities of the entity. The Company continuously reassesses whether it should consolidate under either model.

 

In September 2020, the Company invested approximately $5.0 million to sponsor the launch of the FG Special Situations Fund, LP (“The Fund”). The Fund, a VIE which the Company was required to consolidate through November 30, 2021, was considered an investment company for GAAP purposes and followed the accounting and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus, began to account for its investment in the Fund under the equity method of accounting.

 

During the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, Greenfirst Forest Products Holdings LLC, and OppFi. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $8.9 million, FG Merger Investors LLC, with a carrying value of $3.4 million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $1.4 million. The carrying value of these direct limited partner interests approximate to ownership of 29% of FGAC Investors LLC, 19% of FG Merger Investors LLC, and 16% of Greenfirst Forest Products Holdings, LLC. The Fund also distributed OppFi publicly traded securities to the Company with a carrying value of $1.9 million.

 

As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. The Company has determined that each of these entities meets the criteria of a VIE. For each new position, the Company analyzed ASC 810 – Consolidation and has determined it is not the primary beneficiary of FGAC Investors LLC, FG Merger Investors LLC or Greenfirst Forest Products Holdings LLC, but does have the ability to exercise significant influence over each of these. Therefore, the Company will apply the equity method of accounting for each of these investments.

 

9
 

 

In October of 2022, the Company invested $2.0 million into FGC, which the Company has determined meets the criteria of a VIE. The Company holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not the primary beneficiary of FGC, and thus does not consolidate FGC.

 

The Company’s risk of loss associated with its non-consolidated VIEs is limited. As of September 30, 2023, and December 31, 2022, the carrying value and maximum loss exposure of the Company’s non-consolidated VIE’s was $16.5 million and $18.8 million, respectively.

 

See Note 4 for further information regarding the Company’s investments.

 

The Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying consolidated financial statements include the valuation of our equity method investments, current expected credit losses, the valuation of net deferred income taxes and deferred policy acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.

 

Investments in Equity Securities

 

Investments in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations as a component of net investment income.

 

Other Investments

 

Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses more than 20% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock and to other investments when such other investments possess substantially identical subordinated interests to common stock.

 

In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our claim on the investee’s book value.

 

When we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods, with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative equity in earnings represent returns on investment and are classified as cash inflows from investing activities.

 

10
 

 

In addition to investments accounted for under the equity method of accounting, other investments also consist of equity we have purchased in a limited partnership, a limited liability company, and a corporation for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an asset measured at fair value on a nonrecurring basis. Any profit distributions the Company receives on these investments are included in net investment income.

 

Other investments also include a convertible note and a senior unsecured promissory note.

 

See Note 4 for additional information regarding the Company’s investments.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.

 

Pursuant to the Company’s insurance license, the Authority has required that FGRe hold a minimum capital requirement of $200,000 in cash in a bank in the Cayman Islands which holds an “A” license issued under the Banks and Trust Companies Act (2020 Revision).

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).

 

Concentration of Credit Risk

 

Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $250,000. As of September 30, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.

 

Premium Revenue Recognition

 

The Company participates in quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.

 

11
 

 

Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represents estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.

 

Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.

 

Current Expected Credit Loss

 

In the first quarter of 2023, the Company adopted ASU 2016-13, as amended, Financial Instruments – Credit Losses (“ASU 2016-13”), which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The financial assets included in the caption “Reinsurance balances recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. The amendments in this update were effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted, however smaller reporting companies, like the Company, could delay adoption until January 2023. Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $0.1 million as of January 1, 2023. The Company updates the model each quarter and adjusts the balance accordingly. There was no change to the allowance during the third quarter.

 

In the first quarter of 2023, the Company allocated $200,000 into a promissory note. The promissory note is carried at amortized cost on the Company’s consolidated balance sheet under the caption “other investments.” Due to being held at amortized cost, the promissory note falls into the scope of ASU 2016-13. Due to immateriality, the Company does not have a current expected credit allowance against the promissory note.

 

Deferred Policy Acquisition Costs

 

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.

 

Funds Deposited for Benefit of Reinsured Companies

 

“Funds Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held to support our reinsurance contracts. As of September 30, 2023 and December 31, 2022, the total cash collateral posted to support all of our reinsurance treaties was approximately $7.1 million and $9.3 million, respectively.

 

12
 

 

Loss and Loss Adjustment Expense Reserves

 

The Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports the Company has received from ceding companies. The Company then uses a variety of statistical and actuarial techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures and projected ultimate premium to be written by our cedants; (2) expected loss ratios by type of business; (3) actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions. The Company also engages independent actuarial specialists, at least annually, to assist management in establishing appropriate reserves. Since reserves are estimates, the final settlement of losses may vary from the reserves established, and any adjustments to the estimates, which may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the reserves recorded.

 

U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.

 

Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.

 

Stock-Based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – Stock Compensation, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period, which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.

 

The Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which vest solely based upon the passage of time. The fair value of each RSU is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest.

 

Based upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock compensation expense for expected forfeitures as of September 30, 2023.

 

Fair Value of Financial Instruments

 

The carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other accrued expenses, approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s financial instruments.

 

13
 

 

Earnings (Loss) Per Common Share

 

Basic earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.

 

Diluted earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings (loss) per share if their effect is anti-dilutive.

 

Note 3. Recently Adopted and Issued Accounting Standards

 

Accounting Standards Adopted

 

As discussed, the Company adopted ASU 2016-13 during the first quarter of 2023 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $0.1 million as of January 1, 2023.

 

Note 4. Investments and Fair Value Disclosures

 

The following table summarizes the Company’s equity securities held at fair value as of September 30, 2023 and December 31, 2022:

 

(in thousands)                
As of September 30, 2023  Cost Basis  

Gross

Unrealized

Gains

  

Gross

Unrealized

Losses

  

Carrying

Amount

 
OppFi common stock and warrants  $1,916   $    271   $         -   $2,187 
Total investments  $1,916   $271   $-   $2,187 

 

As of December 31, 2022  Cost Basis  

Gross

Unrealized

Gains

  

Gross

Unrealized

Losses

  

Carrying

Amount

 
Hagerty common stock  $889   $   $48   $841 
Total investments  $889   $            $      48   $841 

 

OppFi Common Stock

 

As a result of the Fund unwinding, the Company received approximately 860,000 shares of OppFi common stock. On the date of the distribution, the common shares had an aggregate fair value of approximately $1.9 million.

 

Hagerty Common Stock

 

On December 15, 2022, FGMP distributed 99,999 common shares of Hagerty to the Company. On the date of distribution, the common shares had an aggregate fair value of approximately $889,000. The Company sold the common shares during the first quarter of 2023 for a realized loss of approximately $16,000.

 

Equity Method Investments

 

Other investments on the Company’s consolidated balance sheets include our equity method investments in FGMP, FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings LLC.

 

14
 

 

On January 4, 2021, FGMP was formed as a Delaware limited partnership to co-sponsor newly formed SPACs with their founders or partners, as well as other merchant banking interests. The Company is the sole managing member of the general partner of FGMP and holds a limited partner interest of approximately 46% in FGMP directly and through its subsidiaries. FGMP participates as a co-sponsor of the SPACs launched under our SPAC Platform as well as merchant banking initiatives.

 

For the three months ended September 30, 2023, the Company recorded equity method gains from FGMP of approximately $1.2 million. No capital contributions were made to FGMP during the quarter. For the nine months ended September 30, 2023, the Company contributed $0.1 million into FGMP and has recorded equity method gains of approximately $4.1 million. The carrying value of our investment in FGMP as of September 30, 2023 was approximately $9.9 million compared to $5.7 million as of December 31, 2022. Of the $9.9 million carrying value of our investment in FGMP at September 30, 2023 the Company may allocate up to approximately $0.4 million to incentivize and compensate individuals and entities for the successful merger of SPACs launched under our platform.

 

Equity method investments previously included our investment in the Fund. However, during the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings LLC. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $8.9 million, FG Merger Investors LLC, with a carrying value of $3.4 million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $1.4 million. The Company determined that it has the ability to exercise significant influence over FGAC Investors LLC, FG Merger Investors LLC and Greenfirst Forest Products Holdings LLC, and thus will account for each of these investments under the equity method of accounting. After taking into account second quarter equity pickups, the combined carrying value of these investments at June 30, 2023 was approximately $11.9 million. For the three months ended September 30, 2023, the Company contributed $0.5 million into FG Merger Investors LLC, and recorded an equity method gain of approximately $2.4 million. The Company recorded an equity method loss from Greenfirst Forest Products Holdings LLC of approximately $0.1 million and a gain of $0.1 million from FGAC Investors LLC for the three months ended September 30, 2023. The combined carrying value of these investments at September 30, 2023 was approximately $14.7 million.

 

Financial information for our investments accounted for under the equity method, in the aggregate, is as follows:

 

  

As of
September 30,
2023

   As of
December 31, 2022
 
(in thousands)          
Other investments  $72,585   $35,366 
Cash   275    113 
Other assets   177    165 
Total assets   73,037    35,644 
           
Total liabilities   439    65 

 

  

Nine months ended

September 30, 2023

  

Nine months ended

September 30, 2022

 
(in thousands)          
Net investment income  $17,417   $8,170 
Other income   129    - 
General and administrative expenses   (1,149)   (95)
Net income    16,397    8,075 

 

15
 

 

Certain investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing equity for SPACs that have not yet closed.

 

Investments without Readily Determinable Fair Value

 

In addition to our equity method investments, other investments, as listed on our consolidated balance sheets, consist of equity we have purchased in companies for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Any profit distributions the Company receives on these investments are included in net investment income.

 

The carrying value of investments without readily determinable fair value were increased by $0.3 million for the nine months ended September 30, 2023, as compared to zero for the nine months ended September 30, 2022. The increase was due to an observable price change in FGC during the second quarter of 2023. This amount is included in net investment income on the Company’s consolidated statements of operations. The Company did not record any changes during the three months ended September 30, 2023, and September 30, 2022. The Company’s total carrying value in investments without a readily determinable fair value was $2.3 million as of September 30, 2023, compared to approximately $2.3 million as of December 31, 2022.

 

Other

 

Other investments, in addition to equity method investments and investments without readily determinable fair value, include a convertible promissory note and a senior unsecured promissory note.

 

On September 29, 2023, the Company invested $250,000 in a convertible promissory note with ThinkMarkets. The promissory note has an interest rate of 15% annually, with interest payments due monthly, and matures on August 1, 2025. Commencing upon the closing of the contemplated business combination, the Company has the option to convert any unpaid loan amount and all accrued and unpaid interest into fully paid shares of FGAC common stock, at a conversion price of $5.00 per share. The Company evaluated the convertible promissory note’s settlement provisions and elected the fair value option to value this instrument. Under the fair value election, the convertible promissory note is measured initially and subsequently at fair value, which as of September 30, 2023, both are calculated to be $250,000.

 

On March 16, 2023, the Company invested $200,000 in a senior unsecured loan to Craveworthy LLC (“Craveworthy”). The loan has an interest rate of 13% and a maturity of March 15, 2024. The $200,000 principal and any interest accrued may be prepaid voluntarily by Craveworthy but is not required to be paid until the date of maturity. As of September 30, 2023, the entire principal amount of $200,000 as well as approximately $15,000 of accrued interest was outstanding.

 

On March 15, 2023, the Company invested $500,000 in a convertible promissory note with iCore. During the third quarter, the Company elected to convert all unpaid principal and interest due from the convertible promissory note with iCore into fully paid common shares of iCore. As part of the conversion, the Company received approximately 219,000 common shares of iCore. During the third quarter, the Company sold all of the common shares received from conversion for approximately $3.7 million in cash proceeds, resulting in a realized gain of approximately $3.1 million.

 

Impairment

 

For equity securities without readily determinable fair values, impairment is determined via a qualitative assessment which considers indicators to evaluate whether the investment is impaired. Some of these indicators include a significant deterioration in the earnings performance or asset quality of the investee, a significant adverse change in regulatory, economic or general market conditions in which the investee operates, or doubt over an investee’s ability to continue as a going concern. If the investment is deemed to be impaired after conducting this analysis, the Company would estimate the fair value of the investment to determine the amount of impairment loss.

 

16
 

 

For equity method investments, evidence of a loss in value might include a series of operating losses of an investee, the absence of an ability to recover the carrying amount of the investment, or a deterioration in the value of the investee’s underlying assets. If these, or other indicators lead to the conclusion that there is a decrease in the value of the investment that is other than temporary, the Company would recognize that decrease in value even though the decrease may be in excess of what would otherwise be recognized under the equity method of accounting.

 

The risks and uncertainties inherent in the assessment methodology used to determine impairment include, but may not be limited to, the following:

 

  the opinions of professional investment managers and appraisers could be incorrect;
     
  the past operating performance and cash flows generated from the investee’s operations may not reflect their future performance; and
     
  the estimated fair values for investment for which observable market prices are not available are inherently imprecise.

 

We have not recorded an impairment on our investments for either of the nine months ended September 30, 2023 and 2022.

 

Net investment income for the three and nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022   2023   2022 
($ in thousands)  Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
Investment income:                    
Realized gain (loss) on common stock  $3,078   $(2,472)  $3,062   $(11,441)
Change in unrealized holding on common stock   404    2,448    319    10,521 
Equity method earnings   3,460    11,226    4,192    6,080 
Increase in investments without readily determinable fair value   -    -    250    - 
(Decrease) increase in fair value of convertible note   (52)   -    125    - 
Other   71    (28)   324    (46)
Net investment income  $6,961   $11,174   $8,272   $5,114 

 

Fair Value Measurements

 

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. The FASB has issued guidance that defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal, or most advantageous market in an orderly transaction between market participants. This guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance categorizes assets and liabilities at fair value into one of three different levels depending on the observation of the inputs employed in the measurements, as follows:

 

  Level 1 – inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets providing the most reliable measurement of fair value since it is directly observable.
     
  Level 2 – inputs to the valuation methodology which include quoted prices for similar assets or liabilities in active markets. These inputs are observable, either directly or indirectly, for substantially the full-term of the financial instrument.

 

17
 

 

  Level 3 – inputs to the valuation methodology which are unobservable and significant to the measurement of fair value.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a variety of factors, including the type of investment, whether the investment is new and not yet established in the marketplace, the liquidity of markets and other characteristics specific to the individual investment. In some cases, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the hierarchy based on the lowest level input that is significant to the fair value measurement. When determining fair value, the Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.

 

Financial instruments measured, on a recurring basis, at fair value as of September 30, 2023 and December 31, 2022 in accordance with the guidance promulgated by the FASB are as follows.

 

 

(in thousands)                
                 
As of September 30, 2023  Level 1   Level 2   Level 3   Total 
Oppfi common stock and warrants  $2,187   $   $   $2,187 
ThinkMarkets convertible note  $        250    250 
   $2,187   $   $250   $2,437 
                     
As of December 31, 2022                    
Hagerty common stock  $841   $   $   $841 
   $841   $   $   $841 

 

On September 29, 2023, the Company invested $250,000 in a convertible promissory note with ThinkMarkets. As of September 30, 2023, the Company approximates the fair value of the note to be $250,000.

 

The following tables provide a reconciliation of the fair value of recurring Level 3 fair value measurements for the three- and nine-months ended September 30, 2023 and September 30, 2022:

 

   2023   2022 
(in thousands)  Nine months ended September 30, 
   2023   2022 
Assets:        
Convertible note          
Beginning balance   -    - 
Consideration paid   750    - 
Increase in fair value of convertible note   125    - 
Transfer out   (625)     
Balance, September 30  $250   $- 

 

   2023   2022 
(in thousands)  Three months ended September 30, 
   2023   2022 
Assets:        
Convertible note          
Beginning balance   677    - 
Consideration paid   250    - 
Decrease in fair value of convertible note   (52)   - 
Transfer out   (625)     
Balance, September 30  $250   $- 

 

Note 5. Loss and Loss Adjustment Expense Reserves

 

A significant degree of judgment is required to determine amounts recorded in the consolidated financial statements for the provision for loss and loss adjustment expense (“LAE”) reserves. The process for establishing this provision reflects the uncertainties and significant judgmental factors inherent in predicting future results of both known and unknown loss events. The process of establishing the provision for loss and LAE reserves relies on the judgment and opinions of many individuals, including the opinions of the Company’s management, as well as the management of ceding companies and their actuaries.

 

18
 

 

In estimating losses, the Company may assess any of the following:

 

  a review of in-force treaties that may provide coverage and incur losses;
  general forecasts, catastrophe and scenario modelling analyses and results shared by cedents;
  reviews of industry insured loss estimates and market share analyses;
  management’s judgment; and
  loss development factor selections, initial expected loss ratio selections, and weighting of methods used

 

Under the terms of certain of our quota-share agreements, and due to the nature of claims and premium reporting, a lag exists between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. The reports we receive from our cedents have pre-determined due dates. In the case of the Company’s FAL contracts, third quarter 2023 premium and loss information will not be made available to the Company until subsequent to the filing of this quarterly report. Thus, our third quarter results, including the loss and loss adjustment expense reserves presented herein, have been based upon a combination of actual results from the 2023 calendar year as well as forecasts for 2023 reported to us by the ceding companies. We have approximated third quarter 2023 results under our FAL contracts based upon this historical and forecasted information.

 

While the Company believes its estimate of loss and loss adjustment expense reserves are adequate as of September 30, 2023, based on available information, actual losses may ultimately differ materially from the Company’s current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information is provided.

 

A summary of changes in outstanding loss and loss adjustment expense reserves for the nine months ended September 30, 2023 and 2022, is as follows:

 

   2023   2022 
(in thousands)  Nine months ended September 30, 
   2023   2022 
Balance, beginning of period, net of reinsurance  $4,409   $2,133 
Incurred related to:          
Current year   5,420    4,984 
Prior year   661    814 
Paid related to:          
Current year   (3,675)   (2,568)
Prior years   (903)   (1,230)
Balance, September 30, net of reinsurance  $5,912   $4,133 

 

Note 6. Income Taxes

 

Actual income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax rates to income before income tax expense as follows:

 

($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Provision for taxes at U.S., statutory marginal income tax rate of 21%  $1,182  $2,154   $852  $201 
Valuation allowance for deferred tax assets deemed unrealizable   (1,200)   (2,168)   (871)   (219)
Non-deductible expenses associated with the Share Repurchase Transaction       2    1    2 
Share-based compensation   18    12    18    16 
Income tax expense (benefit)  $   $   $   $- 

 

19
 

 

Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes as compared to the amounts used for income tax purposes. The Company’s gross deferred tax assets and liabilities are $8.0 million and $3.4 million as of September 30, 2023. The Company has recorded a valuation allowance against its deferred tax assets of $4.6 million, as of September 30, 2023, due to the uncertain nature surrounding our ability to realize these tax benefits in the future. Significant components of the Company’s net deferred tax assets are as follows:

 

         
(in thousands)    
  

As of
September 30, 2023

  

As of
December 31, 2022

 
Deferred income tax assets:          
Net operating loss carryforward  $4,670   $4,171 
Loss and loss adjustment expense reserves   52    39 
Unearned premium reserves   395    287 
Capital loss carryforward   2,491    4,313 
Share-based compensation   424    242 
Investments   10    5 
Other   8    9 
Deferred income tax assets  $8,050   $9,066 
Less: Valuation allowance   (4,615)   (5,463)
Deferred income tax assets net of valuation allowance  $3,435   $3,603 
           
Deferred income tax liabilities:          
Investments  $3,125   $3,282 
Deferred policy acquisition costs   310    321 
Deferred income tax liabilities  $3,435   $3,603 
           
Net deferred income tax asset (liability)  $   $ 

 

As of September 30, 2023, the Company had net operating loss carryforwards (“NOLs”) for federal income tax purposes of approximately $22.2 million, which will be available to offset future taxable income. Approximately $0.5 million expire on December 31, 2039, $0.1 million expire on December 31, 2040, and $1.6 million of the Company’s NOLs will expire on December 31, 2041. The remaining $20.0 million of the Company’s NOLs do not expire under current tax law. Additionally, the Company has approximately $11.9 million of capital loss carryforward that can only be used to offset capital gains and which will expire in December 2026 if not used prior.

 

As of September 30, 2023, the Company had no unrecognized tax benefits. The Company analyzed its tax positions in accordance with the provisions of Accounting Standards Codification Topic 740, Income Taxes, and has determined that there are currently no uncertain tax positions. The Company generally recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense.

 

Note 7. Equity Incentive Plan Grants

 

On December 15, 2021, our shareholders approved the FG Financial Group, Inc. 2021 Equity Incentive Plan (the “2021 Plan”). The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (or “SARs”), restricted shares, restricted share units, and other share-based awards, and provides for a maximum of 1,500,000 shares available for issuance.

 

20
 

 

On March 24, 2023, the Company’s board of directors approved an amendment to the 2021 Plan to increase the number of shares available for issuance from 1,500,000 to 2,000,000.

 

In addition, on March 24, 2023, the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.

 

RSUs Outstanding

 

The following table summarizes RSU activity for the nine months ended September 30, 2023 and 2022:

 

Restricted Stock Units  Number of Units  

Weighted

Average Grant Date Fair Value

 
Non-vested units, January 1, 2023   256,382   $2.57 
Granted   821,974    2.76 
Vested   (227,301)   2.71 
Forfeited        
Non-vested units, September 30, 2023   851,055   $1.40 
           
Non-vested units, January 1, 2022   164,655   $4.35 
Granted   158,225    1.58 
Vested   (50,065)   4.81 
Forfeited        
Non-vested units, September 30, 2022   272,815   $2.66 

 

On August 19, 2022, we issued a total of 158,225 RSUs to our non-employee directors. The RSUs vest in five equal annual installments, beginning with the first anniversary of the grant date.

 

On February 17, 2023, we granted a total of 415,000 RSUs to various members of the Company’s management. The RSUs vest in three equal annual installments, beginning with the date the shares were granted.

 

In the third quarter of 2023, we granted a total of 36,974 RSUs to non-executive members of our Company’s board of directors. The RSU’s vest immediately.

 

On January 18, 2021, the Company entered into an Equity Award Letter Agreement (the “Letter Agreement”) with Mr. Swets, pursuant to which the Company clarified its intention to grant an additional 370,000 stock options, restricted shares or restricted stock units pursuant to a future award, subject to the approval of an amended and/or new equity plan, among other conditions. On February 17, 2023, in satisfaction of the obligations in the letter agreement, the Company granted 370,000 RSUs to Mr. Swets that will vest on the first anniversary of the grant date.

 

Restricted Shares

 

On July 31, 2022, the Company issued 25,000 restricted shares under the 2021 Equity Incentive Plan to an employee of the Company. The restriction was lifted on the first anniversary of the grant date.

 

Stock Options Outstanding

 

On January 12, 2021, in connection with Larry G. Swets, Jr.’s appointment as Chief Executive Officer, the Company entered into a Stock Option Agreement (the “Stock Option”) with Mr. Swets. The Stock Option entitles Mr. Swets to purchase up to 130,000 shares of the Company’s common stock at an exercise price of $3.38 per share. The Stock Option becomes vested and fully exercisable in 20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through each applicable vesting date and that the Company’s book value per share has increased by 15% or more as compared to the Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031.

 

21
 

 

The Stock Option contains performance and service conditions that affect vesting. Pursuant to ASC Topic 718- Stock Compensation, these conditions have not been reflected in estimating the fair value of the award upon its grant date; however, the Company employed a Monte-Carlo model to estimate the likelihood of satisfaction of the required performance and service conditions. This resulted in a derived service period of approximately 3.3 years under the grant.

 

In estimating the fair value of the Stock Option, the Company estimated volatility based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the Stock Option. The expected life of the Stock Option is assumed to be equivalent to its contractual term. The dividend rate is based on our historical rate, which the Company anticipates will remain at zero. The following assumptions were used to determine the estimated fair value of the Stock Option:

 

Expected volatility   45.60%
Expected life (years)   10.00 
Risk-free interest rate   5.15%
Dividend yield   0.00%

 

The following table summarizes activity for stock options issued for the nine months ended September 30, 2023 and 2022.

 

Common Stock Options  Shares   Weighted Ave
Exercise Price
   Weighted Ave
Remaining
Contractual
Term (yrs)
   Weighted Ave
Grant Date
Fair Value
   Aggregate Intrinsic Value 
Outstanding, January 1, 2023   130,000   $3.38    8.04   $1.88   $- 
Exercisable, January 1, 2023      $       $   $ 
Granted   -    -              
Exercised                    
Cancelled                    
Outstanding, September 30, 2023   130,000   $3.38    7.29   $1.88   $ 
Exercisable, September 30, 2023      $       $   $ 
                          
Outstanding, January 1, 2022   130,000   $3.38    9.04   $1.88   $49,400 
Exercisable, January 1, 2022      $       $   $ 
Granted                    
Exercised                    
Cancelled                    
Outstanding, September 30, 2022   130,000   $3.38    8.29   $1.88   $ 
Exercisable, September 30, 2022      $       $   $ 

 

Total stock-based compensation expense for the nine months ended September 30, 2023 and 2022 was approximately $1.5 million and $180,000, respectively. As of September 30, 2023, total unrecognized stock compensation expense of approximately $1.8 million remains, which will be recognized through December 31, 2026. Stock compensation expense has been reflected in the Company’s financial statements as part of general and administrative expense.

 

Warrants

 

No warrants were granted or exercised during the nine months ended September 30, 2023 and 2022. On February 24, 2022, 1,500,000 warrants with an exercise price of $15.00 expired. As of September 30, 2023, the Company did not have any warrants outstanding.

 

22
 

 

Note 8. Related Party Transactions

 

Related party transactions are carried out in the normal course of operations and are measured in part by the amount of consideration paid or received, as established and agreed by the parties. Management believes that consideration paid for such services in each case approximates fair value. Except where disclosed elsewhere in these consolidated financial statements, the following is a summary of related party transactions.

 

Joint Venture Agreement

 

On March 31, 2020, the Company entered into the Limited Liability Company Agreement of Fundamental Global Asset Management, LLC (“FGAM”), a joint venture owned 50% by each of the Company and FG. The purpose of FGAM is to sponsor, capitalize and provide strategic advice to investment managers in connection with the launch and/or growth of their asset management businesses and the investment products they sponsor (each, a “Sponsored Fund”).

 

FGAM is governed by a Board of Managers consisting of four managers, two of which have been appointed by each Member. The Company has appointed two of its independent directors to the Board of Managers of FGAM. Certain major actions, including any decision to sponsor a new investment manager, require the prior consent of both Members.

 

FG Special Situations Fund

 

The Company participated as a limited partner in the Fund. The general partner of the Fund, and the investment advisor of the Fund, was ultimately controlled by Mr. Cerminara, the Chairman of the Company’s Board of Directors. Portions of the Company’s investment into the Fund were used to sponsor the launch of SPACs affiliated with certain of our officers and directors.

 

The Fund began the process of winding down in the first quarter of 2023 and completed the process in the second quarter of 2023. As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. Mr. Cerminara, Mr. Swets and Mr. Baqar, our Executive Vice President and Chief Financial Officer, serve as managers of FGAC Investors LLC and FG Merger Investors LLC, while Mr. Cerminara ultimately controls Greenfirst Forest Products Holdings, LLC.

 

FG Merchant Partners

 

FGMP was formed to co-sponsor newly formed SPACs with their founders or partners. Certain of our directors and officers also hold limited partner interests in FGMP. Mr. Swets holds a limited partner interest through Itasca Financial LLC, an advisory and investment firm for which Mr. Swets is managing member. Mr. Baqar also holds a limited partner interest through Sequoia Financial LLC, an advisory firm for which Mr. Baqar is managing member. Mr. Cerminara also holds a limited partner interest through Fundamental Global, LLC, a holding company for which Mr. Cerminara is the manager and one of the members.

 

FGMP has invested in the founder shares and warrants of Aldel, FG Merger Corp, FG Acquisition Corp, FGC and Craveworthy. Certain of our directors and officers are affiliated with these entities.

 

FG Communities

 

In October of 2022, the Company directly invested $2.0 million into FGC. The Company also holds an interest through its ownership in FGMP. FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC. Mr. Cerminara is the President and a director of FGC.

 

23
 

 

Craveworthy

 

On March 16, 2023, the Company invested $200,000 in a senior unsecured loan to Craveworthy. Mr. Swets has an indirect interest in Craveworthy, independent from the interests held by the Company through its ownership in FGMP.

 

Think Markets

 

On September 29, 2023, the Company invested $250,000 in a convertible promissory note to support the business combination of Think Markets and FG Acquisition Corp. Mr. Swets and Mr. Baqar are executive officers of FG Acquisition Corp.

 

Shared Services Agreement

 

On March 31, 2020, the Company entered into a Shared Services Agreement (the “Shared Services Agreement”) with Fundamental Global Management, LLC (“FGM”), an affiliate of FG, pursuant to which FGM provides the Company with certain services related to the day-to-day management of the Company, including assisting with regulatory compliance, evaluating the Company’s financial and operational performance, providing a management team to supplement the executive officers of the Company, and such other services consistent with those customarily performed by executive officers and employees of a public company. In exchange for these services, the Company pays FGM a fee of $456,000 per quarter (the “Shared Services Fee”), plus reimbursement of expenses incurred by FGM in connection with the performance of the Services, subject to certain limitations approved by the Company’s Board of Directors or Compensation Committee from time to time.

 

The Shared Services Agreement has an initial term of three years, and thereafter renews automatically for successive one-year terms unless terminated in accordance with its terms. The Shared Services Agreement may be terminated by FGM or by the Company, by a vote of the Company’s independent directors, at the end of the initial or automatic renewal term upon 120 days’ notice, subject to payment by the Company of certain costs incurred by FGM to wind down the provision of services and, in the case of a termination by the Company without cause, payment of a termination fee equal to the Shared Services Fee paid for the two quarters preceding termination.

 

The Company paid $1,368,000 and $1,368,000 to FGM under the Shared Services Agreement for each of the nine months ended September 30, 2023 and 2022, respectively.

 

Note 9. Net Earnings Per Share

 

Net earnings per share is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding during the periods presented. In calculating diluted earnings per share, those potential common shares that are found to be anti-dilutive are excluded from the calculation. The table below provides a summary of the numerators and denominators used in determining basic and diluted earnings per share for the three and nine months ended September 30, 2023 and 2022.

 

   2023   2022   2023   2022 
($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Basic and diluted:                    
Net income from continuing operations  $5,628   $10,255   $4,055   $955 
Dividends declared on Series A Preferred Shares   (447)   (447)   (1,339)   (1,342)
Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations   5,181    9,808    2,716    (387)
Weighted average common shares   10,303,739    9,333,709    9,813,438    7,564,017 
Income (loss) per common share from continuing operations  $0.50   $1.05   $0.28   $(0.05)
                     
Weighted average common shares outstanding   10,303,739    9,333,709    9,813,438    7,564,017 

 

24
 

 

The following potentially dilutive securities outstanding as of September 30, 2023 and 2022 have been excluded from the computation of diluted weighted-average shares outstanding as their effect would be anti-dilutive.

 

   As of September 30, 
   2023   2022 
Options to purchase common stock   130,000    130,000 
Restricted stock units   851,055    297,815 
    981,055    427,815 

 

Note 10. Commitments and Contingencies

 

Legal Proceedings:

 

As of September 30, 2023, the Company was not aware of any material claims or actions pending or threatened against us. From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. Currently, it is not possible to predict legal outcomes and their impact on the future development of claims. Any such development will be affected by future court decisions and interpretations. Because of these uncertainties, additional liabilities may arise for amounts in excess of the Company’s current reserves.

 

Operating Lease Commitments:

 

In July 2021, the Company entered into a lease agreement for office space in St. Petersburg, FL. The lease had a term of 12 months and was not renewed upon expiration. Total minimum rent over the 12-month term was approximately $17,000. Due to the short-term nature of the lease, the Company recognized lease expense on a straight-line basis over the term of the lease, with any variable lease payments recognized in the period in which the obligation for the payment occurred. Rent expense related to the St. Petersburg office was zero and approximately $10,000 for the nine months ended September 30, 2023 and September 30, 2022, respectively.

 

In April 2022, the Company entered into a lease agreement for office space in Itasca, IL. The lease has a term of 44 months beginning on May 1, 2022. Total minimum rent over the term of the lease is expected to be approximately $77,000. The Company has accounted for the lease under ASC 842, Leases. The annual discount rate used for the Itasca office was 8%. As of September 30, 2023, the right of use asset and lease liability are approximately $44,000, each, and held in “Other assets” and “Other liabilities” on the balance sheet, respectively. Rent expense related to the Itasca office was approximately $16,000 and $8,800 for the nine months ended September 30, 2023 and September 30, 2022, respectively.

 

Note 11. Segment Reporting

 

The Company has two operating segments—insurance and asset management. The chief operating decision maker (“CODM”) is the Company’s Chief Executive Officer. The measure of profit or loss used by the CODM to identify and measure the Company’s reportable segments is income before income tax. Our insurance segment consists of the operations of our Cayman Islands-based reinsurance subsidiary, FGRe, as well as the returns associated with the investments made by our reinsurance operations. Our asset management segment includes our investments made outside of reinsurance operations.

 

The following table presents the financial information for each segment that is specifically identifiable or based on allocations using internal methodology as of and for the three and nine months ended September 30, 2023 and 2022. The ‘other’ category in the table below consists largely of corporate general and administrative expenses which have not been allocated to a specific segment. Segment assets for the “other” category primarily consist of unrestricted cash in the amounts of $3.8 million and $8.7 million as of September 30, 2023 and 2022, respectively.

 

25
 

 

(in thousands)

 

For the three months ended September 30, 2023

  Insurance   Asset Management   Other   Total 
Net premiums earned  $4,192   $   $   $4,192 
Net investment income   5,032    1,922    7    6,961 
Other income   -    24    -    24 
Total revenue   9,224    1,946    7    11,177 
Income (loss) before income tax   5,465    1,946    (1,783)   5,628 
                     
For the nine months ended September 30, 2023                    
Net premiums earned  $11,534   $   $   $11,534 
Net investment income   8,108    150    14    8,272 
Other income       84        84 
Total revenue   19,642    234    14    19,890 
Income (loss) before income tax   9,366    234    (5,545)   4,055 
                     
As of September 30, 2023                    
Segment assets  $35,776   $18,436   $4,616   $58,828 
                     
For the three months ended September 30, 2022                    
Net premiums earned  $4,383   $   $   $4,383 
Net investment income   2,468    8,706        11,174 
Other income       89    125    214 
Total revenue   6,851    8,795    125    15,771 
Income (loss) before income tax   3,274    8,798    (1,817)   10,255 
                     
For the nine months ended September 30, 2022                    
Net premiums earned  $9,809   $   $   $9,809 
Net investment income   1,562    3,552        5,114 
Other income       141    125    266 
Total revenue   11,371    3,693    125    15,189 
Income (loss) before income tax   2,728    3,680    (5,453)   955 
                     
As of September 30, 2022                    
Segment assets  $21,662   $17,777   $9,484   $48,923 

 

Note 12. Subsequent Events

 

The Corporation has evaluated subsequent events through the filing date of the financial statements and determined that there have been no events that have occurred that would require additional disclosures.

 

26
 

 

FG FINANCIAL GROUP, INC.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion in conjunction with our consolidated financial statements and related notes and information included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report for the year ended December 31, 2022 on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 24, 2023.

 

Unless context denotes otherwise, the terms “Company,” “FGF,” “we,” “us,” and “our,” refer to FG Financial Group, Inc., and its subsidiaries.

 

Cautionary Note about Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements are therefore entitled to the protection of the safe harbor provisions of these laws. These statements may be identified by the use of forward-looking terminology such as “anticipate,” “believe,” “budget,” “can,” “contemplate,” “continue,” “could,” “envision,” “estimate,” “expect,” “evaluate,” “forecast,” “goal,” “guidance,” “indicate,” “intend,” “likely,” “may,” “might,” “outlook,” “plan,” “possibly,” “potential,” “predict,” “probable,” “probably,” “pro-forma,” “project,” “seek,” “should,” “target,” “view,” “will,” “would,” “will be,” “will continue,” “will likely result” or the negative thereof or other variations thereon or comparable terminology. In particular, discussions and statements regarding the Company’s future business plans and initiatives are forward-looking in nature. We have based these forward-looking statements on our current expectations, assumptions, estimates, and projections. While we believe these to be reasonable, such forward-looking statements are only predictions and involve a number of risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results, performance, or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements, and may impact our ability to implement and execute on our future business plans and initiatives.

 

Management cautions that the forward-looking statements in this Quarterly Report on Form 10-Q are not guarantees of future performance, and we cannot assume that such statements will be realized or the forward-looking events and circumstances will occur. Factors that might cause such a difference include, without limitation: general conditions in the global economy; our lack of operating history or established reputation in the reinsurance industry; our inability to obtain or maintain the necessary approvals to operate reinsurance subsidiaries; risks associated with operating in the reinsurance industry, including inadequately priced insured risks, credit risk associated with brokers we may do business with, and inadequate retrocessional coverage; our inability to execute on our investment and investment management strategy, including our strategy to invest in the risk capital of special purpose acquisition companies (SPACs); potential loss of value of investments; risk of becoming an investment company; fluctuations in our short-term results as we implement our new business strategy; risks of being unable to attract and retain qualified management and personnel to implement and execute on our business and growth strategy; failure of our information technology systems, data breaches and cyber-attacks; our ability to establish and maintain an effective system of internal controls; our limited operating history as a public company; the requirements of being a public company and losing our status as a smaller reporting company or becoming an accelerated filer; any potential conflicts of interest between us and our controlling stockholders and different interests of controlling stockholders; potential conflicts of interest between us and our directors and executive officers; risks associated with our related party transactions and investments; and risks associated with our investments in SPAC, including the failure of any such SPAC to complete its initial business combination. Our expectations and future plans and initiatives may not be realized. If one of these risks or uncertainties materializes, or if our underlying assumptions prove incorrect, actual results may vary materially from those expected, estimated or projected. You are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements are made only as of the date hereof and do not necessarily reflect our outlook at any other point in time. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect new information, future events or developments.

 

27
 

 

Overview

 

FG Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss-capped reinsurance, while allocating capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. From our inception in October 2012 through December 2019, we operated as an insurance holding company, writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three former insurance subsidiaries, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.

 

As of September 30, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity collectively beneficially owned approximately 55.0% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.

 

Critical Accounting Estimates

 

Critical accounting estimates are those estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. Actual results may differ materially from these estimates. Set forth below is qualitative and quantitative information necessary to understand the estimation uncertainty and the impact the critical accounting estimate has had or is reasonably likely to have on financial condition or results of operations, to the extent the information is material and reasonably available.

 

Other Investments

 

Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. As discussed further in Note 4, certain investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing equity for SPACs that have not yet completed a business combination.

 

Current Expected Credit Loss

 

Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties.

 

Upon adoption of ASU 2016-13, the Company calculated an approximately $0.1 million allowance for expected credit losses for its reinsurance balances receivable.

 

Valuation of Net Deferred Income Taxes

 

The provision for income taxes is calculated based on the expected tax treatment of transactions recorded in the Company’s consolidated financial statements. In determining its provision for income taxes, the Company interprets tax legislation in a variety of jurisdictions and makes assumptions about the expected timing of the reversal of deferred income tax assets and liabilities and the valuation of net deferred income taxes.

 

28
 

 

The ultimate realization of the deferred income tax asset balance is dependent upon the generation of future taxable income during the periods in which the Company’s temporary differences reverse and become deductible. A valuation allowance is established when it is more likely than not that all or a portion of the deferred income tax asset balance will not be realized. In determining whether a valuation allowance is needed, management considers all available positive and negative evidence affecting specific deferred income tax asset balances, including the Company’s past and anticipated future performance, the reversal of deferred income tax liabilities, and the availability of tax planning strategies. To the extent a valuation allowance is established in a period, an expense must be recorded within the income tax provision in the consolidated statements of income and comprehensive income.

 

Premium Revenue Recognition

 

The Company participates in reinsurance quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period. Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected ultimate premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represent estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Additional premiums due on a contract that has no remaining coverage period are earned in full when written. Unearned premiums represent the unexpired portion of reinsurance provided.

 

Deferred Policy Acquisition Costs

 

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal reinsurance business, and consist principally of commissions, taxes, and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs, then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.

 

Loss and Loss Adjustment Expense Reserves

 

Loss and loss adjustment expense reserve estimates are based on estimates derived from reports received from ceding companies. These estimates are periodically reviewed by the Company’s management and adjusted as necessary. Since reserves are estimates, the final settlement of losses may vary from the reserves established and any adjustments to the estimates, which may be material, are recorded in the period they are determined.

 

29
 

 

Loss estimates may also be based upon actuarial and statistical projections, an assessment of currently available data, predictions of future developments, estimates of future trends and other factors. Significant assumptions used by the Company’s management and third-party actuarial specialists include loss development factor selections, initial expected loss ratio selections, and weighting of methods used. The final settlement of losses may vary, perhaps materially, from the reserves recorded. All adjustments to the estimates are recorded in the period in which they are determined. U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events. Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Cedent reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the cedent has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.

 

Stock-Based Compensation Expense

 

The Company uses the fair-value method of accounting for stock-based compensation awards granted. The Company has determined the fair value of its outstanding stock options on their grant date using the Black-Scholes option pricing model along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The Company determines the fair value of restricted stock units (“RSUs”) on their grant date using the fair value of the Company’s common stock on the date the RSUs were issued (for those RSU which vest solely based upon the passage of time). The fair value of these awards is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest, with a corresponding increase to additional paid-in capital. When the stock options are exercised, or correspondingly, when the RSUs vest, the amount of proceeds together with the amount recorded in additional paid-in capital is recorded in shareholders’ equity.

 

Recent Accounting Pronouncements

 

See Item 8, Note 3 – Recently Adopted and Issued Accounting Standards in the Notes to the Consolidated Financial Statements for a discussion of recent accounting pronouncements and their effect, if any, on the Company.

 

Analysis of Financial Condition

 

As of September 30, 2023 Compared to December 31, 2022

 

Investments

 

See Item 8, Note 4, Investments and Fair Value Disclosures, for information regarding the Company’s investments held at fair value as of September 30, 2023 and December 31, 2022.

 

Equity Method Investments

 

See Item 8, Note 4, under the caption, “Equity Method Investments,” for information relating to the Company’s investments accounted for under the equity method.

 

Investments without Readily Determinable Fair Value

 

See Item 8, Note 4, under the caption, “Investments without Readily Determinable Fair Value,” for information relating to Company investments for which readily determinable fair values do not exist.

 

Funds Deposited with Reinsured Companies

 

See Item 8, Note 2, under the caption, “Funds Deposited for benefit of Reinsured Companies,” for information relating to FGRe’s collateral deposits.

 

30
 

 

Reinsurance Balances Receivable

 

Reinsurance balances receivable were $14.5 million, net of a current expected loss allowance of $0.1 million, as of September 30, 2023 compared to $9.3 million as of December 31, 2022, representing net amounts due to the Company under our quota-share agreements. As the Company estimates the ultimate premiums, loss expenses and other costs associated with some of these contracts, based on information received by us from the ceding companies, a significant portion of this balance is based on estimates and, ultimately, may not be collected by the Company.

 

Net Deferred Taxes

 

See Item 8, Note 6, Income Taxes, for information relating to deferred income taxes.

 

Loss and Loss Adjustment Expense Reserves

 

See Item 8, Note 5, Loss and Loss Adjustment Expense Reserves, for information relating to loss and loss adjustment expense and judgments required for recording such items.

 

Off Balance Sheet Arrangements

 

None.

 

Shareholders’ Equity

 

8.00% Cumulative Preferred Stock, Series A

 

The total number of Series A Preferred Stock shares outstanding as of September 30, 2023 is 894,580.

 

Dividends on the Series A Preferred Stock are cumulative from the date of original issue and are payable quarterly on the 15th day of March, June, September and December of each year, when, as and if declared by our Board of Directors. Dividends are payable out of amounts legally available therefore at a rate equal to 8.00% per annum per $25.00 of stated liquidation preference per share, or $2.00 per share of Series A Preferred Stock per year. Our Board of Directors declared the third quarter 2023 dividend on the shares of Series A Preferred Stock on August 10, 2023. The Series A Preferred Stock shares trade on the Nasdaq Stock Market under the symbol “FGFPP.”

 

Common Stock

 

In June 2022, we sold a total of 2,750,000 shares of our common stock in an underwritten public offering, at a price of $1.58 per share, for net proceeds of approximately $3.8 million. On August 2, 2022, ThinkEquity, the underwriter with respect to the public offering, partially exercised its overallotment option and we sold an additional 71,770 shares of our common stock, at a price of 1.58 per share, for net proceeds of $0.1 million. The Company intends to use the net proceeds from the underwritten public offering for working capital and other general corporate purposes.

 

On November 3, 2022, the Company entered into a Sales Agreement with ThinkEquity LLC, pursuant to which the Company may offer and sell, from time to time through ThinkEquity LLC, shares of the Company’s common stock, subject to the terms and conditions of the Sales Agreement. During the first quarter of 2023, the Company sold approximately 27,000 shares under the Sales Agreement for net proceeds of approximately $74,000. On May 26, 2023, the Sales Agreement was terminated.

 

In June of 2023, the Company sold a total of 865,000 shares of common stock in an underwritten public offering, at a price of $1.85 per share, for net proceeds of approximately $1.3 million. The Company intends to use the net proceeds from the underwritten public offering for general working capital purposes.

 

The total number of common stock outstanding as of September 30, 2023 is 10,303,739.

 

31
 

 

Change in Shareholders’ Equity

 

The table below presents the primary components of changes to total shareholders’ equity for the nine months ended September 30, 2023 and 2022.

 

   Preferred Shares
Outstanding
   Common Shares
Outstanding
  

Total Shareholders’

Equity attributable
to FG Financial
Group, Inc.

 
Balance, January 1, 2022   894,580    6,497,205   $34,009 
Stock compensation expense       75,065    180 
Dividends declared on Series A Preferred Stock           (1,341)
Issuance of common stock        2,821,770    3,889 
Net income           955 
Balance, September 30, 2022   894,580    9,394,040   $37,692 
                
Balance, January 1, 2023   894,580    9,410,473   $37,296 
Stock compensation expense       1,080    1,481 
Dividends declared on Series A Preferred Stock           (1,339)
Issuance of common stock       892,186    1,280 
Net income           4,055 
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023   -    -    (106)
Balance, September 30, 2023   894,580    10,303,739   $42,667 

 

Results of Operations

 

Three and Nine Months Ended September 30, 2023 Compared with Three and Nine Months Ended September 30, 2022

 

Net Premiums Earned

 

Net premiums earned represent actual premiums earned on our reinsurance agreements as well as estimated premiums earned on our FAL agreement as disclosed previously. All actual and estimated premiums earned are the result of property and casualty assumed premium. For the nine months ended September 30, 2023 and 2022, earned premiums are approximately $11.5 million and $9.8 million, respectively. For the three months ended September 30, 2023 and 2022, earned premiums are approximately $4.1 million and $4.4 million, respectively. The increase in reinsurance premiums for the nine months ended was due primarily to the additional reinsurance agreement entered into with FAL to cover risks written by the syndicate during the calendar year 2023.

 

32
 

 

Net Investment Income

 

Net investment income (loss) for the three and nine months ended September 30, 2023 and 2022 is as follows:

 

($ in thousands) 

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Investment income (loss):                    
Realized gain (loss) on common stock  $3,078   $(2,472)  $3,062   $(11,441)
Change in unrealized holding on common stock   404    2,448    319    10,521 
Equity method earnings   3,460    11,226    4,192    6,080 
Increase in investments without a readily determinable fair value   -    -    250    - 
Decrease (increase) in fair value of convertible note   (52)   -    125    - 
Other   71    (28)   324    (46)
Net investment (loss) income  $6,961   $11,174   $8,272   $5,114 

 

Other Income

 

Other income was $84,000 compared to $266,000 for the nine months ended September 30, 2023 and 2022, respectively, and is primarily comprised of service fee revenue we have earned under our SPAC Platform.

 

Net Losses and Loss Adjustment Expenses

 

Net losses and loss adjustment expenses (“LAE”) for the three months ended September 30, 2023 and 2022, were $2.2 million and $2.4 million, respectively ($6.1M and $5.8M for the nine months ended September 30, 2023 and 2022, respectively). As discussed under Note 5, Loss and Loss Adjustment Expense Reserves, a portion of this charge represents an estimate based upon a full calendar year forecast of results provided to us by the ceding companies under our FAL arrangements.

 

General and Administrative Expenses

 

General and administrative expenses increased by $1.2 million to $7.2 million for the nine months ended September 30, 2023, compared to $6.0 million for the nine months ended September 30, 2022. For the three months ended September 30, 2023, general and administrative expenses was $2.3 million, compared to $2.0 million for the three months ended September 30, 2022. The increase for both 2023 periods was primarily due to an increase in stock compensation expense, which is a non-cash charge to the consolidated statements of operations.

 

Income Tax Expense (Benefit)

 

Our actual effective tax rate varies from the statutory federal income tax rates as shown in the following table.

 

($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Provision for taxes at U.S., statutory marginal income tax rate of 21%  $1,182  $2,154   $852  $201 
Valuation allowance for deferred tax assets deemed unrealizable   (1,200)   (2,168)   (871)   (219)
Non-deductible expenses associated with the Share Repurchase Transaction       2    1    2 
Share-based compensation   18    12    18    16 
Income tax expense (benefit)  $   $   $   $ 

 

As of September 30, 2023 and 2022, the Company has gross deferred tax assets of approximately $8.0 million and $7.9 million, respectively; however the Company has recorded a valuation allowance against all of its deferred tax assets due to the uncertain nature surrounding our ability to realize these tax benefits in the future, resulting in a net deferred income tax asset of $0 as of September 30, 2023 and 2022.

 

33
 

 

Net Income (Loss)

 

Information regarding our net loss and loss per share for the three months and nine months ended September 30, 2023 and 2022 is as shown in the following table:

 

($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Basic and diluted:                    
Net income from continuing operations  $5,628   $10,255   $4,055   $955 
Dividends declared on Series A Preferred Shares   (447)   (447)   (1,339)   (1,342)
Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations   5,181    9,808    2,716    (387)
Weighted average common shares   10,303,739    9,333,709    9,813,438    7,564,017 
Income (loss) per common share from continuing operations  $0.50   $1.05   $0.28   $(0.05)
                     
Weighted average common shares outstanding   10,303,739    9,333,709    9,813,438    7,564,017 

 

Liquidity and Capital Resources

 

The purpose of liquidity management is to ensure that there is sufficient cash to meet all financial commitments and obligations as they fall due. The liquidity requirements of the Company and its subsidiaries have been met primarily by funds generated from operations and from the proceeds from the sales of our common stock. Cash provided from these sources has historically been used for making investments, loss and LAE payments, as well as other operating expenses.

 

Cash Flows

 

The following table summarizes the Company’s consolidated cash flows for the nine months ended September 30, 2023 and 2022.

 

(in thousands) 

Nine months ended

September 30,

 
Summary of Cash Flows  2023   2022 
Cash and cash equivalents – beginning of period  $3,010   $15,542 
           
Net cash used by operating activities   (1,530)   (3,941)
Net cash provided (used) by investing activities   4,104    (4,502)
Net cash (used) provided by financing activities   (59)   2,548 
Net Increase (decrease) in cash and cash equivalents   2,515    (5,895)
           
Cash and cash equivalents – end of period  $5,525   $9,647 

 

For the nine months ended September 30, 2023, net cash used by operating activities was approximately $1.5 million, primarily driven by net income for the period of $4.0 million, an increase in unearned premium reserves of $2.6 million, a decrease in funds deposited with reinsured companies of $2.2 million, an increase in loss and loss adjustment expense reserves of $1.5 million, and an increase in stock compensation expense of $1.5 million. This was offset by a change in equity method and other investments of approximately $4.9 million, a realized gain of $3.0 million, and a increase in reinsurance balances receivable of $5.3 million.

 

For the nine months ended September 30, 2023, net cash provided by investing activities was $4.1 million, primarily related to the sale of equity securities, offset by our investments into convertible notes and equity method investments.

 

34
 

 

Net cash used by financing activities was approximately $0.1 million, as a result of our common stock offering for approximately $1.3 million offset by cash dividends declared on our Series A Preferred Shares for approximately $1.4 million.

 

For the nine months ended September 30, 2022, net cash used by operating activities was approximately $3.9 million, the major drivers of which were as follows:

 

● Our net income of approximately $1.0 million for the period;

 

● Approximately $10.5 million for a non-cash charge related to the unrealized holding gain, offset by $11.2 million in realized loss on sale associated with our shares of FedNat common stock; and

 

● Approximately $2.9 million for a non-cash charge related to the unrealized holding gains on our various investments.

 

● Approximately $2.7 million increase to amounts held on deposit with reinsured companies.

 

For the nine months ended September 30, 2022, net cash used by investing activities was $4.5 million primarily related to our increased investment in the Fund to sponsor FG Merger and FG Acquisition. Net cash provided by financing activities was approximately $2.5 million, as a result of our common stock offering for approximately $3.8 million offset by cash dividends declared on our Series A Preferred Shares for approximately $1.3 million.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

The Company’s management performed an evaluation under the supervision and with the participation of the Company’s principal executive officer and principal financial officer of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as such term is defined in Rules 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2023. Based upon this evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2023, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

As of September 30, 2023, the Company was not a party to any legal proceedings and was not aware of any material claims or actions pending or threatened against us. From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. Currently, it is not possible to predict legal outcomes and their impact on the future development of claims. Any such development will be affected by future court decisions and interpretations. Because of these uncertainties, additional liabilities may arise for amounts in excess of the Company’s current reserves.

 

35
 

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A. “Risk Factors” to our annual report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 24, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit   Description
31.1*   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act.
31.2*   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act.
32.1**   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase.
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

** Furnished herewith.

 

36
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    FG FINANCIAL GROUP, INC.
       
Date: November 9, 2023 By:  /s/ Larry G. Swets, Jr.
      Larry G. Swets, Jr., Chief Executive Officer
      (principal executive officer)
       
Date: November 9, 2023 By: /s/ Hassan R. Baqar
      Hassan R. Baqar, Chief Financial Officer
      (principal financial and accounting officer)

 

37

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Larry G. Swets, Jr., certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2023 of FG Financial Group, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9, 2023  
   
By:  /s/ Larry G. Swets, Jr.  
  Larry G. Swets, Jr., Chief Executive Officer  
  (Principal Executive Officer)  

 

 

 

EX-31.2 3 ex31-2.htm

 

EXHIBIT 31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Hassan R. Baqar, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2023 of FG Financial Group, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9, 2023  
   
By:  /s/ Hassan R. Baqar  
  Hassan R. Baqar, Chief Financial Officer  
  (Principal Financial Officer and Principal Accounting Officer)  

 

 

 

EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q (the “Report”) of FG Financial Group, Inc. (the “Company”) for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Larry G. Swets, Jr., the Principal Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 9, 2023  
   
By:  /s/ Larry G. Swets, Jr.  
  Larry G. Swets, Jr., Chief Executive Officer  
  (Principal Executive Officer)  

 

 

 

EX-32.2 5 ex32-2.htm

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q (the “Report”) of FG Financial Group, Inc. (the “Company”) for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Hassan R. Baqar, the Chief Financial Officer and Principal Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 9, 2023  
   
By:  /s/ Hassan R. Baqar  
  Hassan R. Baqar, Chief Financial Officer  
 

(Principal Financial Officer and Principal

Accounting Officer)

 

 

 

 

EX-101.SCH 6 fgf-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statement of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Nature of Business link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recently Adopted and Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Investments and Fair Value Disclosures link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Loss and Loss Adjustment Expense Reserves link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Equity Incentive Plan Grants link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Net Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Investments and Fair Value Disclosures (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Loss and Loss Adjustment Expense Reserves (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Equity Incentive Plan Grants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Net Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Nature of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Recently Adopted and Issued Accounting Standards (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Schedule of Equity Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Investments Under Equity Method (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Net Investment Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Schedule of Financial Instruments Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Fair Value of Recurring Level 3 Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Investments and Fair Value Disclosures (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Schedule of Reconciliation Effective Tax Rates (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Reconciliation Effective Tax Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Schedule of Deferred Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Schedule of Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Schedule of Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Equity Incentive Plan Grants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Schedule of Potentially Dilutive Securities Excluded from Calculation (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Summary of Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Segment Reporting (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 fgf-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 fgf-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 fgf-20230930_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.001 par value per share 8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Ownership [Axis] Fundamental Global GP, LLC [Member] Legal Entity [Axis] FG Communities Inc [Member] Consolidated Entities [Axis] Variable Interest Entity, Primary Beneficiary [Member] Fundamental Global Asset Management, LLC [Member] FGAC Investors LLC [Member] FG MergerInvestors LLC [Member] Green first Forest Products LLC [Member] Investment, Name [Axis] Greenfirst Forest Products Holdings LLC [Member] Opp Fi [Member] Variable Interest Entity [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Financial Instrument [Axis] Opp Fi Common Stock And Warrants [Member] Hagerty Common Stock [Member] OppFi Common Stock [Member] FG SPAC Partners LP [Member] FGMP [Member] Statistical Measurement [Axis] Maximum [Member] Investment Fund [Member] FG Merger Investors [Member] Measurement Frequency [Axis] Fair Value, Nonrecurring [Member] ThinkMarkets [Member] Craveworthy [Member] I Core Connect Inc [Member] Debt Instrument [Axis] Convertible Promissory Note [Member] Equity Method Investment, Nonconsolidated Investee [Axis] Equity Method Investment [Member] Investment Type [Axis] Realized Gain (Loss) on Common Stock [Member] Change in Unrealized Holding on Common Stock [Member] Equity Method Earnings [Member] Increase in Investments Without Readily Determinable Fair Value [Member] Decrease (Increase) in Fair Value of Convertible Note [Member] Other [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Recurring [Member] Opfi Common Stock And Warrants [Member] Fair Value, Inputs, Level 2 [Member] ThinkMarkets Convertible Note [Member] Award Type [Axis] Expire on December 31, 2039 [Member] Expire on December 31, 2040 [Member] Expire on December 31, 2041 [Member] Not Expire Under Current Tax Law [Member] Expire on December 2026 [Member] Plan Name [Axis] 2021 Incentive Plan [Member] Amendment 2021 Incentive Plan [Member] Title of Individual [Axis] Non Employee Director [Member] Restricted Stock Units (RSUs) [Member] Management [Member] NonExecutive Members [Member] Larry G. Swets Jr [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Equity Award Letter Agreement [Member] Mr. Swets [Member] Employee Director [Member] 2021 Equity Incentive Plan [Member] Stock Option Agreement [Member] Warrant [Member] 2014 Equity Incentive Plan [Member] Joint Venture Agreement [Member] Fundamental Global Asset Management [Member] Think Makets [Member] Shared Services Agreement [Member] Fundamental Global Management, LLC [Member] Antidilutive Securities [Axis] Equity Option [Member] Lease Agreement [Member] Cash and Cash Equivalents [Axis] Unrestricted Cash [Member] Segments [Axis] Insurance [Member] Asset Management [Member] Other Segments [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Equity securities, at fair value (cost basis of $1,916 and $889, respectively) Other investments Cash and cash equivalents Deferred policy acquisition costs Reinsurance balances receivable (net of current expected losses allowance of $84 and zero, respectively) Funds deposited with reinsured companies Other assets Total assets LIABILITIES Loss and loss adjustment expense reserves Unearned premium reserves Accounts payable and accrued expenses Other liabilities Total liabilities Commitments and contingencies (Note 10) SHAREHOLDERS’ EQUITY Series A Preferred Shares, $25.00 par and liquidation value, 1,000,000 shares authorized; 894,580 shares issued and outstanding as of September 30, 2023 and December 31, 2022 Common stock, $0.001 par value; 100,000,000 shares authorized; 10,303,739 and 9,410,473 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively Additional paid-in capital Accumulated deficit Total shareholders’ equity Total liabilities and shareholders’ equity Equity securities, cost basis Reinsurance losses allowance Series A preferred stock, par value Series A preferred stock, shares authorized Series A preferred stock, shares issued Series A preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares Outstanding Income Statement [Abstract] Revenue: Net premiums earned Net investment income Other income Total revenue Expenses: Net losses and loss adjustment expenses Amortization of deferred policy acquisition costs General and administrative expenses Total expenses Net income Dividends declared on Series A Preferred Shares Income (loss) attributable to FG Financial Group, Inc. common shareholders Basic net income (loss) per common share Diluted net income (loss) per common share Weighted average common shares outstanding: Basic Diluted Beginning balance, value Beginning balance, shares Stock based compensation Stock based compensation, shares Dividends declared on Series A Preferred Shares ($0.50 per share) Net income (loss) Common stock issuance Common stock issuance, shares Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023 Ending balance, value Ending balance, shares Statement of Stockholders' Equity [Abstract] Preferred stock dividends per share cash paid Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used by operating activities: Net unrealized holding (gain) on equity investments (Income) from equity method investments, net of distributions received (Increase) in investment without a readily determinable fair value (Increase) in fair value of convertible note Net realized (gain) loss on sale of equity investments Stock compensation expense Changes in operating assets and liabilities: Reinsurance balances receivable Funds deposited with reinsured companies Deferred policy acquisition costs Other assets Loss and loss adjustment expense reserves Unearned premium reserves Accounts payable, accrued expenses and other liabilities Net cash used by operating activities Cash flows from investing activities: Purchases of furniture and equipment Purchases of equity method investments Purchases of other investments Distribution from equity method investments Proceeds from sales of equity securities Return of capital – other investments Net cash provided (used) by investing activities Cash flows from financing activities: Payment of dividends on preferred shares Proceeds from issuance of common stock, net Net cash (used) provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Non-Cash Investing Transactions: Equity securities in OppFi received in connection with FG Special Situations Fund unwind Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Business Accounting Policies [Abstract] Significant Accounting Policies Accounting Changes and Error Corrections [Abstract] Recently Adopted and Issued Accounting Standards Investments And Fair Value Disclosures Investments and Fair Value Disclosures Loss And Loss Adjustment Expense Reserves Loss and Loss Adjustment Expense Reserves Income Tax Disclosure [Abstract] Income Taxes Share-Based Payment Arrangement [Abstract] Equity Incentive Plan Grants Related Party Transactions [Abstract] Related Party Transactions Earnings Per Share [Abstract] Net Earnings Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Segment Reporting [Abstract] Segment Reporting Subsequent Events [Abstract] Subsequent Events Basis of Presentation Consolidation Policies The Use of Estimates in the Preparation of Consolidated Financial Statements Investments in Equity Securities Other Investments Cash and Cash Equivalents Income Taxes Concentration of Credit Risk Premium Revenue Recognition Current Expected Credit Loss Deferred Policy Acquisition Costs Funds Deposited for Benefit of Reinsured Companies Loss and Loss Adjustment Expense Reserves Stock-Based Compensation Fair Value of Financial Instruments Earnings (Loss) Per Common Share Platform Operator, Crypto-Asset [Table] Platform Operator, Crypto-Asset [Line Items] Schedule of Equity Securities Schedule of Investments Under Equity Method Schedule of Net Investment Income (Loss) Schedule of Financial Instruments Measured at Fair Value Schedule of Fair Value of Recurring Level 3 Fair Value Measurements Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves Schedule of Reconciliation Effective Tax Rates Schedule of Deferred Income Taxes Schedule of Restricted Stock Units Activity Schedule of Fair Value of Stock Options Schedule of Stock Option Activity Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share Schedule of Potentially Dilutive Securities Excluded from Calculation Summary of Segment Reporting Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Ownership percentage Number of active reinsurance contracts Investments Real estate investment Debt carry value Equity method investment, ownership percentage Equity method investments Investment interest rate Cash in bank Cash deposit per institution insured by FDIC Accumulated deficit Cash collateral total Cumulative earnings deficit Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Investments, Cost basis Investments, Gross Unrealized Gains Investments, Gross Unrealized Losses Investments, Carrying Amount Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Other investments Cash Total assets Total liabilities Net investment income General and administrative expenses Net income Schedule of Investments [Table] Schedule of Investments [Line Items] Equity securities, common stock Beginning balance Consideration paid Increase in fair value of convertible note Transfer out Balance, September 30 Decrease in fair value of convertible note Number of shares issued Number of shares issued, value Sale of stock number of shares sold Equity method investments Equity method investment realized gain (loss) Gain loss on investments Undistributed earnings Investment fund Contributed Increase carrying value of investments Debt instrument interest rate Debt instrument maturity date Shares issued price per share Senior unsecured promissory note Debt instrument principal amount Accrued interest Proceeds from issuance of common stock Fair value of note Schedule Of Changes In Outstanding Loss And Loss Adjustment Expense Reserves Balance, beginning of period, net of reinsurance Incurred related to: Current year Prior year Paid related to: Current year Prior years Balance, September 30, net of reinsurance Income tax rate Provision for taxes at U.S. statutory marginal income tax rate of 21% Valuation allowance for deferred tax assets deemed unrealizable Non-deductible expenses associated with the Share Repurchase Transaction Share-based compensation Income tax benefit Deferred income tax assets: Net operating loss carryforward Loss and loss adjustment expense reserves Unearned premium reserves Capital loss carryforward Share-based compensation Investments Other Deferred income tax assets Less: Valuation allowance Deferred income tax assets net of valuation allowance Deferred income tax liabilities: Investments Deferred policy acquisition costs Deferred income tax liabilities Net deferred income tax asset (liability) Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Deferred tax assets, gross Deferred tax liabilities Deferred tax valuation allowances Operating Loss Carryforwards Number of Non-vested Units, Beginning balance Weighted Average Grant Date Fair Value, Beginning balance Number of Non-vested Units, Granted Weighted Average Grant Date Fair Value, Granted Number of Non-vested Units, Vested Weighted Average Grant Date Fair Value, Vested Number of Non-vested Units, Forfeited Weighted Average Grant Date Fair Value, Forfeited Number of Non-vested Units, Ending balance Weighted Average Grant Date Fair Value, Ending balance Expected volatility Expected life (years) Risk-free interest rate Dividend yield Shares, Outstanding, Beginning balance Weighted Average Exercise Price, Outstanding, Beginning balance Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance Aggregate Intrinsic Value, Outstanding, Beginning balance Shares, Exercisable, Beginning balance Weighted Average Exercise Price, Exercisable, Beginning balance Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance Aggregate Intrinsic Value, Exercisable, Beginning balance Shares, Granted Weighted Average Exercise Price, Granted Weighted Average Grant date Fair Value, Granted Aggregate Intrinsic Value, Granted Shares, Exercised Weighted Average Exercise Price, Exercised Weighted Average Grant date Fair Value, Exercised Aggregate Intrinsic Value, Exercised Shares, Cancelled Weighted Average Exercise Price, Cancelled Weighted Average Grant date Fair Value, Cancelled Aggregate Intrinsic Value, Cancelled Shares, Outstanding, Ending balance Weighted Average Exercise Price, Outstanding, Ending balance Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance Weighted Ave Grant Date Fair Value, Outstanding, Ending balance Aggregate Intrinsic Value, Outstanding, Ending balance Shares, Exercisable, Ending balance Weighted Average Exercise Price, Exercisable, Ending balance Weighted Ave Grant Date Fair Value, Exercisable, Ending balance Aggregate Intrinsic Value, Exercisable, Ending balance Number of share available for issuance ESPP Plan, description Number of restricted stock issued Number of restricted units granted Grant an additional stock options Number of shares issued Exercise price of shares Stock option,description Stock option service period Share-based payment arrangement, expense Unrecognized stock based compensation expense Warrants outstanding Exercise price of warrants Investment ownership percentage Shared services fee Net income from continuing operations Dividends declared on Series A Preferred Shares Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations Weighted average common shares Income (loss) per common share from continuing operations Weighted average common shares outstanding Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities outstanding Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Lease term Payments for rent Rent expense Lessee discount rate Operating asset and lease liability Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Net investment income (loss) Total revenue Income (loss) before income tax Segment assets Schedule of Cash and Cash Equivalents [Table] Cash and Cash Equivalents [Line Items] Number of operating segments Unrestricted cash Funds deposited for benefit of reinsured companies. obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Net Losses And Loss Adjustment Expenses. Increase in investment without readily determinable fair value Increase in fair value of convertible note. Increase decrease in fundsDdeposited with reinsured companies. Equity securities in oppfi received in connection with fg special situations fund unwind Dividends declared on Series A Preferred Shares. Cumulative effect of adoption of accounting guidance for expected credit losses. Fundamental Global Investor [Member] FG Merger Corp [Member] FG Acquisition Corp [Member] FG Communities Inc [Member] Fundamental Global Asset Management, LLC [Member]. FG MergerInvestors LLC [Member] FGAC Investors LLC [Member] Green first Forest Products LLC [Member] Greenfirst Forest Products Holdings LLC [Member] Opp Fi [Member] Variable Interest Entity [Member] Other Investment [Policy Text Block] Current Expected Credit Loss [Policy Text Block] Loss And Loss Adjustment Expense Reserves [Policy Text Block] Investments And Fair Value Disclosures [Text Block] OppFi Common Stock [Member] Hagerty Common Stock [Member] FG SPAC Partners LP [Member] FGMP [Member] Investment Fund [Member] FG Merger Investors [Member] Equity Method Investment [Member] I Core Connect Inc [Member] Craveworthy [Member] ThinkMarkets Convertible Note [Member] Consideration paid Transfer out. Loss And Loss Adjustment Expense Reserves [Text Block] Incurred related to [Abstract] Incurred related to: Prior years. Paid related to [Abstract] Paid related to: Prior years. Income tax expense benefit from continuing and discontinued operations. Expire on December 31, 2039 [Member] Expire on December 31, 2040 [Member] Expire on December 31, 2041 [Member] Not Expire Under Current Tax Law [Member] Expire on December 2026 [Member] 2021 Incentive Plan [Member] Amendment 2021 Incentive Plan [Member] Employee stock purchase plan description. Non Employee Director [Member] Larry G. Swets Jr [Member] Equity Award Letter Agreement [Member]. Employee Director [Member] Twenty Twenty One Equity Incentive Plan [Member] Stock Option Agreement [Member] Stock option, description. 2014 Equity Incentive Plan [Member] Sharebased Compensation Arrangement years. Share based compensation arrangement by share based payment award options outstanding weighted average grant date fair value. Weighted ave grant date fair value, exercisable. Weighted Average Grant date Fair Value, Exercised. Share based compensation arrangement by share based payment award options cancelled in period weighted average grant date fair value. Aggregate Intrinsic Value, Granted. Joint Venture Agreement [Member] Fundamental Global Asset Management [Member] Think Makets [Member] Shared services fee. Shared Services Agreement [Member] Fundamental Global Management, LLC [Member] Weighted average common shares outstanding. Warrants to purchase common stock [Member] Lease Agreement [Member] Operating asset and lease liability. Unrestricted Cash [Member] Insurance [Member] Asset Management [Member] Number of active reinsurance contracts. ThinkMarkets [Member] Realized Gain (Loss) on Common Stock [Member] Change in Unrealized Holding on Common Stock [Member] Equity Method Earnings [Member] Opfi Common Stock [Member] NonExecutive Members [Member] Mr. Swets [Member] Decrease (Increase) in Fair Value of Convertible Note [Member] Increase in Investments Without Readily Determinable Fair Value [Member] Other [Member] Convertible Promissory Note [Member] Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity RevenuesFromContractWithCustomerExcludingAssessedTax Operating Expenses Net Income (Loss) Available to Common Stockholders, Basic Equity, Attributable to Parent Shares, Outstanding Unrealized Gain (Loss) on Investments Income (Loss) from Equity Method Investments IncreaseInInvestmentWithoutReadilyDeterminableFairValue Gain (Loss) on Sale of Other Investments Increase (Decrease) in Insurance Settlements Receivable IncreaseDecreaseInFundsDepositedWithReinsuredCompanies Increase (Decrease) in Deferred Policy Acquisition Costs Increase (Decrease) in Other Operating Assets Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Increase (Decrease) in Unearned Premiums Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Equity Method Investments Payments to Acquire Other Investments Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Preferred Stock and Preference Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Income Tax, Policy [Policy Text Block] LossAndLossAdjustmentExpenseReservesPolicyTextBlock Other Investments [Default Label] Investment Income, Net Gross Profit Reinsurance Recoverables, Gross Reinsurance Recoverable, Credit Loss Expense (Reversal) Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Deferred Tax Assets, Investments Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities, Investments Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost Deferred Tax Liabilities, Gross Deferred Tax Assets, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value EX-101.PRE 10 fgf-20230930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 09, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-36366  
Entity Registrant Name FG Financial Group, Inc.  
Entity Central Index Key 0001591890  
Entity Tax Identification Number 46-1119100  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 104 S. Walnut Street  
Entity Address, Address Line Two Unit 1A  
Entity Address, City or Town Itasca  
Entity Address, State or Province IL  
Entity Address, Postal Zip Code 60143  
City Area Code (847)  
Local Phone Number 773-1665  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,558,930
Common Stock, $0.001 par value per share    
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol FGF  
Security Exchange Name NASDAQ  
8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share    
Title of 12(b) Security 8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share  
Trading Symbol FGFPP  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
ASSETS    
Equity securities, at fair value (cost basis of $1,916 and $889, respectively) $ 2,187 $ 841
Other investments 27,365 24,839
Cash and cash equivalents 5,525 3,010
Deferred policy acquisition costs 1,480 1,527
Reinsurance balances receivable (net of current expected losses allowance of $84 and zero, respectively) 14,469 9,269
Funds deposited with reinsured companies 7,075 9,277
Other assets 727 712
Total assets 58,828 49,475
LIABILITIES    
Loss and loss adjustment expense reserves 5,912 4,409
Unearned premium reserves 9,394 6,823
Accounts payable and accrued expenses 720 723
Other liabilities 135 225
Total liabilities 16,161 12,180
Commitments and contingencies (Note 10)
SHAREHOLDERS’ EQUITY    
Series A Preferred Shares, $25.00 par and liquidation value, 1,000,000 shares authorized; 894,580 shares issued and outstanding as of September 30, 2023 and December 31, 2022 22,365 22,365
Common stock, $0.001 par value; 100,000,000 shares authorized; 10,303,739 and 9,410,473 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 10 9
Additional paid-in capital 52,781 50,021
Accumulated deficit (32,489) (35,100)
Total shareholders’ equity 42,667 37,295
Total liabilities and shareholders’ equity $ 58,828 $ 49,475
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Equity securities, cost basis $ 1,916 $ 889
Reinsurance losses allowance $ 84 $ 0
Series A preferred stock, par value $ 25.00 $ 25.00
Series A preferred stock, shares authorized 1,000,000 1,000,000
Series A preferred stock, shares issued 894,580 894,580
Series A preferred stock, shares outstanding 894,580 894,580
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 10,303,739 9,410,473
Common stock, shares Outstanding 10,303,739 9,410,473
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue:        
Net premiums earned $ 4,192 $ 4,383 $ 11,534 $ 9,809
Net investment income 6,961 11,174 8,272 5,114
Other income 24 214 84 266
Total revenue 11,177 15,771 19,890 15,189
Expenses:        
Net losses and loss adjustment expenses 2,205 2,406 6,081 5,798
Amortization of deferred policy acquisition costs 1,003 1,109 2,533 2,427
General and administrative expenses 2,341 2,001 7,221 6,009
Total expenses 5,549 5,516 15,835 14,234
Net income 5,628 10,255 4,055 955
Dividends declared on Series A Preferred Shares 447 447 1,339 1,342
Income (loss) attributable to FG Financial Group, Inc. common shareholders $ 5,181 $ 9,808 $ 2,716 $ (387)
Basic net income (loss) per common share $ 0.50 $ 1.05 $ 0.28 $ (0.05)
Diluted net income (loss) per common share $ 0.50 $ 1.05 $ 0.28 $ (0.05)
Weighted average common shares outstanding:        
Basic 10,303,739 9,333,709 9,813,438 7,564,017
Diluted 10,303,739 9,333,709 9,813,438 7,564,017
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 22,365 $ 6 $ 46,037 $ (34,399) $ 34,009
Beginning balance, shares at Dec. 31, 2021 894,580 6,497,205      
Stock based compensation $ 1 62 63
Stock based compensation, shares   30,796      
Dividends declared on Series A Preferred Shares ($0.50 per share) (447) (447)
Net income (loss) (3,823) (3,823)
Ending balance, value at Mar. 31, 2022 $ 22,365 $ 7 46,099 (38,669) 29,802
Ending balance, shares at Mar. 31, 2022 894,580 6,528,001      
Beginning balance, value at Dec. 31, 2021 $ 22,365 $ 6 46,037 (34,399) 34,009
Beginning balance, shares at Dec. 31, 2021 894,580 6,497,205      
Net income (loss)         955
Ending balance, value at Sep. 30, 2022 $ 22,365 $ 9 50,104 (34,786) 37,692
Ending balance, shares at Sep. 30, 2022 894,580 9,394,040      
Beginning balance, value at Mar. 31, 2022 $ 22,365 $ 7 46,099 (38,669) 29,802
Beginning balance, shares at Mar. 31, 2022 894,580 6,528,001      
Stock based compensation 53 52
Dividends declared on Series A Preferred Shares ($0.50 per share) (447) (447)
Net income (loss) (5,478) (5,478)
Common stock issuance $ 2 3,781 3,784
Common stock issuance, shares   2,750,000      
Ending balance, value at Jun. 30, 2022 $ 22,365 $ 9 49,933 (44,594) 27,713
Ending balance, shares at Jun. 30, 2022 894,580 9,278,001      
Stock based compensation 65 65
Stock based compensation, shares   44,269      
Dividends declared on Series A Preferred Shares ($0.50 per share) (447) (447)
Net income (loss) 10,255 10,255
Common stock issuance 106 106
Common stock issuance, shares   71,770      
Ending balance, value at Sep. 30, 2022 $ 22,365 $ 9 50,104 (34,786) 37,692
Ending balance, shares at Sep. 30, 2022 894,580 9,394,040      
Beginning balance, value at Dec. 31, 2022 $ 22,365 $ 9 50,021 (35,100) 37,295
Beginning balance, shares at Dec. 31, 2022 894,580 9,410,473      
Stock based compensation 641 641
Stock based compensation, shares   1,080      
Dividends declared on Series A Preferred Shares ($0.50 per share) (447) (447)
Net income (loss) 1,350 1,350
Common stock issuance     74   74
Common stock issuance, shares   27,186      
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023       (106) (106)
Ending balance, value at Mar. 31, 2023 $ 22,365 $ 9 50,736 (34,303) 38,807
Ending balance, shares at Mar. 31, 2023 894,580 9,438,739      
Beginning balance, value at Dec. 31, 2022 $ 22,365 $ 9 50,021 (35,100) 37,295
Beginning balance, shares at Dec. 31, 2022 894,580 9,410,473      
Net income (loss)         4,055
Ending balance, value at Sep. 30, 2023 $ 22,365 $ 10 52,781 (32,489) 42,667
Ending balance, shares at Sep. 30, 2023 894,580 10,303,739      
Beginning balance, value at Mar. 31, 2023 $ 22,365 $ 9 50,736 (34,303) 38,807
Beginning balance, shares at Mar. 31, 2023 894,580 9,438,739      
Stock based compensation 361 361
Dividends declared on Series A Preferred Shares ($0.50 per share) (444) (444)
Net income (loss) (2,923) (2,923)
Common stock issuance $ 1 1,205 1,206
Common stock issuance, shares   865,000      
Ending balance, value at Jun. 30, 2023 $ 22,365 $ 10 52,302 (37,670) 37,007
Ending balance, shares at Jun. 30, 2023 894,580 10,303,739      
Stock based compensation 479 479
Dividends declared on Series A Preferred Shares ($0.50 per share) (447) (447)
Net income (loss) 5,628 5,628
Ending balance, value at Sep. 30, 2023 $ 22,365 $ 10 $ 52,781 $ (32,489) $ 42,667
Ending balance, shares at Sep. 30, 2023 894,580 10,303,739      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares
3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]            
Preferred stock dividends per share cash paid $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 4,055 $ 955
Adjustments to reconcile net loss to net cash used by operating activities:    
Net unrealized holding (gain) on equity investments (319) (10,521)
(Income) from equity method investments, net of distributions received (4,192) (2,880)
(Increase) in investment without a readily determinable fair value (250)
(Increase) in fair value of convertible note (125)
Net realized (gain) loss on sale of equity investments (3,062) 11,263
Stock compensation expense 1,481 180
Changes in operating assets and liabilities:    
Reinsurance balances receivable (5,307) (3,857)
Funds deposited with reinsured companies 2,202 (2,237)
Deferred policy acquisition costs 47 (1,134)
Other assets (42) (121)
Loss and loss adjustment expense reserves 1,503 2,000
Unearned premium reserves 2,571 2,955
Accounts payable, accrued expenses and other liabilities (92) (544)
Net cash used by operating activities (1,530) (3,941)
Cash flows from investing activities:    
Purchases of furniture and equipment (77)
Purchases of equity method investments (495) (6,795)
Purchases of other investments (950)
Distribution from equity method investments 761 1,521
Proceeds from sales of equity securities 4,604 664
Return of capital – other investments 184 185
Net cash provided (used) by investing activities 4,104 (4,502)
Cash flows from financing activities:    
Payment of dividends on preferred shares (1,339) (1,341)
Proceeds from issuance of common stock, net 1,280 3,889
Net cash (used) provided by financing activities (59) 2,548
Net increase (decrease) in cash and cash equivalents 2,515 (5,895)
Cash and cash equivalents at beginning of period 3,010 15,542
Cash and cash equivalents at end of period 5,525 9,647
Non-Cash Investing Transactions:    
Equity securities in OppFi received in connection with FG Special Situations Fund unwind $ 1,916
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Business
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Business

Note 1. Nature of Business

 

FG Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss-capped reinsurance, while allocating capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also provides asset management services.

 

From our inception in October 2012 through December 2019, we operated as an insurance holding company, writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three former insurance subsidiaries to FedNat Holding Company (“FedNat”) for a combination of cash and FedNat common stock, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.

 

As of September 30, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity, collectively beneficially owned approximately 55% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.

 

Reincorporation

 

Effective at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the “Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws. The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.

 

Other than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management, assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management.

 

The Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00% Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”

 

Current Business

 

Our strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking activities with asymmetrical risk/reward opportunities. As part of our refined focus, we have adopted the following capital allocation philosophy:

 

Grow intrinsic value per share with a long-term focus using fundamental research, allocating capital to asymmetric risk/reward opportunities.”

 

Currently, the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special Purpose Acquisition Corporation “SPAC” Platform businesses, and our merchant banking division.

 

 

Insurance

 

Sponsor Protection Coverage and Risk, Inc. has been formed as a special purpose captive in South Carolina to provide reinsurance coverage for Sides A, B, & C Directors and Officers Liability insurance coverage for related and unrelated entities of FG Reinsurance Ltd (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as small cap businesses performing an initial public offering. Sponsor Protection Coverage and Risk, Inc. has yet to write any business.

 

Reinsurance

 

The Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised) of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”). The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which are not fully collateralized.

 

As of September 30, 2023, the Company had seven active reinsurance contracts, including participating in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate during the 2021, 2022 and 2023 calendar years.

 

Asset Management

 

FG Strategic Consulting, LLC, (“FGSC”) a wholly owned subsidiary of the Company, looks to provide investment advisory services, including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization, recommending investment dispositions, and providing advice regarding macro-economic conditions.

 

SPAC Platform and Merchant Banking

 

On December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company, to facilitate the launch of our “SPAC Platform.” Under the SPAC Platform, we provide various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs.

 

In the third quarter of 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division.

 

 

In the fourth quarter of 2022, the Company invested $2.0 million into its first merchant banking project, FG Communities, Inc. (“FGC”). FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies

Note 2. Significant Accounting Policies

 

Basis of Presentation

 

These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Consolidation Policies

 

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

The consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that could potentially be significant to the legal entity.

 

The determination of whether a legal entity is consolidated under either model is reassessed where there is a substantive change in the governing documents or contractual arrangements of the entity, to the capital structure of the entity or in the activities of the entity. The Company continuously reassesses whether it should consolidate under either model.

 

In September 2020, the Company invested approximately $5.0 million to sponsor the launch of the FG Special Situations Fund, LP (“The Fund”). The Fund, a VIE which the Company was required to consolidate through November 30, 2021, was considered an investment company for GAAP purposes and followed the accounting and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus, began to account for its investment in the Fund under the equity method of accounting.

 

During the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, Greenfirst Forest Products Holdings LLC, and OppFi. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $8.9 million, FG Merger Investors LLC, with a carrying value of $3.4 million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $1.4 million. The carrying value of these direct limited partner interests approximate to ownership of 29% of FGAC Investors LLC, 19% of FG Merger Investors LLC, and 16% of Greenfirst Forest Products Holdings, LLC. The Fund also distributed OppFi publicly traded securities to the Company with a carrying value of $1.9 million.

 

As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. The Company has determined that each of these entities meets the criteria of a VIE. For each new position, the Company analyzed ASC 810 – Consolidation and has determined it is not the primary beneficiary of FGAC Investors LLC, FG Merger Investors LLC or Greenfirst Forest Products Holdings LLC, but does have the ability to exercise significant influence over each of these. Therefore, the Company will apply the equity method of accounting for each of these investments.

 

 

In October of 2022, the Company invested $2.0 million into FGC, which the Company has determined meets the criteria of a VIE. The Company holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not the primary beneficiary of FGC, and thus does not consolidate FGC.

 

The Company’s risk of loss associated with its non-consolidated VIEs is limited. As of September 30, 2023, and December 31, 2022, the carrying value and maximum loss exposure of the Company’s non-consolidated VIE’s was $16.5 million and $18.8 million, respectively.

 

See Note 4 for further information regarding the Company’s investments.

 

The Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying consolidated financial statements include the valuation of our equity method investments, current expected credit losses, the valuation of net deferred income taxes and deferred policy acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.

 

Investments in Equity Securities

 

Investments in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations as a component of net investment income.

 

Other Investments

 

Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses more than 20% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock and to other investments when such other investments possess substantially identical subordinated interests to common stock.

 

In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our claim on the investee’s book value.

 

When we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods, with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative equity in earnings represent returns on investment and are classified as cash inflows from investing activities.

 

 

In addition to investments accounted for under the equity method of accounting, other investments also consist of equity we have purchased in a limited partnership, a limited liability company, and a corporation for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an asset measured at fair value on a nonrecurring basis. Any profit distributions the Company receives on these investments are included in net investment income.

 

Other investments also include a convertible note and a senior unsecured promissory note.

 

See Note 4 for additional information regarding the Company’s investments.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.

 

Pursuant to the Company’s insurance license, the Authority has required that FGRe hold a minimum capital requirement of $200,000 in cash in a bank in the Cayman Islands which holds an “A” license issued under the Banks and Trust Companies Act (2020 Revision).

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).

 

Concentration of Credit Risk

 

Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $250,000. As of September 30, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.

 

Premium Revenue Recognition

 

The Company participates in quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.

 

 

Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represents estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.

 

Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.

 

Current Expected Credit Loss

 

In the first quarter of 2023, the Company adopted ASU 2016-13, as amended, Financial Instruments – Credit Losses (“ASU 2016-13”), which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The financial assets included in the caption “Reinsurance balances recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. The amendments in this update were effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted, however smaller reporting companies, like the Company, could delay adoption until January 2023. Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $0.1 million as of January 1, 2023. The Company updates the model each quarter and adjusts the balance accordingly. There was no change to the allowance during the third quarter.

 

In the first quarter of 2023, the Company allocated $200,000 into a promissory note. The promissory note is carried at amortized cost on the Company’s consolidated balance sheet under the caption “other investments.” Due to being held at amortized cost, the promissory note falls into the scope of ASU 2016-13. Due to immateriality, the Company does not have a current expected credit allowance against the promissory note.

 

Deferred Policy Acquisition Costs

 

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.

 

Funds Deposited for Benefit of Reinsured Companies

 

“Funds Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held to support our reinsurance contracts. As of September 30, 2023 and December 31, 2022, the total cash collateral posted to support all of our reinsurance treaties was approximately $7.1 million and $9.3 million, respectively.

 

 

Loss and Loss Adjustment Expense Reserves

 

The Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports the Company has received from ceding companies. The Company then uses a variety of statistical and actuarial techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures and projected ultimate premium to be written by our cedants; (2) expected loss ratios by type of business; (3) actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions. The Company also engages independent actuarial specialists, at least annually, to assist management in establishing appropriate reserves. Since reserves are estimates, the final settlement of losses may vary from the reserves established, and any adjustments to the estimates, which may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the reserves recorded.

 

U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.

 

Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.

 

Stock-Based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – Stock Compensation, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period, which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.

 

The Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which vest solely based upon the passage of time. The fair value of each RSU is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest.

 

Based upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock compensation expense for expected forfeitures as of September 30, 2023.

 

Fair Value of Financial Instruments

 

The carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other accrued expenses, approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s financial instruments.

 

 

Earnings (Loss) Per Common Share

 

Basic earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.

 

Diluted earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings (loss) per share if their effect is anti-dilutive.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Recently Adopted and Issued Accounting Standards
9 Months Ended
Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract]  
Recently Adopted and Issued Accounting Standards

Note 3. Recently Adopted and Issued Accounting Standards

 

Accounting Standards Adopted

 

As discussed, the Company adopted ASU 2016-13 during the first quarter of 2023 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $0.1 million as of January 1, 2023.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Investments and Fair Value Disclosures
9 Months Ended
Sep. 30, 2023
Investments And Fair Value Disclosures  
Investments and Fair Value Disclosures

Note 4. Investments and Fair Value Disclosures

 

The following table summarizes the Company’s equity securities held at fair value as of September 30, 2023 and December 31, 2022:

 

(in thousands)                
As of September 30, 2023  Cost Basis  

Gross

Unrealized

Gains

  

Gross

Unrealized

Losses

  

Carrying

Amount

 
OppFi common stock and warrants  $1,916   $    271   $         -   $2,187 
Total investments  $1,916   $271   $-   $2,187 

 

As of December 31, 2022  Cost Basis  

Gross

Unrealized

Gains

  

Gross

Unrealized

Losses

  

Carrying

Amount

 
Hagerty common stock  $889   $   $48   $841 
Total investments  $889   $            $      48   $841 

 

OppFi Common Stock

 

As a result of the Fund unwinding, the Company received approximately 860,000 shares of OppFi common stock. On the date of the distribution, the common shares had an aggregate fair value of approximately $1.9 million.

 

Hagerty Common Stock

 

On December 15, 2022, FGMP distributed 99,999 common shares of Hagerty to the Company. On the date of distribution, the common shares had an aggregate fair value of approximately $889,000. The Company sold the common shares during the first quarter of 2023 for a realized loss of approximately $16,000.

 

Equity Method Investments

 

Other investments on the Company’s consolidated balance sheets include our equity method investments in FGMP, FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings LLC.

 

 

On January 4, 2021, FGMP was formed as a Delaware limited partnership to co-sponsor newly formed SPACs with their founders or partners, as well as other merchant banking interests. The Company is the sole managing member of the general partner of FGMP and holds a limited partner interest of approximately 46% in FGMP directly and through its subsidiaries. FGMP participates as a co-sponsor of the SPACs launched under our SPAC Platform as well as merchant banking initiatives.

 

For the three months ended September 30, 2023, the Company recorded equity method gains from FGMP of approximately $1.2 million. No capital contributions were made to FGMP during the quarter. For the nine months ended September 30, 2023, the Company contributed $0.1 million into FGMP and has recorded equity method gains of approximately $4.1 million. The carrying value of our investment in FGMP as of September 30, 2023 was approximately $9.9 million compared to $5.7 million as of December 31, 2022. Of the $9.9 million carrying value of our investment in FGMP at September 30, 2023 the Company may allocate up to approximately $0.4 million to incentivize and compensate individuals and entities for the successful merger of SPACs launched under our platform.

 

Equity method investments previously included our investment in the Fund. However, during the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings LLC. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $8.9 million, FG Merger Investors LLC, with a carrying value of $3.4 million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $1.4 million. The Company determined that it has the ability to exercise significant influence over FGAC Investors LLC, FG Merger Investors LLC and Greenfirst Forest Products Holdings LLC, and thus will account for each of these investments under the equity method of accounting. After taking into account second quarter equity pickups, the combined carrying value of these investments at June 30, 2023 was approximately $11.9 million. For the three months ended September 30, 2023, the Company contributed $0.5 million into FG Merger Investors LLC, and recorded an equity method gain of approximately $2.4 million. The Company recorded an equity method loss from Greenfirst Forest Products Holdings LLC of approximately $0.1 million and a gain of $0.1 million from FGAC Investors LLC for the three months ended September 30, 2023. The combined carrying value of these investments at September 30, 2023 was approximately $14.7 million.

 

Financial information for our investments accounted for under the equity method, in the aggregate, is as follows:

 

  

As of
September 30,
2023

   As of
December 31, 2022
 
(in thousands)          
Other investments  $72,585   $35,366 
Cash   275    113 
Other assets   177    165 
Total assets   73,037    35,644 
           
Total liabilities   439    65 

 

  

Nine months ended

September 30, 2023

  

Nine months ended

September 30, 2022

 
(in thousands)          
Net investment income  $17,417   $8,170 
Other income   129    - 
General and administrative expenses   (1,149)   (95)
Net income    16,397    8,075 

 

 

Certain investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing equity for SPACs that have not yet closed.

 

Investments without Readily Determinable Fair Value

 

In addition to our equity method investments, other investments, as listed on our consolidated balance sheets, consist of equity we have purchased in companies for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Any profit distributions the Company receives on these investments are included in net investment income.

 

The carrying value of investments without readily determinable fair value were increased by $0.3 million for the nine months ended September 30, 2023, as compared to zero for the nine months ended September 30, 2022. The increase was due to an observable price change in FGC during the second quarter of 2023. This amount is included in net investment income on the Company’s consolidated statements of operations. The Company did not record any changes during the three months ended September 30, 2023, and September 30, 2022. The Company’s total carrying value in investments without a readily determinable fair value was $2.3 million as of September 30, 2023, compared to approximately $2.3 million as of December 31, 2022.

 

Other

 

Other investments, in addition to equity method investments and investments without readily determinable fair value, include a convertible promissory note and a senior unsecured promissory note.

 

On September 29, 2023, the Company invested $250,000 in a convertible promissory note with ThinkMarkets. The promissory note has an interest rate of 15% annually, with interest payments due monthly, and matures on August 1, 2025. Commencing upon the closing of the contemplated business combination, the Company has the option to convert any unpaid loan amount and all accrued and unpaid interest into fully paid shares of FGAC common stock, at a conversion price of $5.00 per share. The Company evaluated the convertible promissory note’s settlement provisions and elected the fair value option to value this instrument. Under the fair value election, the convertible promissory note is measured initially and subsequently at fair value, which as of September 30, 2023, both are calculated to be $250,000.

 

On March 16, 2023, the Company invested $200,000 in a senior unsecured loan to Craveworthy LLC (“Craveworthy”). The loan has an interest rate of 13% and a maturity of March 15, 2024. The $200,000 principal and any interest accrued may be prepaid voluntarily by Craveworthy but is not required to be paid until the date of maturity. As of September 30, 2023, the entire principal amount of $200,000 as well as approximately $15,000 of accrued interest was outstanding.

 

On March 15, 2023, the Company invested $500,000 in a convertible promissory note with iCore. During the third quarter, the Company elected to convert all unpaid principal and interest due from the convertible promissory note with iCore into fully paid common shares of iCore. As part of the conversion, the Company received approximately 219,000 common shares of iCore. During the third quarter, the Company sold all of the common shares received from conversion for approximately $3.7 million in cash proceeds, resulting in a realized gain of approximately $3.1 million.

 

Impairment

 

For equity securities without readily determinable fair values, impairment is determined via a qualitative assessment which considers indicators to evaluate whether the investment is impaired. Some of these indicators include a significant deterioration in the earnings performance or asset quality of the investee, a significant adverse change in regulatory, economic or general market conditions in which the investee operates, or doubt over an investee’s ability to continue as a going concern. If the investment is deemed to be impaired after conducting this analysis, the Company would estimate the fair value of the investment to determine the amount of impairment loss.

 

 

For equity method investments, evidence of a loss in value might include a series of operating losses of an investee, the absence of an ability to recover the carrying amount of the investment, or a deterioration in the value of the investee’s underlying assets. If these, or other indicators lead to the conclusion that there is a decrease in the value of the investment that is other than temporary, the Company would recognize that decrease in value even though the decrease may be in excess of what would otherwise be recognized under the equity method of accounting.

 

The risks and uncertainties inherent in the assessment methodology used to determine impairment include, but may not be limited to, the following:

 

  the opinions of professional investment managers and appraisers could be incorrect;
     
  the past operating performance and cash flows generated from the investee’s operations may not reflect their future performance; and
     
  the estimated fair values for investment for which observable market prices are not available are inherently imprecise.

 

We have not recorded an impairment on our investments for either of the nine months ended September 30, 2023 and 2022.

 

Net investment income for the three and nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022   2023   2022 
($ in thousands)  Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
Investment income:                    
Realized gain (loss) on common stock  $3,078   $(2,472)  $3,062   $(11,441)
Change in unrealized holding on common stock   404    2,448    319    10,521 
Equity method earnings   3,460    11,226    4,192    6,080 
Increase in investments without readily determinable fair value   -    -    250    - 
(Decrease) increase in fair value of convertible note   (52)   -    125    - 
Other   71    (28)   324    (46)
Net investment income  $6,961   $11,174   $8,272   $5,114 

 

Fair Value Measurements

 

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. The FASB has issued guidance that defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal, or most advantageous market in an orderly transaction between market participants. This guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance categorizes assets and liabilities at fair value into one of three different levels depending on the observation of the inputs employed in the measurements, as follows:

 

  Level 1 – inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets providing the most reliable measurement of fair value since it is directly observable.
     
  Level 2 – inputs to the valuation methodology which include quoted prices for similar assets or liabilities in active markets. These inputs are observable, either directly or indirectly, for substantially the full-term of the financial instrument.

 

 

  Level 3 – inputs to the valuation methodology which are unobservable and significant to the measurement of fair value.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a variety of factors, including the type of investment, whether the investment is new and not yet established in the marketplace, the liquidity of markets and other characteristics specific to the individual investment. In some cases, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the hierarchy based on the lowest level input that is significant to the fair value measurement. When determining fair value, the Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.

 

Financial instruments measured, on a recurring basis, at fair value as of September 30, 2023 and December 31, 2022 in accordance with the guidance promulgated by the FASB are as follows.

 

 

(in thousands)                
                 
As of September 30, 2023  Level 1   Level 2   Level 3   Total 
Oppfi common stock and warrants  $2,187   $   $   $2,187 
ThinkMarkets convertible note  $        250    250 
   $2,187   $   $250   $2,437 
                     
As of December 31, 2022                    
Hagerty common stock  $841   $   $   $841 
   $841   $   $   $841 

 

On September 29, 2023, the Company invested $250,000 in a convertible promissory note with ThinkMarkets. As of September 30, 2023, the Company approximates the fair value of the note to be $250,000.

 

The following tables provide a reconciliation of the fair value of recurring Level 3 fair value measurements for the three- and nine-months ended September 30, 2023 and September 30, 2022:

 

   2023   2022 
(in thousands)  Nine months ended September 30, 
   2023   2022 
Assets:        
Convertible note          
Beginning balance   -    - 
Consideration paid   750    - 
Increase in fair value of convertible note   125    - 
Transfer out   (625)     
Balance, September 30  $250   $- 

 

   2023   2022 
(in thousands)  Three months ended September 30, 
   2023   2022 
Assets:        
Convertible note          
Beginning balance   677    - 
Consideration paid   250    - 
Decrease in fair value of convertible note   (52)   - 
Transfer out   (625)     
Balance, September 30  $250   $- 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Loss and Loss Adjustment Expense Reserves
9 Months Ended
Sep. 30, 2023
Loss And Loss Adjustment Expense Reserves  
Loss and Loss Adjustment Expense Reserves

Note 5. Loss and Loss Adjustment Expense Reserves

 

A significant degree of judgment is required to determine amounts recorded in the consolidated financial statements for the provision for loss and loss adjustment expense (“LAE”) reserves. The process for establishing this provision reflects the uncertainties and significant judgmental factors inherent in predicting future results of both known and unknown loss events. The process of establishing the provision for loss and LAE reserves relies on the judgment and opinions of many individuals, including the opinions of the Company’s management, as well as the management of ceding companies and their actuaries.

 

 

In estimating losses, the Company may assess any of the following:

 

  a review of in-force treaties that may provide coverage and incur losses;
  general forecasts, catastrophe and scenario modelling analyses and results shared by cedents;
  reviews of industry insured loss estimates and market share analyses;
  management’s judgment; and
  loss development factor selections, initial expected loss ratio selections, and weighting of methods used

 

Under the terms of certain of our quota-share agreements, and due to the nature of claims and premium reporting, a lag exists between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. The reports we receive from our cedents have pre-determined due dates. In the case of the Company’s FAL contracts, third quarter 2023 premium and loss information will not be made available to the Company until subsequent to the filing of this quarterly report. Thus, our third quarter results, including the loss and loss adjustment expense reserves presented herein, have been based upon a combination of actual results from the 2023 calendar year as well as forecasts for 2023 reported to us by the ceding companies. We have approximated third quarter 2023 results under our FAL contracts based upon this historical and forecasted information.

 

While the Company believes its estimate of loss and loss adjustment expense reserves are adequate as of September 30, 2023, based on available information, actual losses may ultimately differ materially from the Company’s current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information is provided.

 

A summary of changes in outstanding loss and loss adjustment expense reserves for the nine months ended September 30, 2023 and 2022, is as follows:

 

   2023   2022 
(in thousands)  Nine months ended September 30, 
   2023   2022 
Balance, beginning of period, net of reinsurance  $4,409   $2,133 
Incurred related to:          
Current year   5,420    4,984 
Prior year   661    814 
Paid related to:          
Current year   (3,675)   (2,568)
Prior years   (903)   (1,230)
Balance, September 30, net of reinsurance  $5,912   $4,133 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 6. Income Taxes

 

Actual income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax rates to income before income tax expense as follows:

 

($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Provision for taxes at U.S., statutory marginal income tax rate of 21%  $1,182  $2,154   $852  $201 
Valuation allowance for deferred tax assets deemed unrealizable   (1,200)   (2,168)   (871)   (219)
Non-deductible expenses associated with the Share Repurchase Transaction       2    1    2 
Share-based compensation   18    12    18    16 
Income tax expense (benefit)  $   $   $   $- 

 

 

Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes as compared to the amounts used for income tax purposes. The Company’s gross deferred tax assets and liabilities are $8.0 million and $3.4 million as of September 30, 2023. The Company has recorded a valuation allowance against its deferred tax assets of $4.6 million, as of September 30, 2023, due to the uncertain nature surrounding our ability to realize these tax benefits in the future. Significant components of the Company’s net deferred tax assets are as follows:

 

         
(in thousands)    
  

As of
September 30, 2023

  

As of
December 31, 2022

 
Deferred income tax assets:          
Net operating loss carryforward  $4,670   $4,171 
Loss and loss adjustment expense reserves   52    39 
Unearned premium reserves   395    287 
Capital loss carryforward   2,491    4,313 
Share-based compensation   424    242 
Investments   10    5 
Other   8    9 
Deferred income tax assets  $8,050   $9,066 
Less: Valuation allowance   (4,615)   (5,463)
Deferred income tax assets net of valuation allowance  $3,435   $3,603 
           
Deferred income tax liabilities:          
Investments  $3,125   $3,282 
Deferred policy acquisition costs   310    321 
Deferred income tax liabilities  $3,435   $3,603 
           
Net deferred income tax asset (liability)  $   $ 

 

As of September 30, 2023, the Company had net operating loss carryforwards (“NOLs”) for federal income tax purposes of approximately $22.2 million, which will be available to offset future taxable income. Approximately $0.5 million expire on December 31, 2039, $0.1 million expire on December 31, 2040, and $1.6 million of the Company’s NOLs will expire on December 31, 2041. The remaining $20.0 million of the Company’s NOLs do not expire under current tax law. Additionally, the Company has approximately $11.9 million of capital loss carryforward that can only be used to offset capital gains and which will expire in December 2026 if not used prior.

 

As of September 30, 2023, the Company had no unrecognized tax benefits. The Company analyzed its tax positions in accordance with the provisions of Accounting Standards Codification Topic 740, Income Taxes, and has determined that there are currently no uncertain tax positions. The Company generally recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plan Grants
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plan Grants

Note 7. Equity Incentive Plan Grants

 

On December 15, 2021, our shareholders approved the FG Financial Group, Inc. 2021 Equity Incentive Plan (the “2021 Plan”). The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (or “SARs”), restricted shares, restricted share units, and other share-based awards, and provides for a maximum of 1,500,000 shares available for issuance.

 

 

On March 24, 2023, the Company’s board of directors approved an amendment to the 2021 Plan to increase the number of shares available for issuance from 1,500,000 to 2,000,000.

 

In addition, on March 24, 2023, the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.

 

RSUs Outstanding

 

The following table summarizes RSU activity for the nine months ended September 30, 2023 and 2022:

 

Restricted Stock Units  Number of Units  

Weighted

Average Grant Date Fair Value

 
Non-vested units, January 1, 2023   256,382   $2.57 
Granted   821,974    2.76 
Vested   (227,301)   2.71 
Forfeited        
Non-vested units, September 30, 2023   851,055   $1.40 
           
Non-vested units, January 1, 2022   164,655   $4.35 
Granted   158,225    1.58 
Vested   (50,065)   4.81 
Forfeited        
Non-vested units, September 30, 2022   272,815   $2.66 

 

On August 19, 2022, we issued a total of 158,225 RSUs to our non-employee directors. The RSUs vest in five equal annual installments, beginning with the first anniversary of the grant date.

 

On February 17, 2023, we granted a total of 415,000 RSUs to various members of the Company’s management. The RSUs vest in three equal annual installments, beginning with the date the shares were granted.

 

In the third quarter of 2023, we granted a total of 36,974 RSUs to non-executive members of our Company’s board of directors. The RSU’s vest immediately.

 

On January 18, 2021, the Company entered into an Equity Award Letter Agreement (the “Letter Agreement”) with Mr. Swets, pursuant to which the Company clarified its intention to grant an additional 370,000 stock options, restricted shares or restricted stock units pursuant to a future award, subject to the approval of an amended and/or new equity plan, among other conditions. On February 17, 2023, in satisfaction of the obligations in the letter agreement, the Company granted 370,000 RSUs to Mr. Swets that will vest on the first anniversary of the grant date.

 

Restricted Shares

 

On July 31, 2022, the Company issued 25,000 restricted shares under the 2021 Equity Incentive Plan to an employee of the Company. The restriction was lifted on the first anniversary of the grant date.

 

Stock Options Outstanding

 

On January 12, 2021, in connection with Larry G. Swets, Jr.’s appointment as Chief Executive Officer, the Company entered into a Stock Option Agreement (the “Stock Option”) with Mr. Swets. The Stock Option entitles Mr. Swets to purchase up to 130,000 shares of the Company’s common stock at an exercise price of $3.38 per share. The Stock Option becomes vested and fully exercisable in 20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through each applicable vesting date and that the Company’s book value per share has increased by 15% or more as compared to the Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031.

 

 

The Stock Option contains performance and service conditions that affect vesting. Pursuant to ASC Topic 718- Stock Compensation, these conditions have not been reflected in estimating the fair value of the award upon its grant date; however, the Company employed a Monte-Carlo model to estimate the likelihood of satisfaction of the required performance and service conditions. This resulted in a derived service period of approximately 3.3 years under the grant.

 

In estimating the fair value of the Stock Option, the Company estimated volatility based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the Stock Option. The expected life of the Stock Option is assumed to be equivalent to its contractual term. The dividend rate is based on our historical rate, which the Company anticipates will remain at zero. The following assumptions were used to determine the estimated fair value of the Stock Option:

 

Expected volatility   45.60%
Expected life (years)   10.00 
Risk-free interest rate   5.15%
Dividend yield   0.00%

 

The following table summarizes activity for stock options issued for the nine months ended September 30, 2023 and 2022.

 

Common Stock Options  Shares   Weighted Ave
Exercise Price
   Weighted Ave
Remaining
Contractual
Term (yrs)
   Weighted Ave
Grant Date
Fair Value
   Aggregate Intrinsic Value 
Outstanding, January 1, 2023   130,000   $3.38    8.04   $1.88   $- 
Exercisable, January 1, 2023      $       $   $ 
Granted   -    -              
Exercised                    
Cancelled                    
Outstanding, September 30, 2023   130,000   $3.38    7.29   $1.88   $ 
Exercisable, September 30, 2023      $       $   $ 
                          
Outstanding, January 1, 2022   130,000   $3.38    9.04   $1.88   $49,400 
Exercisable, January 1, 2022      $       $   $ 
Granted                    
Exercised                    
Cancelled                    
Outstanding, September 30, 2022   130,000   $3.38    8.29   $1.88   $ 
Exercisable, September 30, 2022      $       $   $ 

 

Total stock-based compensation expense for the nine months ended September 30, 2023 and 2022 was approximately $1.5 million and $180,000, respectively. As of September 30, 2023, total unrecognized stock compensation expense of approximately $1.8 million remains, which will be recognized through December 31, 2026. Stock compensation expense has been reflected in the Company’s financial statements as part of general and administrative expense.

 

Warrants

 

No warrants were granted or exercised during the nine months ended September 30, 2023 and 2022. On February 24, 2022, 1,500,000 warrants with an exercise price of $15.00 expired. As of September 30, 2023, the Company did not have any warrants outstanding.

 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 8. Related Party Transactions

 

Related party transactions are carried out in the normal course of operations and are measured in part by the amount of consideration paid or received, as established and agreed by the parties. Management believes that consideration paid for such services in each case approximates fair value. Except where disclosed elsewhere in these consolidated financial statements, the following is a summary of related party transactions.

 

Joint Venture Agreement

 

On March 31, 2020, the Company entered into the Limited Liability Company Agreement of Fundamental Global Asset Management, LLC (“FGAM”), a joint venture owned 50% by each of the Company and FG. The purpose of FGAM is to sponsor, capitalize and provide strategic advice to investment managers in connection with the launch and/or growth of their asset management businesses and the investment products they sponsor (each, a “Sponsored Fund”).

 

FGAM is governed by a Board of Managers consisting of four managers, two of which have been appointed by each Member. The Company has appointed two of its independent directors to the Board of Managers of FGAM. Certain major actions, including any decision to sponsor a new investment manager, require the prior consent of both Members.

 

FG Special Situations Fund

 

The Company participated as a limited partner in the Fund. The general partner of the Fund, and the investment advisor of the Fund, was ultimately controlled by Mr. Cerminara, the Chairman of the Company’s Board of Directors. Portions of the Company’s investment into the Fund were used to sponsor the launch of SPACs affiliated with certain of our officers and directors.

 

The Fund began the process of winding down in the first quarter of 2023 and completed the process in the second quarter of 2023. As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. Mr. Cerminara, Mr. Swets and Mr. Baqar, our Executive Vice President and Chief Financial Officer, serve as managers of FGAC Investors LLC and FG Merger Investors LLC, while Mr. Cerminara ultimately controls Greenfirst Forest Products Holdings, LLC.

 

FG Merchant Partners

 

FGMP was formed to co-sponsor newly formed SPACs with their founders or partners. Certain of our directors and officers also hold limited partner interests in FGMP. Mr. Swets holds a limited partner interest through Itasca Financial LLC, an advisory and investment firm for which Mr. Swets is managing member. Mr. Baqar also holds a limited partner interest through Sequoia Financial LLC, an advisory firm for which Mr. Baqar is managing member. Mr. Cerminara also holds a limited partner interest through Fundamental Global, LLC, a holding company for which Mr. Cerminara is the manager and one of the members.

 

FGMP has invested in the founder shares and warrants of Aldel, FG Merger Corp, FG Acquisition Corp, FGC and Craveworthy. Certain of our directors and officers are affiliated with these entities.

 

FG Communities

 

In October of 2022, the Company directly invested $2.0 million into FGC. The Company also holds an interest through its ownership in FGMP. FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC. Mr. Cerminara is the President and a director of FGC.

 

 

Craveworthy

 

On March 16, 2023, the Company invested $200,000 in a senior unsecured loan to Craveworthy. Mr. Swets has an indirect interest in Craveworthy, independent from the interests held by the Company through its ownership in FGMP.

 

Think Markets

 

On September 29, 2023, the Company invested $250,000 in a convertible promissory note to support the business combination of Think Markets and FG Acquisition Corp. Mr. Swets and Mr. Baqar are executive officers of FG Acquisition Corp.

 

Shared Services Agreement

 

On March 31, 2020, the Company entered into a Shared Services Agreement (the “Shared Services Agreement”) with Fundamental Global Management, LLC (“FGM”), an affiliate of FG, pursuant to which FGM provides the Company with certain services related to the day-to-day management of the Company, including assisting with regulatory compliance, evaluating the Company’s financial and operational performance, providing a management team to supplement the executive officers of the Company, and such other services consistent with those customarily performed by executive officers and employees of a public company. In exchange for these services, the Company pays FGM a fee of $456,000 per quarter (the “Shared Services Fee”), plus reimbursement of expenses incurred by FGM in connection with the performance of the Services, subject to certain limitations approved by the Company’s Board of Directors or Compensation Committee from time to time.

 

The Shared Services Agreement has an initial term of three years, and thereafter renews automatically for successive one-year terms unless terminated in accordance with its terms. The Shared Services Agreement may be terminated by FGM or by the Company, by a vote of the Company’s independent directors, at the end of the initial or automatic renewal term upon 120 days’ notice, subject to payment by the Company of certain costs incurred by FGM to wind down the provision of services and, in the case of a termination by the Company without cause, payment of a termination fee equal to the Shared Services Fee paid for the two quarters preceding termination.

 

The Company paid $1,368,000 and $1,368,000 to FGM under the Shared Services Agreement for each of the nine months ended September 30, 2023 and 2022, respectively.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Net Earnings Per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Net Earnings Per Share

Note 9. Net Earnings Per Share

 

Net earnings per share is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding during the periods presented. In calculating diluted earnings per share, those potential common shares that are found to be anti-dilutive are excluded from the calculation. The table below provides a summary of the numerators and denominators used in determining basic and diluted earnings per share for the three and nine months ended September 30, 2023 and 2022.

 

   2023   2022   2023   2022 
($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Basic and diluted:                    
Net income from continuing operations  $5,628   $10,255   $4,055   $955 
Dividends declared on Series A Preferred Shares   (447)   (447)   (1,339)   (1,342)
Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations   5,181    9,808    2,716    (387)
Weighted average common shares   10,303,739    9,333,709    9,813,438    7,564,017 
Income (loss) per common share from continuing operations  $0.50   $1.05   $0.28   $(0.05)
                     
Weighted average common shares outstanding   10,303,739    9,333,709    9,813,438    7,564,017 

 

 

The following potentially dilutive securities outstanding as of September 30, 2023 and 2022 have been excluded from the computation of diluted weighted-average shares outstanding as their effect would be anti-dilutive.

 

   As of September 30, 
   2023   2022 
Options to purchase common stock   130,000    130,000 
Restricted stock units   851,055    297,815 
    981,055    427,815 

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 10. Commitments and Contingencies

 

Legal Proceedings:

 

As of September 30, 2023, the Company was not aware of any material claims or actions pending or threatened against us. From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. Currently, it is not possible to predict legal outcomes and their impact on the future development of claims. Any such development will be affected by future court decisions and interpretations. Because of these uncertainties, additional liabilities may arise for amounts in excess of the Company’s current reserves.

 

Operating Lease Commitments:

 

In July 2021, the Company entered into a lease agreement for office space in St. Petersburg, FL. The lease had a term of 12 months and was not renewed upon expiration. Total minimum rent over the 12-month term was approximately $17,000. Due to the short-term nature of the lease, the Company recognized lease expense on a straight-line basis over the term of the lease, with any variable lease payments recognized in the period in which the obligation for the payment occurred. Rent expense related to the St. Petersburg office was zero and approximately $10,000 for the nine months ended September 30, 2023 and September 30, 2022, respectively.

 

In April 2022, the Company entered into a lease agreement for office space in Itasca, IL. The lease has a term of 44 months beginning on May 1, 2022. Total minimum rent over the term of the lease is expected to be approximately $77,000. The Company has accounted for the lease under ASC 842, Leases. The annual discount rate used for the Itasca office was 8%. As of September 30, 2023, the right of use asset and lease liability are approximately $44,000, each, and held in “Other assets” and “Other liabilities” on the balance sheet, respectively. Rent expense related to the Itasca office was approximately $16,000 and $8,800 for the nine months ended September 30, 2023 and September 30, 2022, respectively.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Reporting

Note 11. Segment Reporting

 

The Company has two operating segments—insurance and asset management. The chief operating decision maker (“CODM”) is the Company’s Chief Executive Officer. The measure of profit or loss used by the CODM to identify and measure the Company’s reportable segments is income before income tax. Our insurance segment consists of the operations of our Cayman Islands-based reinsurance subsidiary, FGRe, as well as the returns associated with the investments made by our reinsurance operations. Our asset management segment includes our investments made outside of reinsurance operations.

 

The following table presents the financial information for each segment that is specifically identifiable or based on allocations using internal methodology as of and for the three and nine months ended September 30, 2023 and 2022. The ‘other’ category in the table below consists largely of corporate general and administrative expenses which have not been allocated to a specific segment. Segment assets for the “other” category primarily consist of unrestricted cash in the amounts of $3.8 million and $8.7 million as of September 30, 2023 and 2022, respectively.

 

 

(in thousands)

 

For the three months ended September 30, 2023

  Insurance   Asset Management   Other   Total 
Net premiums earned  $4,192   $   $   $4,192 
Net investment income   5,032    1,922    7    6,961 
Other income   -    24    -    24 
Total revenue   9,224    1,946    7    11,177 
Income (loss) before income tax   5,465    1,946    (1,783)   5,628 
                     
For the nine months ended September 30, 2023                    
Net premiums earned  $11,534   $   $   $11,534 
Net investment income   8,108    150    14    8,272 
Other income       84        84 
Total revenue   19,642    234    14    19,890 
Income (loss) before income tax   9,366    234    (5,545)   4,055 
                     
As of September 30, 2023                    
Segment assets  $35,776   $18,436   $4,616   $58,828 
                     
For the three months ended September 30, 2022                    
Net premiums earned  $4,383   $   $   $4,383 
Net investment income   2,468    8,706        11,174 
Other income       89    125    214 
Total revenue   6,851    8,795    125    15,771 
Income (loss) before income tax   3,274    8,798    (1,817)   10,255 
                     
For the nine months ended September 30, 2022                    
Net premiums earned  $9,809   $   $   $9,809 
Net investment income   1,562    3,552        5,114 
Other income       141    125    266 
Total revenue   11,371    3,693    125    15,189 
Income (loss) before income tax   2,728    3,680    (5,453)   955 
                     
As of September 30, 2022                    
Segment assets  $21,662   $17,777   $9,484   $48,923 

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 12. Subsequent Events

 

The Corporation has evaluated subsequent events through the filing date of the financial statements and determined that there have been no events that have occurred that would require additional disclosures.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Consolidation Policies

Consolidation Policies

 

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

The consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that could potentially be significant to the legal entity.

 

The determination of whether a legal entity is consolidated under either model is reassessed where there is a substantive change in the governing documents or contractual arrangements of the entity, to the capital structure of the entity or in the activities of the entity. The Company continuously reassesses whether it should consolidate under either model.

 

In September 2020, the Company invested approximately $5.0 million to sponsor the launch of the FG Special Situations Fund, LP (“The Fund”). The Fund, a VIE which the Company was required to consolidate through November 30, 2021, was considered an investment company for GAAP purposes and followed the accounting and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus, began to account for its investment in the Fund under the equity method of accounting.

 

During the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, Greenfirst Forest Products Holdings LLC, and OppFi. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $8.9 million, FG Merger Investors LLC, with a carrying value of $3.4 million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $1.4 million. The carrying value of these direct limited partner interests approximate to ownership of 29% of FGAC Investors LLC, 19% of FG Merger Investors LLC, and 16% of Greenfirst Forest Products Holdings, LLC. The Fund also distributed OppFi publicly traded securities to the Company with a carrying value of $1.9 million.

 

As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. The Company has determined that each of these entities meets the criteria of a VIE. For each new position, the Company analyzed ASC 810 – Consolidation and has determined it is not the primary beneficiary of FGAC Investors LLC, FG Merger Investors LLC or Greenfirst Forest Products Holdings LLC, but does have the ability to exercise significant influence over each of these. Therefore, the Company will apply the equity method of accounting for each of these investments.

 

 

In October of 2022, the Company invested $2.0 million into FGC, which the Company has determined meets the criteria of a VIE. The Company holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not the primary beneficiary of FGC, and thus does not consolidate FGC.

 

The Company’s risk of loss associated with its non-consolidated VIEs is limited. As of September 30, 2023, and December 31, 2022, the carrying value and maximum loss exposure of the Company’s non-consolidated VIE’s was $16.5 million and $18.8 million, respectively.

 

See Note 4 for further information regarding the Company’s investments.

 

The Use of Estimates in the Preparation of Consolidated Financial Statements

The Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying consolidated financial statements include the valuation of our equity method investments, current expected credit losses, the valuation of net deferred income taxes and deferred policy acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.

 

Investments in Equity Securities

Investments in Equity Securities

 

Investments in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations as a component of net investment income.

 

Other Investments

Other Investments

 

Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses more than 20% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock and to other investments when such other investments possess substantially identical subordinated interests to common stock.

 

In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our claim on the investee’s book value.

 

When we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods, with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative equity in earnings represent returns on investment and are classified as cash inflows from investing activities.

 

 

In addition to investments accounted for under the equity method of accounting, other investments also consist of equity we have purchased in a limited partnership, a limited liability company, and a corporation for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an asset measured at fair value on a nonrecurring basis. Any profit distributions the Company receives on these investments are included in net investment income.

 

Other investments also include a convertible note and a senior unsecured promissory note.

 

See Note 4 for additional information regarding the Company’s investments.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

Cash and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.

 

Pursuant to the Company’s insurance license, the Authority has required that FGRe hold a minimum capital requirement of $200,000 in cash in a bank in the Cayman Islands which holds an “A” license issued under the Banks and Trust Companies Act (2020 Revision).

 

Income Taxes

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).

 

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $250,000. As of September 30, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.

 

Premium Revenue Recognition

Premium Revenue Recognition

 

The Company participates in quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.

 

 

Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represents estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.

 

Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.

 

Current Expected Credit Loss

Current Expected Credit Loss

 

In the first quarter of 2023, the Company adopted ASU 2016-13, as amended, Financial Instruments – Credit Losses (“ASU 2016-13”), which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The financial assets included in the caption “Reinsurance balances recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. The amendments in this update were effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted, however smaller reporting companies, like the Company, could delay adoption until January 2023. Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $0.1 million as of January 1, 2023. The Company updates the model each quarter and adjusts the balance accordingly. There was no change to the allowance during the third quarter.

 

In the first quarter of 2023, the Company allocated $200,000 into a promissory note. The promissory note is carried at amortized cost on the Company’s consolidated balance sheet under the caption “other investments.” Due to being held at amortized cost, the promissory note falls into the scope of ASU 2016-13. Due to immateriality, the Company does not have a current expected credit allowance against the promissory note.

 

Deferred Policy Acquisition Costs

Deferred Policy Acquisition Costs

 

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.

 

Funds Deposited for Benefit of Reinsured Companies

Funds Deposited for Benefit of Reinsured Companies

 

“Funds Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held to support our reinsurance contracts. As of September 30, 2023 and December 31, 2022, the total cash collateral posted to support all of our reinsurance treaties was approximately $7.1 million and $9.3 million, respectively.

 

 

Loss and Loss Adjustment Expense Reserves

Loss and Loss Adjustment Expense Reserves

 

The Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports the Company has received from ceding companies. The Company then uses a variety of statistical and actuarial techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures and projected ultimate premium to be written by our cedants; (2) expected loss ratios by type of business; (3) actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions. The Company also engages independent actuarial specialists, at least annually, to assist management in establishing appropriate reserves. Since reserves are estimates, the final settlement of losses may vary from the reserves established, and any adjustments to the estimates, which may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the reserves recorded.

 

U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.

 

Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – Stock Compensation, which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period, which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.

 

The Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which vest solely based upon the passage of time. The fair value of each RSU is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest.

 

Based upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock compensation expense for expected forfeitures as of September 30, 2023.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other accrued expenses, approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s financial instruments.

 

 

Earnings (Loss) Per Common Share

Earnings (Loss) Per Common Share

 

Basic earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.

 

Diluted earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings (loss) per share if their effect is anti-dilutive.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Investments and Fair Value Disclosures (Tables)
9 Months Ended
Sep. 30, 2023
Platform Operator, Crypto-Asset [Line Items]  
Schedule of Equity Securities

The following table summarizes the Company’s equity securities held at fair value as of September 30, 2023 and December 31, 2022:

 

(in thousands)                
As of September 30, 2023  Cost Basis  

Gross

Unrealized

Gains

  

Gross

Unrealized

Losses

  

Carrying

Amount

 
OppFi common stock and warrants  $1,916   $    271   $         -   $2,187 
Total investments  $1,916   $271   $-   $2,187 

 

As of December 31, 2022  Cost Basis  

Gross

Unrealized

Gains

  

Gross

Unrealized

Losses

  

Carrying

Amount

 
Hagerty common stock  $889   $   $48   $841 
Total investments  $889   $            $      48   $841 
Schedule of Investments Under Equity Method

Financial information for our investments accounted for under the equity method, in the aggregate, is as follows:

 

  

As of
September 30,
2023

   As of
December 31, 2022
 
(in thousands)          
Other investments  $72,585   $35,366 
Cash   275    113 
Other assets   177    165 
Total assets   73,037    35,644 
           
Total liabilities   439    65 

 

  

Nine months ended

September 30, 2023

  

Nine months ended

September 30, 2022

 
(in thousands)          
Net investment income  $17,417   $8,170 
Other income   129    - 
General and administrative expenses   (1,149)   (95)
Net income    16,397    8,075 
Schedule of Net Investment Income (Loss)

Net investment income for the three and nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022   2023   2022 
($ in thousands)  Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
Investment income:                    
Realized gain (loss) on common stock  $3,078   $(2,472)  $3,062   $(11,441)
Change in unrealized holding on common stock   404    2,448    319    10,521 
Equity method earnings   3,460    11,226    4,192    6,080 
Increase in investments without readily determinable fair value   -    -    250    - 
(Decrease) increase in fair value of convertible note   (52)   -    125    - 
Other   71    (28)   324    (46)
Net investment income  $6,961   $11,174   $8,272   $5,114 
Schedule of Financial Instruments Measured at Fair Value

Financial instruments measured, on a recurring basis, at fair value as of September 30, 2023 and December 31, 2022 in accordance with the guidance promulgated by the FASB are as follows.

 

 

(in thousands)                
                 
As of September 30, 2023  Level 1   Level 2   Level 3   Total 
Oppfi common stock and warrants  $2,187   $   $   $2,187 
ThinkMarkets convertible note  $        250    250 
   $2,187   $   $250   $2,437 
                     
As of December 31, 2022                    
Hagerty common stock  $841   $   $   $841 
   $841   $   $   $841 
Fair Value, Inputs, Level 3 [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Schedule of Fair Value of Recurring Level 3 Fair Value Measurements

The following tables provide a reconciliation of the fair value of recurring Level 3 fair value measurements for the three- and nine-months ended September 30, 2023 and September 30, 2022:

 

   2023   2022 
(in thousands)  Nine months ended September 30, 
   2023   2022 
Assets:        
Convertible note          
Beginning balance   -    - 
Consideration paid   750    - 
Increase in fair value of convertible note   125    - 
Transfer out   (625)     
Balance, September 30  $250   $- 

 

   2023   2022 
(in thousands)  Three months ended September 30, 
   2023   2022 
Assets:        
Convertible note          
Beginning balance   677    - 
Consideration paid   250    - 
Decrease in fair value of convertible note   (52)   - 
Transfer out   (625)     
Balance, September 30  $250   $- 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Loss and Loss Adjustment Expense Reserves (Tables)
9 Months Ended
Sep. 30, 2023
Loss And Loss Adjustment Expense Reserves  
Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves

A summary of changes in outstanding loss and loss adjustment expense reserves for the nine months ended September 30, 2023 and 2022, is as follows:

 

   2023   2022 
(in thousands)  Nine months ended September 30, 
   2023   2022 
Balance, beginning of period, net of reinsurance  $4,409   $2,133 
Incurred related to:          
Current year   5,420    4,984 
Prior year   661    814 
Paid related to:          
Current year   (3,675)   (2,568)
Prior years   (903)   (1,230)
Balance, September 30, net of reinsurance  $5,912   $4,133 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation Effective Tax Rates

Actual income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax rates to income before income tax expense as follows:

 

($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Provision for taxes at U.S., statutory marginal income tax rate of 21%  $1,182  $2,154   $852  $201 
Valuation allowance for deferred tax assets deemed unrealizable   (1,200)   (2,168)   (871)   (219)
Non-deductible expenses associated with the Share Repurchase Transaction       2    1    2 
Share-based compensation   18    12    18    16 
Income tax expense (benefit)  $   $   $   $- 
Schedule of Deferred Income Taxes

 

         
(in thousands)    
  

As of
September 30, 2023

  

As of
December 31, 2022

 
Deferred income tax assets:          
Net operating loss carryforward  $4,670   $4,171 
Loss and loss adjustment expense reserves   52    39 
Unearned premium reserves   395    287 
Capital loss carryforward   2,491    4,313 
Share-based compensation   424    242 
Investments   10    5 
Other   8    9 
Deferred income tax assets  $8,050   $9,066 
Less: Valuation allowance   (4,615)   (5,463)
Deferred income tax assets net of valuation allowance  $3,435   $3,603 
           
Deferred income tax liabilities:          
Investments  $3,125   $3,282 
Deferred policy acquisition costs   310    321 
Deferred income tax liabilities  $3,435   $3,603 
           
Net deferred income tax asset (liability)  $   $ 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plan Grants (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Units Activity

The following table summarizes RSU activity for the nine months ended September 30, 2023 and 2022:

 

Restricted Stock Units  Number of Units  

Weighted

Average Grant Date Fair Value

 
Non-vested units, January 1, 2023   256,382   $2.57 
Granted   821,974    2.76 
Vested   (227,301)   2.71 
Forfeited        
Non-vested units, September 30, 2023   851,055   $1.40 
           
Non-vested units, January 1, 2022   164,655   $4.35 
Granted   158,225    1.58 
Vested   (50,065)   4.81 
Forfeited        
Non-vested units, September 30, 2022   272,815   $2.66 
Schedule of Fair Value of Stock Options

 

Expected volatility   45.60%
Expected life (years)   10.00 
Risk-free interest rate   5.15%
Dividend yield   0.00%
Schedule of Stock Option Activity

The following table summarizes activity for stock options issued for the nine months ended September 30, 2023 and 2022.

 

Common Stock Options  Shares   Weighted Ave
Exercise Price
   Weighted Ave
Remaining
Contractual
Term (yrs)
   Weighted Ave
Grant Date
Fair Value
   Aggregate Intrinsic Value 
Outstanding, January 1, 2023   130,000   $3.38    8.04   $1.88   $- 
Exercisable, January 1, 2023      $       $   $ 
Granted   -    -              
Exercised                    
Cancelled                    
Outstanding, September 30, 2023   130,000   $3.38    7.29   $1.88   $ 
Exercisable, September 30, 2023      $       $   $ 
                          
Outstanding, January 1, 2022   130,000   $3.38    9.04   $1.88   $49,400 
Exercisable, January 1, 2022      $       $   $ 
Granted                    
Exercised                    
Cancelled                    
Outstanding, September 30, 2022   130,000   $3.38    8.29   $1.88   $ 
Exercisable, September 30, 2022      $       $   $ 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Net Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share

 

   2023   2022   2023   2022 
($ in thousands) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   2023   2022 
Basic and diluted:                    
Net income from continuing operations  $5,628   $10,255   $4,055   $955 
Dividends declared on Series A Preferred Shares   (447)   (447)   (1,339)   (1,342)
Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations   5,181    9,808    2,716    (387)
Weighted average common shares   10,303,739    9,333,709    9,813,438    7,564,017 
Income (loss) per common share from continuing operations  $0.50   $1.05   $0.28   $(0.05)
                     
Weighted average common shares outstanding   10,303,739    9,333,709    9,813,438    7,564,017 
Schedule of Potentially Dilutive Securities Excluded from Calculation

The following potentially dilutive securities outstanding as of September 30, 2023 and 2022 have been excluded from the computation of diluted weighted-average shares outstanding as their effect would be anti-dilutive.

 

   As of September 30, 
   2023   2022 
Options to purchase common stock   130,000    130,000 
Restricted stock units   851,055    297,815 
    981,055    427,815 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Summary of Segment Reporting

(in thousands)

 

For the three months ended September 30, 2023

  Insurance   Asset Management   Other   Total 
Net premiums earned  $4,192   $   $   $4,192 
Net investment income   5,032    1,922    7    6,961 
Other income   -    24    -    24 
Total revenue   9,224    1,946    7    11,177 
Income (loss) before income tax   5,465    1,946    (1,783)   5,628 
                     
For the nine months ended September 30, 2023                    
Net premiums earned  $11,534   $   $   $11,534 
Net investment income   8,108    150    14    8,272 
Other income       84        84 
Total revenue   19,642    234    14    19,890 
Income (loss) before income tax   9,366    234    (5,545)   4,055 
                     
As of September 30, 2023                    
Segment assets  $35,776   $18,436   $4,616   $58,828 
                     
For the three months ended September 30, 2022                    
Net premiums earned  $4,383   $   $   $4,383 
Net investment income   2,468    8,706        11,174 
Other income       89    125    214 
Total revenue   6,851    8,795    125    15,771 
Income (loss) before income tax   3,274    8,798    (1,817)   10,255 
                     
For the nine months ended September 30, 2022                    
Net premiums earned  $9,809   $   $   $9,809 
Net investment income   1,562    3,552        5,114 
Other income       141    125    266 
Total revenue   11,371    3,693    125    15,189 
Income (loss) before income tax   2,728    3,680    (5,453)   955 
                     
As of September 30, 2022                    
Segment assets  $21,662   $17,777   $9,484   $48,923 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Business (Details Narrative)
Sep. 30, 2023
Integer
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Oct. 31, 2022
USD ($)
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Number of active reinsurance contracts | Integer 7      
FG Communities Inc [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Investments | $   $ 200,000 $ 2,000,000.0 $ 2,000,000.0
Fundamental Global GP, LLC [Member] | Common Stock [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Ownership percentage 55.00%      
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Details Narrative) - USD ($)
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jan. 01, 2023
Dec. 31, 2022
Oct. 31, 2022
Sep. 30, 2020
Investment interest rate 20.00%            
Cash in bank $ 200,000            
Cash deposit per institution insured by FDIC 250,000            
Accumulated deficit       $ 100,000      
Cash collateral total 7,100,000       $ 9,300,000    
FGAC Investors LLC [Member]              
Equity method investment, ownership percentage   29.00%          
FG MergerInvestors LLC [Member]              
Equity method investment, ownership percentage   19.00%          
Greenfirst Forest Products Holdings LLC [Member]              
Equity method investment, ownership percentage   16.00%          
Variable Interest Entity [Member]              
Equity method investments 16,500,000       18,800,000    
FGAC Investors LLC [Member]              
Debt carry value 8,900,000 $ 8,900,000          
FG MergerInvestors LLC [Member]              
Debt carry value 3,400,000 3,400,000          
Green first Forest Products LLC [Member]              
Debt carry value $ 1,400,000 1,400,000          
Opp Fi [Member]              
Debt carry value   $ 1,900,000          
FG Communities Inc [Member]              
Investments     $ 200,000   $ 2,000,000.0 $ 2,000,000.0  
Variable Interest Entity, Primary Beneficiary [Member] | Fundamental Global Asset Management, LLC [Member]              
Real estate investment             $ 5,000,000.0
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Recently Adopted and Issued Accounting Standards (Details Narrative)
$ in Millions
Jan. 01, 2023
USD ($)
Accounting Changes and Error Corrections [Abstract]  
Cumulative earnings deficit $ 0.1
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Equity Securities (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Investments, Cost basis $ 1,916 $ 889
Investments, Gross Unrealized Gains 271
Investments, Gross Unrealized Losses 48
Investments, Carrying Amount 2,187 841
Opp Fi Common Stock And Warrants [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Investments, Cost basis 1,916  
Investments, Gross Unrealized Gains 271  
Investments, Gross Unrealized Losses  
Investments, Carrying Amount $ 2,187  
Hagerty Common Stock [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Investments, Cost basis   889
Investments, Gross Unrealized Gains  
Investments, Gross Unrealized Losses   48
Investments, Carrying Amount   $ 841
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Investments Under Equity Method (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]          
Cash $ 200,000   $ 200,000    
Other assets 727,000   727,000   $ 712,000
Total assets 58,828,000 $ 48,923,000 58,828,000 $ 48,923,000 49,475,000
Total liabilities 16,161,000   16,161,000   12,180,000
Other income 24,000 214,000 84,000 266,000  
General and administrative expenses (2,341,000) $ (2,001,000) (7,221,000) (6,009,000)  
Equity Method Investment [Member]          
Schedule of Equity Method Investments [Line Items]          
Other investments 72,585,000   72,585,000   35,366,000
Cash 275,000   275,000   113,000
Other assets 177,000   177,000   165,000
Total assets 73,037,000   73,037,000   35,644,000
Total liabilities $ 439,000   439,000   $ 65,000
Net investment income     17,417,000 8,170,000  
Other income     129,000  
General and administrative expenses     (1,149,000) (95,000)  
Net income     $ 16,397,000 $ 8,075,000  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Net Investment Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule of Investments [Line Items]        
Net investment income $ 6,961 $ 11,174 $ 8,272 $ 5,114
Realized Gain (Loss) on Common Stock [Member]        
Schedule of Investments [Line Items]        
Net investment income 3,078 (2,472) 3,062 (11,441)
Change in Unrealized Holding on Common Stock [Member]        
Schedule of Investments [Line Items]        
Net investment income 404 2,448 319 10,521
Equity Method Earnings [Member]        
Schedule of Investments [Line Items]        
Net investment income 3,460 11,226 4,192 6,080
Increase in Investments Without Readily Determinable Fair Value [Member]        
Schedule of Investments [Line Items]        
Net investment income 250
Decrease (Increase) in Fair Value of Convertible Note [Member]        
Schedule of Investments [Line Items]        
Net investment income (52) 125
Other [Member]        
Schedule of Investments [Line Items]        
Net investment income $ 71 $ (28) $ 324 $ (46)
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Financial Instruments Measured at Fair Value (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock $ 2,437 $ 841
Opfi Common Stock And Warrants [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock 2,187  
ThinkMarkets Convertible Note [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock 250  
Hagerty Common Stock [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock   841
Fair Value, Inputs, Level 1 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock 2,187 841
Fair Value, Inputs, Level 1 [Member] | Opfi Common Stock And Warrants [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock 2,187  
Fair Value, Inputs, Level 1 [Member] | ThinkMarkets Convertible Note [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock  
Fair Value, Inputs, Level 1 [Member] | Hagerty Common Stock [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock   841
Fair Value, Inputs, Level 2 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock
Fair Value, Inputs, Level 2 [Member] | Opfi Common Stock And Warrants [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock  
Fair Value, Inputs, Level 2 [Member] | ThinkMarkets Convertible Note [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock  
Fair Value, Inputs, Level 2 [Member] | Hagerty Common Stock [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock  
Fair Value, Inputs, Level 3 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock 250
Fair Value, Inputs, Level 3 [Member] | Opfi Common Stock And Warrants [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock  
Fair Value, Inputs, Level 3 [Member] | ThinkMarkets Convertible Note [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock $ 250  
Fair Value, Inputs, Level 3 [Member] | Hagerty Common Stock [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Equity securities, common stock  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Fair Value of Recurring Level 3 Fair Value Measurements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Platform Operator, Crypto-Asset [Line Items]        
Increase in fair value of convertible note     $ 125
Fair Value, Inputs, Level 3 [Member]        
Platform Operator, Crypto-Asset [Line Items]        
Beginning balance $ 677
Consideration paid 250 750
Increase in fair value of convertible note     125
Transfer out (625)   (625)  
Balance, September 30 250 $ 250
Decrease in fair value of convertible note $ (52)    
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Investments and Fair Value Disclosures (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 29, 2023
Mar. 16, 2023
Dec. 15, 2022
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jun. 30, 2023
Mar. 15, 2023
Jan. 04, 2021
Sale of stock number of shares sold         16,000            
Increase carrying value of investments           $ 300,000 $ 0        
Proceeds from issuance of common stock           1,280,000 $ 3,889,000        
Convertible Promissory Note [Member]                      
Fair value of note $ 250,000                    
Fair Value, Nonrecurring [Member]                      
Investments       $ 2,300,000   2,300,000   $ 2,300,000      
FGMP [Member]                      
Equity method investment realized gain (loss)       1,200,000   4,100,000          
Gain loss on investments           100,000          
Undistributed earnings           9,900,000   $ 5,700,000      
Investments       9,900,000   9,900,000          
FGMP [Member] | Maximum [Member]                      
Investments       400,000   400,000          
FGAC Investors LLC [Member]                      
Debt carry value       8,900,000   8,900,000     $ 8,900,000    
FG MergerInvestors LLC [Member]                      
Debt carry value       3,400,000   3,400,000     3,400,000    
Contributed       500,000              
Green first Forest Products LLC [Member]                      
Debt carry value       1,400,000   1,400,000     1,400,000    
ThinkMarkets [Member]                      
Investments $ 250,000                    
Debt instrument interest rate 15.00%                    
Debt instrument maturity date Aug. 01, 2025                    
Shares issued price per share $ 5.00                    
Other investments       250,000   250,000          
Craveworthy [Member]                      
Debt instrument interest rate   13.00%                  
Debt instrument maturity date   Mar. 15, 2024                  
Senior unsecured promissory note   $ 200,000                  
Debt instrument principal amount   $ 200,000   200,000   200,000          
Accrued interest       15,000   15,000          
I Core Connect Inc [Member]                      
Investments                   $ 500,000  
FG SPAC Partners LP [Member]                      
Equity method investments                     46.00%
Investment Fund [Member]                      
Investment fund       14,700,000   $ 14,700,000     $ 11,900,000    
FGAC Investors LLC [Member]                      
Equity method investments                 29.00%    
Equity method investment realized gain (loss)       2,400,000              
FG Merger Investors [Member]                      
Equity method investment realized gain (loss)       100,000              
Greenfirst Forest Products Holdings LLC [Member]                      
Equity method investments                 16.00%    
Equity method investment realized gain (loss)       $ 100,000              
OppFi Common Stock [Member]                      
Number of shares issued           860,000          
Number of shares issued, value           $ 1,900,000          
Hagerty Common Stock [Member]                      
Number of shares issued     99,999                
Number of shares issued, value     $ 889,000                
I Core Connect Inc [Member]                      
Number of shares issued           219,000          
Equity method investment realized gain (loss)           $ 3,100,000          
Proceeds from issuance of common stock           $ 3,700,000          
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Loss And Loss Adjustment Expense Reserves    
Balance, beginning of period, net of reinsurance $ 4,409 $ 2,133
Incurred related to:    
Current year 5,420 4,984
Prior year 661 814
Paid related to:    
Current year (3,675) (2,568)
Prior years (903) (1,230)
Balance, September 30, net of reinsurance $ 5,912 $ 4,133
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Reconciliation Effective Tax Rates (Details) (Parenthetical)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Income tax rate 21.00% 21.00% 21.00% 21.00%
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Reconciliation Effective Tax Rates (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Provision for taxes at U.S. statutory marginal income tax rate of 21% $ 1,182 $ 2,154 $ 852 $ 201
Valuation allowance for deferred tax assets deemed unrealizable (1,200) (2,168) (871) (219)
Non-deductible expenses associated with the Share Repurchase Transaction 2 1 2
Share-based compensation 18 12 18 16
Income tax benefit
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Deferred Income Taxes (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Deferred income tax assets:    
Net operating loss carryforward $ 4,670 $ 4,171
Loss and loss adjustment expense reserves 52 39
Unearned premium reserves 395 287
Capital loss carryforward 2,491 4,313
Share-based compensation 424 242
Investments 10 5
Other 8 9
Deferred income tax assets 8,050 9,066
Less: Valuation allowance (4,615) (5,463)
Deferred income tax assets net of valuation allowance 3,435 3,603
Deferred income tax liabilities:    
Investments 3,125 3,282
Deferred policy acquisition costs 310 321
Deferred income tax liabilities 3,435 3,603
Net deferred income tax asset (liability)
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Deferred tax assets, gross $ 8,050 $ 9,066
Deferred tax liabilities 3,400  
Deferred tax valuation allowances 4,600  
Operating Loss Carryforwards 22,200  
Expire on December 31, 2039 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Operating Loss Carryforwards 500  
Expire on December 31, 2040 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Operating Loss Carryforwards 100  
Expire on December 31, 2041 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Operating Loss Carryforwards 1,600  
Not Expire Under Current Tax Law [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Operating Loss Carryforwards 20,000  
Expire on December 2026 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Operating Loss Carryforwards $ 11,900  
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Non-vested Units, Beginning balance 256,382 164,655
Weighted Average Grant Date Fair Value, Beginning balance $ 2.57 $ 4.35
Number of Non-vested Units, Granted 821,974 158,225
Weighted Average Grant Date Fair Value, Granted $ 2.76 $ 1.58
Number of Non-vested Units, Vested (227,301) (50,065)
Weighted Average Grant Date Fair Value, Vested $ 2.71 $ 4.81
Number of Non-vested Units, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Non-vested Units, Ending balance 851,055 272,815
Weighted Average Grant Date Fair Value, Ending balance $ 1.40 $ 2.66
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Fair Value of Stock Options (Details)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Expected volatility 45.60%
Expected life (years) 10 years
Risk-free interest rate 5.15%
Dividend yield 0.00%
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Stock Option Activity (Details) - 2014 Equity Incentive Plan [Member] - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares, Outstanding, Beginning balance 130,000 130,000
Weighted Average Exercise Price, Outstanding, Beginning balance $ 3.38 $ 3.38
Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance 8 years 14 days 9 years 14 days
Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance $ 1.88 $ 1.88
Aggregate Intrinsic Value, Outstanding, Beginning balance $ 49,400
Shares, Exercisable, Beginning balance
Weighted Average Exercise Price, Exercisable, Beginning balance
Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance
Aggregate Intrinsic Value, Exercisable, Beginning balance
Shares, Granted
Weighted Average Exercise Price, Granted
Weighted Average Grant date Fair Value, Granted
Aggregate Intrinsic Value, Granted
Shares, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Grant date Fair Value, Exercised
Aggregate Intrinsic Value, Exercised
Shares, Cancelled
Weighted Average Exercise Price, Cancelled
Weighted Average Grant date Fair Value, Cancelled
Aggregate Intrinsic Value, Cancelled
Shares, Outstanding, Ending balance 130,000 130,000
Weighted Average Exercise Price, Outstanding, Ending balance $ 3.38 $ 3.38
Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance 7 years 3 months 14 days 8 years 3 months 14 days
Weighted Ave Grant Date Fair Value, Outstanding, Ending balance $ 1.88 $ 1.88
Aggregate Intrinsic Value, Outstanding, Ending balance
Shares, Exercisable, Ending balance
Weighted Average Exercise Price, Exercisable, Ending balance
Weighted Ave Grant Date Fair Value, Exercisable, Ending balance
Aggregate Intrinsic Value, Exercisable, Ending balance
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plan Grants (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 17, 2023
Aug. 19, 2022
Jul. 31, 2022
Jan. 18, 2021
Jan. 12, 2021
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Mar. 24, 2023
Feb. 24, 2022
Dec. 15, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
ESPP Plan, description                 the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.    
Share-based payment arrangement, expense             $ 1,500,000 $ 180,000      
Unrecognized stock based compensation expense           $ 1,800,000 $ 1,800,000        
Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Warrants outstanding                   1,500,000  
Exercise price of warrants                   $ 15.00  
Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of restricted units granted             821,974 158,225      
Non Employee Director [Member] | Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of restricted stock issued   158,225                  
Management [Member] | Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of restricted units granted 415,000                    
NonExecutive Members [Member] | Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of restricted units granted           36,974          
Larry G. Swets Jr [Member] | Equity Award Letter Agreement [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Grant an additional stock options       370,000              
Larry G. Swets Jr [Member] | Stock Option Agreement [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Grant an additional stock options         130,000            
Exercise price of shares         $ 3.38            
Stock option,description         The Stock Option becomes vested and fully exercisable in 20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through each applicable vesting date and that the Company’s book value per share has increased by 15% or more as compared to the Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031.            
Stock option service period             3 years 3 months 18 days        
Mr. Swets [Member] | Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of restricted units granted 370,000                    
2021 Incentive Plan [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of share available for issuance                 1,500,000    
2021 Incentive Plan [Member] | Maximum [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of share available for issuance                     1,500,000
Amendment 2021 Incentive Plan [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of share available for issuance                 2,000,000    
2021 Equity Incentive Plan [Member] | Employee Director [Member] | Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of shares issued     25,000                
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions (Details Narrative) - USD ($)
9 Months Ended
Mar. 31, 2020
Sep. 30, 2023
Sep. 30, 2022
Sep. 29, 2023
Mar. 31, 2023
Mar. 16, 2023
Dec. 31, 2022
Oct. 31, 2022
FG Communities Inc [Member]                
Investments         $ 200,000   $ 2,000,000.0 $ 2,000,000.0
Craveworthy [Member]                
Senior unsecured promissory note           $ 200,000    
Think Makets [Member]                
Investments       $ 250,000        
Joint Venture Agreement [Member] | Fundamental Global Asset Management [Member]                
Investment ownership percentage 50.00%              
Shared Services Agreement [Member] | Fundamental Global Management, LLC [Member]                
Shared services fee $ 456,000 $ 1,368,000 $ 1,368,000          
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Net income from continuing operations $ 5,628 $ 10,255 $ 4,055 $ 955
Dividends declared on Series A Preferred Shares (447) (447) (1,339) (1,342)
Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations $ 5,181 $ 9,808 $ 2,716 $ (387)
Weighted average common shares 10,303,739 9,333,709 9,813,438 7,564,017
Income (loss) per common share from continuing operations $ 0.50 $ 1.05 $ 0.28 $ (0.05)
Weighted average common shares outstanding 10,303,739 9,333,709 9,813,438 7,564,017
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Potentially Dilutive Securities Excluded from Calculation (Details) - shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities outstanding 981,055 427,815
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities outstanding 130,000 130,000
Restricted Stock Units (RSUs) [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities outstanding 851,055 297,815
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Apr. 30, 2022
Jul. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Rent expense $ 16,000 $ 8,800    
Lessee discount rate 8.00%      
Operating asset and lease liability $ 44,000      
Lease Agreement [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Lease term     44 months 12 months
Payments for rent     $ 77,000 $ 17,000
Rent expense $ 0 $ 10,000    
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Segment Reporting (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Net premiums earned $ 4,192 $ 4,383 $ 11,534 $ 9,809  
Net investment income (loss) 6,961 11,174 8,272 5,114  
Other income 24 214 84 266  
Total revenue 11,177 15,771 19,890 15,189  
Income (loss) before income tax 5,628 10,255 4,055 955  
Segment assets 58,828 48,923 58,828 48,923 $ 49,475
Insurance [Member]          
Segment Reporting Information [Line Items]          
Net premiums earned 4,192 4,383 11,534 9,809  
Net investment income (loss) 5,032 2,468 8,108 1,562  
Other income  
Total revenue 9,224 6,851 19,642 11,371  
Income (loss) before income tax 5,465 3,274 9,366 2,728  
Segment assets 35,776 21,662 35,776 21,662  
Asset Management [Member]          
Segment Reporting Information [Line Items]          
Net premiums earned  
Net investment income (loss) 1,922 8,706 150 3,552  
Other income 24 89 84 141  
Total revenue 1,946 8,795 234 3,693  
Income (loss) before income tax 1,946 8,798 234 3,680  
Segment assets 18,436 17,777 18,436 17,777  
Other Segments [Member]          
Segment Reporting Information [Line Items]          
Net premiums earned  
Net investment income (loss) 7 14  
Other income 125 125  
Total revenue 7 125 14 125  
Income (loss) before income tax (1,783) (1,817) (5,545) (5,453)  
Segment assets $ 4,616 $ 9,484 $ 4,616 $ 9,484  
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting (Details Narrative)
9 Months Ended
Sep. 30, 2023
USD ($)
Segment
Sep. 30, 2022
USD ($)
Cash and Cash Equivalents [Line Items]    
Number of operating segments | Segment 2  
Unrestricted cash $ 200,000  
Unrestricted Cash [Member]    
Cash and Cash Equivalents [Line Items]    
Unrestricted cash $ 3,800,000 $ 8,700,000
XML 61 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001591890 2023-01-01 2023-09-30 0001591890 FGF:CommonStock0.001ParValuePerShareMember 2023-01-01 2023-09-30 0001591890 FGF:Sec8.00CumulativePreferredStockSeries25.00ParValuePerShareMember 2023-01-01 2023-09-30 0001591890 2023-11-09 0001591890 2023-09-30 0001591890 2022-12-31 0001591890 2023-07-01 2023-09-30 0001591890 2022-07-01 2022-09-30 0001591890 2022-01-01 2022-09-30 0001591890 us-gaap:PreferredStockMember 2021-12-31 0001591890 us-gaap:CommonStockMember 2021-12-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591890 us-gaap:RetainedEarningsMember 2021-12-31 0001591890 2021-12-31 0001591890 us-gaap:PreferredStockMember 2022-03-31 0001591890 us-gaap:CommonStockMember 2022-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591890 us-gaap:RetainedEarningsMember 2022-03-31 0001591890 2022-03-31 0001591890 us-gaap:PreferredStockMember 2022-06-30 0001591890 us-gaap:CommonStockMember 2022-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001591890 us-gaap:RetainedEarningsMember 2022-06-30 0001591890 2022-06-30 0001591890 us-gaap:PreferredStockMember 2022-12-31 0001591890 us-gaap:CommonStockMember 2022-12-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591890 us-gaap:RetainedEarningsMember 2022-12-31 0001591890 us-gaap:PreferredStockMember 2023-03-31 0001591890 us-gaap:CommonStockMember 2023-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591890 us-gaap:RetainedEarningsMember 2023-03-31 0001591890 2023-03-31 0001591890 us-gaap:PreferredStockMember 2023-06-30 0001591890 us-gaap:CommonStockMember 2023-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001591890 us-gaap:RetainedEarningsMember 2023-06-30 0001591890 2023-06-30 0001591890 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591890 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591890 2022-01-01 2022-03-31 0001591890 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001591890 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001591890 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001591890 2022-04-01 2022-06-30 0001591890 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001591890 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001591890 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001591890 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591890 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591890 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591890 2023-01-01 2023-03-31 0001591890 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001591890 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001591890 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001591890 2023-04-01 2023-06-30 0001591890 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001591890 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001591890 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001591890 us-gaap:PreferredStockMember 2022-09-30 0001591890 us-gaap:CommonStockMember 2022-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001591890 us-gaap:RetainedEarningsMember 2022-09-30 0001591890 2022-09-30 0001591890 us-gaap:PreferredStockMember 2023-09-30 0001591890 us-gaap:CommonStockMember 2023-09-30 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001591890 us-gaap:RetainedEarningsMember 2023-09-30 0001591890 FGF:FundamentalGlobalInvestorMember us-gaap:CommonStockMember 2023-09-30 0001591890 FGF:FGCommunitiesIncMember 2022-12-31 0001591890 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember FGF:FundamentalGlobalAssetManagementLLCMember 2020-09-30 0001591890 FGF:FGACInvestorsLLCMember 2023-06-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-06-30 0001591890 FGF:GreenfirstForestProductsLLCMember 2023-06-30 0001591890 FGF:FGACInvestorsLLCMember 2023-06-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-06-30 0001591890 FGF:GreenfirstForestProductsHoldingsLLCMember 2023-06-30 0001591890 FGF:OppFiMember 2023-06-30 0001591890 FGF:FGCommunitiesIncMember 2022-10-31 0001591890 FGF:VariableInterestEntityMember 2023-09-30 0001591890 FGF:VariableInterestEntityMember 2022-12-31 0001591890 2023-01-01 0001591890 FGF:FGCommunitiesIncMember 2023-03-31 0001591890 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001591890 FGF:OppFiCommonStockAndWarrantsMember 2023-09-30 0001591890 FGF:OppFiCommonStockAndWarrantsMember 2023-01-01 2023-09-30 0001591890 FGF:HagertyCommonStockMember 2022-12-31 0001591890 FGF:HagertyCommonStockMember 2022-01-01 2022-12-31 0001591890 2022-01-01 2022-12-31 0001591890 FGF:OppFiCommonStockMember 2023-01-01 2023-09-30 0001591890 FGF:HagertyCommonStockMember 2022-12-14 2022-12-15 0001591890 FGF:FGSPACPartnersLPMember 2021-01-04 0001591890 FGF:FGMPMember 2023-07-01 2023-09-30 0001591890 FGF:FGMPMember 2023-01-01 2023-09-30 0001591890 FGF:FGMPMember 2022-01-01 2022-12-31 0001591890 FGF:FGMPMember 2023-09-30 0001591890 srt:MaximumMember FGF:FGMPMember 2023-09-30 0001591890 FGF:FGACInvestorsLLCMember 2023-09-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-09-30 0001591890 FGF:GreenfirstForestProductsLLCMember 2023-09-30 0001591890 FGF:InvestmentFundMember 2023-06-30 0001591890 FGF:FGMergerInvestorsLLCMember 2023-07-01 2023-09-30 0001591890 FGF:FGACInvestorsLLCMember 2023-07-01 2023-09-30 0001591890 FGF:FGMergerInvestorsMember 2023-07-01 2023-09-30 0001591890 FGF:GreenfirstForestProductsHoldingsLLCMember 2023-07-01 2023-09-30 0001591890 FGF:InvestmentFundMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsNonrecurringMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001591890 FGF:ThinkMarketsMember 2023-09-29 0001591890 FGF:ThinkMarketsMember 2023-09-29 2023-09-29 0001591890 FGF:ThinkMarketsMember 2023-09-30 0001591890 FGF:CraveworthyMember 2023-03-16 0001591890 FGF:CraveworthyMember 2023-03-16 2023-03-16 0001591890 FGF:CraveworthyMember 2023-09-30 0001591890 FGF:ICoreConnectIncMember 2023-03-15 0001591890 FGF:ICoreConnectIncMember 2023-01-01 2023-09-30 0001591890 FGF:ConvertiblePromissoryNoteMember 2023-09-29 0001591890 FGF:EquityMethodInvestmentMember 2023-09-30 0001591890 FGF:EquityMethodInvestmentMember 2022-12-31 0001591890 FGF:EquityMethodInvestmentMember 2023-01-01 2023-09-30 0001591890 FGF:EquityMethodInvestmentMember 2022-01-01 2022-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2023-07-01 2023-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2022-07-01 2022-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2023-01-01 2023-09-30 0001591890 FGF:RealizedGainLossOnCommonStockMember 2022-01-01 2022-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2023-07-01 2023-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2022-07-01 2022-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2023-01-01 2023-09-30 0001591890 FGF:ChangeInUnrealizedHoldingOnCommonStockMember 2022-01-01 2022-09-30 0001591890 FGF:EquityMethodEarningsMember 2023-07-01 2023-09-30 0001591890 FGF:EquityMethodEarningsMember 2022-07-01 2022-09-30 0001591890 FGF:EquityMethodEarningsMember 2023-01-01 2023-09-30 0001591890 FGF:EquityMethodEarningsMember 2022-01-01 2022-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2023-07-01 2023-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2022-07-01 2022-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2023-01-01 2023-09-30 0001591890 FGF:IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember 2022-01-01 2022-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2023-07-01 2023-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2022-07-01 2022-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2023-01-01 2023-09-30 0001591890 FGF:DecreaseIncreaseInFairValueOfConvertibleNoteMember 2022-01-01 2022-09-30 0001591890 FGF:OtherMember 2023-07-01 2023-09-30 0001591890 FGF:OtherMember 2022-07-01 2022-09-30 0001591890 FGF:OtherMember 2023-01-01 2023-09-30 0001591890 FGF:OtherMember 2022-01-01 2022-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:OpfiCommonStockAndWarrantsMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:ThinkMarketsConvertibleNoteMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001591890 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001591890 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001591890 us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001591890 us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndThirtyNineMember 2023-09-30 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndFourtyMember 2023-09-30 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndFourtyOneMember 2023-09-30 0001591890 FGF:NotExpireUnderCurrentTaxLawMember 2023-09-30 0001591890 FGF:ExpireOnDecemberTwoThousandAndTwentySixMember 2023-09-30 0001591890 srt:MaximumMember FGF:TwoThousandAndTwentyOneIncentivePlanMember 2021-12-15 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember 2023-03-24 0001591890 FGF:AmendmentTwoThousandAndTwentyOneIncentivePlanMember 2023-03-24 0001591890 2023-03-24 0001591890 FGF:NonEmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-08-18 2022-08-19 0001591890 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember 2023-02-16 2023-02-17 0001591890 FGF:NonExecutiveMembersMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001591890 FGF:LarryGSwetsJrMember FGF:EquityAwardLetterAgreementMember 2021-01-17 2021-01-18 0001591890 FGF:MrSwetsMember us-gaap:RestrictedStockUnitsRSUMember 2023-02-16 2023-02-17 0001591890 FGF:EmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember FGF:TwentyTwentyOneEquityIncentivePlanMember 2022-07-31 2022-07-31 0001591890 FGF:LarryGSwetsJrMember FGF:StockOptionAgreementMember 2021-01-12 2021-01-12 0001591890 FGF:LarryGSwetsJrMember FGF:StockOptionAgreementMember 2023-01-01 2023-09-30 0001591890 us-gaap:WarrantMember 2022-02-24 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-12-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2023-01-01 2023-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2023-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2021-12-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-01-01 2022-09-30 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-09-30 0001591890 FGF:FundamentalGlobalAssetManagementMember FGF:JointVentureAgreementMember 2020-03-31 0001591890 FGF:ThinkMaketsMember 2023-09-29 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2020-03-31 2020-03-31 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2023-01-01 2023-09-30 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2022-01-01 2022-09-30 0001591890 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001591890 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001591890 FGF:LeaseAgreementMember 2021-07-31 0001591890 FGF:LeaseAgreementMember 2023-01-01 2023-09-30 0001591890 FGF:LeaseAgreementMember 2022-01-01 2022-09-30 0001591890 FGF:LeaseAgreementMember 2022-04-30 0001591890 FGF:UnrestrictedCashMember 2023-09-30 0001591890 FGF:UnrestrictedCashMember 2022-09-30 0001591890 FGF:InsuranceMember 2023-07-01 2023-09-30 0001591890 FGF:AssetManagementMember 2023-07-01 2023-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001591890 FGF:InsuranceMember 2023-01-01 2023-09-30 0001591890 FGF:AssetManagementMember 2023-01-01 2023-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001591890 FGF:InsuranceMember 2023-09-30 0001591890 FGF:AssetManagementMember 2023-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2023-09-30 0001591890 FGF:InsuranceMember 2022-07-01 2022-09-30 0001591890 FGF:AssetManagementMember 2022-07-01 2022-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001591890 FGF:InsuranceMember 2022-01-01 2022-09-30 0001591890 FGF:AssetManagementMember 2022-01-01 2022-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001591890 FGF:InsuranceMember 2022-09-30 0001591890 FGF:AssetManagementMember 2022-09-30 0001591890 us-gaap:AllOtherSegmentsMember 2022-09-30 iso4217:USD shares iso4217:USD shares pure FGF:Integer FGF:Segment false --12-31 Q3 0001591890 10-Q true 2023-09-30 2023 false 001-36366 FG Financial Group, Inc. NV 46-1119100 104 S. Walnut Street Unit 1A Itasca IL 60143 (847) 773-1665 Common Stock, $0.001 par value per share FGF NASDAQ 8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share FGFPP NASDAQ Yes Yes Non-accelerated Filer true false false 10558930 1916000 889000 2187000 841000 27365000 24839000 5525000 3010000 1480000 1527000 84000 0 14469000 9269000 7075000 9277000 727000 712000 58828000 49475000 5912000 4409000 9394000 6823000 720000 723000 135000 225000 16161000 12180000 25.00 25.00 1000000 1000000 894580 894580 894580 894580 22365000 22365000 0.001 0.001 100000000 100000000 10303739 10303739 9410473 9410473 10000 9000 52781000 50021000 -32489000 -35100000 42667000 37295000 58828000 49475000 4192000 4383000 11534000 9809000 6961000 11174000 8272000 5114000 24000 214000 84000 266000 11177000 15771000 19890000 15189000 2205000 2406000 6081000 5798000 1003000 1109000 2533000 2427000 2341000 2001000 7221000 6009000 5549000 5516000 15835000 14234000 5628000 10255000 4055000 955000 447000 447000 1339000 1342000 5181000 9808000 2716000 -387000 0.50 0.50 1.05 1.05 0.28 0.28 -0.05 -0.05 10303739 10303739 9333709 9333709 9813438 9813438 7564017 7564017 894580 22365000 6497205 6000 46037000 -34399000 34009000 30796 1000 62000 63000 0.50 -447000 -447000 -3823000 -3823000 894580 22365000 6528001 7000 46099000 -38669000 29802000 2750000 2000 3781000 3784000 53000 52000 0.50 -447000 -447000 -5478000 -5478000 894580 22365000 9278001 9000 49933000 -44594000 27713000 71770 106000 106000 44269 65000 65000 0.50 -447000 -447000 10255000 10255000 894580 22365000 9394040 9000 50104000 -34786000 37692000 894580 22365000 9410473 9000 50021000 -35100000 37295000 894580 22365000 9410473 9000 50021000 -35100000 37295000 27186 74000 74000 1080 641000 641000 0.50 -447000 -447000 1350000 1350000 -106000 -106000 894580 22365000 9438739 9000 50736000 -34303000 38807000 865000 1000 1205000 1206000 361000 361000 0.50 -444000 -444000 -2923000 -2923000 894580 22365000 10303739 10000 52302000 -37670000 37007000 479000 479000 0.50 -447000 -447000 5628000 5628000 5628000 5628000 894580 22365000 10303739 10000 52781000 -32489000 42667000 894580 22365000 10303739 10000 52781000 -32489000 42667000 4055000 955000 319000 10521000 4192000 2880000 250000 125000 3062000 -11263000 1481000 180000 5307000 3857000 2202000 -2237000 -47000 1134000 42000 121000 1503000 2000000 2571000 2955000 -92000 -544000 -1530000 -3941000 77000 495000 6795000 950000 761000 1521000 4604000 664000 184000 185000 4104000 -4502000 1339000 1341000 1280000 3889000 -59000 2548000 2515000 -5895000 3010000 15542000 5525000 9647000 1916000 <p id="xdx_808_eus-gaap--NatureOfOperations_zOJXT0emTUH3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_825_zCza6tBYSaD3">Nature of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FG Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss-capped reinsurance, while allocating capital in partnership with Fundamental Global<sup>®</sup>, and from time to time, other strategic investors, to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also provides asset management services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From our inception in October 2012 through December 2019, we operated as an insurance holding company, writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three former insurance subsidiaries to FedNat Holding Company (“FedNat”) for a combination of cash and FedNat common stock, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity, collectively beneficially owned approximately <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230930__srt--OwnershipAxis__custom--FundamentalGlobalInvestorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztIrdKl7bau5" title="Ownership percentage">55</span>% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reincorporation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the “Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws. The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management, assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00% Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking activities with asymmetrical risk/reward opportunities. As part of our refined focus, we have adopted the following capital allocation philosophy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>“<b>Grow intrinsic value</b></i> per share with a <b><i>long-term focus</i></b> using <b><i>fundamental research</i></b>, allocating capital to <b><i>asymmetric risk/reward</i></b> opportunities.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special Purpose Acquisition Corporation “SPAC” Platform businesses, and our merchant banking division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Insurance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Protection Coverage and Risk, Inc. has been formed as a special purpose captive in South Carolina to provide reinsurance coverage for Sides A, B, &amp; C Directors and Officers Liability insurance coverage for related and unrelated entities of FG Reinsurance Ltd (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as small cap businesses performing an initial public offering. Sponsor Protection Coverage and Risk, Inc. has yet to write any business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reinsurance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised) of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”). The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which are not fully collateralized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company had <span id="xdx_902_ecustom--NumberOfActiveReinsuranceContracts_iI_dc_uInteger_c20230930_zybkej25iSXk" title="Number of active reinsurance contracts">seven</span> active reinsurance contracts, including participating in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate during the 2021, 2022 and 2023 calendar years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset Management</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FG Strategic Consulting, LLC, (“FGSC”) a wholly owned subsidiary of the Company, looks to provide investment advisory services, including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization, recommending investment dispositions, and providing advice regarding macro-economic conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SPAC Platform and Merchant Banking</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company, to facilitate the launch of our “SPAC Platform.” Under the SPAC Platform, we provide various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the third quarter of 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the fourth quarter of 2022, the Company invested $<span id="xdx_906_eus-gaap--Investments_iI_pn5n6_c20221231__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_zf6vzGvAdR41" title="Investments">2.0</span> million into its first merchant banking project, FG Communities, Inc. (“FGC”). FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.55 7 2000000.0 <p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zHwhE80ABWZj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2. <span id="xdx_82C_zjE1Z68KIM78">Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTJ2GzJAJHI" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zSNpvcfJTYmf">Basis of Presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_z6Hy6bFRAbn2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zgd4EWoAsN04">Consolidation Policies</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that could potentially be significant to the legal entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The determination of whether a legal entity is consolidated under either model is reassessed where there is a substantive change in the governing documents or contractual arrangements of the entity, to the capital structure of the entity or in the activities of the entity. The Company continuously reassesses whether it should consolidate under either model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2020, the Company invested approximately $<span id="xdx_909_eus-gaap--RealEstateInvestments_iI_pn5n6_c20200930__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--FundamentalGlobalAssetManagementLLCMember_zTCBkdn3NVuf" title="Real estate investment">5.0</span> million to sponsor the launch of the FG Special Situations Fund, LP (“The Fund”). The Fund, a VIE which the Company was required to consolidate through November 30, 2021, was considered an investment company for GAAP purposes and followed the accounting and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus, began to account for its investment in the Fund under the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, Greenfirst Forest Products Holdings LLC, and OppFi. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--FGACInvestorsLLCMember_zmGz2SgE8Crl" title="Debt carry value">8.9</span> million, FG Merger Investors LLC, with a carrying value of $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--FGMergerInvestorsLLCMember_zRvIQbH82p53" title="Debt carry value">3.4</span> million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--GreenfirstForestProductsLLCMember_z7wYK5EWskYk" title="Debt carry value">1.4</span> million. The carrying value of these direct limited partner interests approximate to ownership of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGACInvestorsLLCMember_zwHHarIVG2Sg" title="Equity method investment, ownership percentage">29</span>% of FGAC Investors LLC, <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGMergerInvestorsLLCMember_zpgiBYAFshJ2" title="Equity method investment, ownership percentage">19</span>% of FG Merger Investors LLC, and <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenfirstForestProductsHoldingsLLCMember_zmRHRYYVEyA8" title="Equity method investment, ownership percentage">16</span>% of Greenfirst Forest Products Holdings, LLC. The Fund also distributed OppFi publicly traded securities to the Company with a carrying value of $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--OppFiMember_zzesMU2HTLk7" title="Debt carry value">1.9</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. The Company has determined that each of these entities meets the criteria of a VIE. For each new position, the Company analyzed ASC 810 – Consolidation and has determined it is not the primary beneficiary of FGAC Investors LLC, FG Merger Investors LLC or Greenfirst Forest Products Holdings LLC, but does have the ability to exercise significant influence over each of these. Therefore, the Company will apply the equity method of accounting for each of these investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October of 2022, the Company invested $<span id="xdx_908_eus-gaap--Investments_iI_pn5n6_c20221031__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_znlKVAdCKqTj" title="Investments">2.0</span> million into FGC, which the Company has determined meets the criteria of a VIE. The Company holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not the primary beneficiary of FGC, and thus does not consolidate FGC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s risk of loss associated with its non-consolidated VIEs is limited. As of September 30, 2023, and December 31, 2022, the carrying value and maximum loss exposure of the Company’s non-consolidated VIE’s was $<span id="xdx_902_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--VariableInterestEntityMember_zwYDKGv7YzA5" title="Equity method investments">16.5</span> million and $<span id="xdx_90F_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--VariableInterestEntityMember_zORj2VBvIDoi" title="Equity method investments">18.8</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Note 4 for further information regarding the Company’s investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--UseOfEstimates_za7TAYPpcIG3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zouOzklYzKm1">The Use of Estimates in the Preparation of Consolidated Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying consolidated financial statements include the valuation of our equity method investments, current expected credit losses, the valuation of net deferred income taxes and deferred policy acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_z6C9PHoZGNyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_z3xW06ZxTyoc">Investments in Equity Securities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations as a component of net investment income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--OtherInvestmentPolicyTextBlock_zHOZu8MLbBYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zCqO6uwD7X15">Other Investments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses more than <span id="xdx_904_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20230930_zDygvGmrJjBg" title="Investment interest rate">20</span>% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock and to other investments when such other investments possess substantially identical subordinated interests to common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our claim on the investee’s book value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods, with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative equity in earnings represent returns on investment and are classified as cash inflows from investing activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to investments accounted for under the equity method of accounting, other investments also consist of equity we have purchased in a limited partnership, a limited liability company, and a corporation for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an asset measured at fair value on a nonrecurring basis. Any profit distributions the Company receives on these investments are included in net investment income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments also include a convertible note and a senior unsecured promissory note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Note 4 for additional information regarding the Company’s investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjYmqnuQW2Cg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zCB5uAgbTd98">Cash and Cash Equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Company’s insurance license, the Authority has required that FGRe hold a minimum capital requirement of $<span id="xdx_903_eus-gaap--Cash_iI_c20230930_z5Ge7Q9X8075" title="Cash in bank">200,000</span> in cash in a bank in the Cayman Islands which holds an “A” license issued under the Banks and Trust Companies Act (2020 Revision).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zaJKvFUGq1Y1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zvL7vZVFVjv1">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zboCgvYF8Oz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zYHf8Ths7095">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zssqVjRbJang" title="Cash deposit per institution insured by FDIC">250,000</span>. As of September 30, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_z9n7sI9Zujdd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zw62U9eRAtCf">Premium Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company participates in quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represents estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--CurrentExpectedCreditLossPolicyTextBlock_zGNEiVxSgAva" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zkGfKqUuCfYf">Current Expected Credit Loss</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the first quarter of 2023, the Company adopted ASU 2016-13, as amended, Financial Instruments – Credit Losses (“ASU 2016-13”), which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The financial assets included in the caption “Reinsurance balances recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. The amendments in this update were effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted, however smaller reporting companies, like the Company, could delay adoption until January 2023. Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $<span id="xdx_901_eus-gaap--CumulativeEarningsDeficit_iI_pn5n6_c20230101_zai3cYW9oOR2" title="Accumulated deficit">0.1</span> million as of January 1, 2023. The Company updates the model each quarter and adjusts the balance accordingly. There was no change to the allowance during the third quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the first quarter of 2023, the Company allocated $<span id="xdx_900_eus-gaap--Investments_iI_c20230331__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_zEoqwCAacQm3" title="Investments">200,000</span> into a promissory note. The promissory note is carried at amortized cost on the Company’s consolidated balance sheet under the caption “other investments.” Due to being held at amortized cost, the promissory note falls into the scope of ASU 2016-13. Due to immateriality, the Company does not have a current expected credit allowance against the promissory note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_zYpMcTpbZFK" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zfYw5Os3aQni">Deferred Policy Acquisition Costs</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--InsuranceContractAcquisitionCostPolicyTextBlock_zbtbvHDV8gmg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zqylhnhCESof">Funds Deposited for Benefit of Reinsured Companies</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">“Funds Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held to support our reinsurance contracts. As of September 30, 2023 and December 31, 2022, the total cash collateral posted to support all of our reinsurance treaties was approximately $<span id="xdx_90B_eus-gaap--SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral_iI_pn5n6_c20230930_zRm3q7qsWwS5" title="Cash collateral total">7.1</span> million and $<span id="xdx_90C_eus-gaap--SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral_iI_pn5n6_c20221231_zcKpqQIM23z3" title="Cash collateral total">9.3</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p id="xdx_846_ecustom--LossAndLossAdjustmentExpenseReservesPolicyTextBlock_zUmaj57jLB96" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zKzjuwzWZdW6">Loss and Loss Adjustment Expense Reserves</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports the Company has received from ceding companies. The Company then uses a variety of statistical and actuarial techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures and projected ultimate premium to be written by our cedants; (2) expected loss ratios by type of business; (3) actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions. The Company also engages independent actuarial specialists, at least annually, to assist management in establishing appropriate reserves. Since reserves are estimates, the final settlement of losses may vary from the reserves established, and any adjustments to the estimates, which may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the reserves recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zSt3Q3kMEiJl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zTAknMYsoF1">Stock-Based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – <i>Stock Compensation,</i> which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period, which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which vest solely based upon the passage of time. The fair value of each RSU is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock compensation expense for expected forfeitures as of September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zkvpcevtBwA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zIAEfS5PHFS4">Fair Value of Financial Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other accrued expenses, approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_znEO5lcClRY3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zsxkyxUQozw5">Earnings (Loss) Per Common Share</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings (loss) per share if their effect is anti-dilutive.</span></p> <p id="xdx_856_zD5eORuTQww4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTJ2GzJAJHI" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zSNpvcfJTYmf">Basis of Presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_z6Hy6bFRAbn2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zgd4EWoAsN04">Consolidation Policies</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that could potentially be significant to the legal entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The determination of whether a legal entity is consolidated under either model is reassessed where there is a substantive change in the governing documents or contractual arrangements of the entity, to the capital structure of the entity or in the activities of the entity. The Company continuously reassesses whether it should consolidate under either model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2020, the Company invested approximately $<span id="xdx_909_eus-gaap--RealEstateInvestments_iI_pn5n6_c20200930__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--FundamentalGlobalAssetManagementLLCMember_zTCBkdn3NVuf" title="Real estate investment">5.0</span> million to sponsor the launch of the FG Special Situations Fund, LP (“The Fund”). The Fund, a VIE which the Company was required to consolidate through November 30, 2021, was considered an investment company for GAAP purposes and followed the accounting and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus, began to account for its investment in the Fund under the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, Greenfirst Forest Products Holdings LLC, and OppFi. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--FGACInvestorsLLCMember_zmGz2SgE8Crl" title="Debt carry value">8.9</span> million, FG Merger Investors LLC, with a carrying value of $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--FGMergerInvestorsLLCMember_zRvIQbH82p53" title="Debt carry value">3.4</span> million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--GreenfirstForestProductsLLCMember_z7wYK5EWskYk" title="Debt carry value">1.4</span> million. The carrying value of these direct limited partner interests approximate to ownership of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGACInvestorsLLCMember_zwHHarIVG2Sg" title="Equity method investment, ownership percentage">29</span>% of FGAC Investors LLC, <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGMergerInvestorsLLCMember_zpgiBYAFshJ2" title="Equity method investment, ownership percentage">19</span>% of FG Merger Investors LLC, and <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenfirstForestProductsHoldingsLLCMember_zmRHRYYVEyA8" title="Equity method investment, ownership percentage">16</span>% of Greenfirst Forest Products Holdings, LLC. The Fund also distributed OppFi publicly traded securities to the Company with a carrying value of $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230630__dei--LegalEntityAxis__custom--OppFiMember_zzesMU2HTLk7" title="Debt carry value">1.9</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. The Company has determined that each of these entities meets the criteria of a VIE. For each new position, the Company analyzed ASC 810 – Consolidation and has determined it is not the primary beneficiary of FGAC Investors LLC, FG Merger Investors LLC or Greenfirst Forest Products Holdings LLC, but does have the ability to exercise significant influence over each of these. Therefore, the Company will apply the equity method of accounting for each of these investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October of 2022, the Company invested $<span id="xdx_908_eus-gaap--Investments_iI_pn5n6_c20221031__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_znlKVAdCKqTj" title="Investments">2.0</span> million into FGC, which the Company has determined meets the criteria of a VIE. The Company holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not the primary beneficiary of FGC, and thus does not consolidate FGC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s risk of loss associated with its non-consolidated VIEs is limited. As of September 30, 2023, and December 31, 2022, the carrying value and maximum loss exposure of the Company’s non-consolidated VIE’s was $<span id="xdx_902_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--VariableInterestEntityMember_zwYDKGv7YzA5" title="Equity method investments">16.5</span> million and $<span id="xdx_90F_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--VariableInterestEntityMember_zORj2VBvIDoi" title="Equity method investments">18.8</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Note 4 for further information regarding the Company’s investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5000000.0 8900000 3400000 1400000 0.29 0.19 0.16 1900000 2000000.0 16500000 18800000 <p id="xdx_84D_eus-gaap--UseOfEstimates_za7TAYPpcIG3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zouOzklYzKm1">The Use of Estimates in the Preparation of Consolidated Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying consolidated financial statements include the valuation of our equity method investments, current expected credit losses, the valuation of net deferred income taxes and deferred policy acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_z6C9PHoZGNyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_z3xW06ZxTyoc">Investments in Equity Securities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations as a component of net investment income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--OtherInvestmentPolicyTextBlock_zHOZu8MLbBYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zCqO6uwD7X15">Other Investments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses more than <span id="xdx_904_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20230930_zDygvGmrJjBg" title="Investment interest rate">20</span>% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock and to other investments when such other investments possess substantially identical subordinated interests to common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our claim on the investee’s book value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods, with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative equity in earnings represent returns on investment and are classified as cash inflows from investing activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to investments accounted for under the equity method of accounting, other investments also consist of equity we have purchased in a limited partnership, a limited liability company, and a corporation for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an asset measured at fair value on a nonrecurring basis. Any profit distributions the Company receives on these investments are included in net investment income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments also include a convertible note and a senior unsecured promissory note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Note 4 for additional information regarding the Company’s investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.20 <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjYmqnuQW2Cg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zCB5uAgbTd98">Cash and Cash Equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Company’s insurance license, the Authority has required that FGRe hold a minimum capital requirement of $<span id="xdx_903_eus-gaap--Cash_iI_c20230930_z5Ge7Q9X8075" title="Cash in bank">200,000</span> in cash in a bank in the Cayman Islands which holds an “A” license issued under the Banks and Trust Companies Act (2020 Revision).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 200000 <p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zaJKvFUGq1Y1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zvL7vZVFVjv1">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zboCgvYF8Oz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zYHf8Ths7095">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zssqVjRbJang" title="Cash deposit per institution insured by FDIC">250,000</span>. As of September 30, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 <p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_z9n7sI9Zujdd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zw62U9eRAtCf">Premium Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company participates in quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represents estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--CurrentExpectedCreditLossPolicyTextBlock_zGNEiVxSgAva" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zkGfKqUuCfYf">Current Expected Credit Loss</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the first quarter of 2023, the Company adopted ASU 2016-13, as amended, Financial Instruments – Credit Losses (“ASU 2016-13”), which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The financial assets included in the caption “Reinsurance balances recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. The amendments in this update were effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted, however smaller reporting companies, like the Company, could delay adoption until January 2023. Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $<span id="xdx_901_eus-gaap--CumulativeEarningsDeficit_iI_pn5n6_c20230101_zai3cYW9oOR2" title="Accumulated deficit">0.1</span> million as of January 1, 2023. The Company updates the model each quarter and adjusts the balance accordingly. There was no change to the allowance during the third quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the first quarter of 2023, the Company allocated $<span id="xdx_900_eus-gaap--Investments_iI_c20230331__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_zEoqwCAacQm3" title="Investments">200,000</span> into a promissory note. The promissory note is carried at amortized cost on the Company’s consolidated balance sheet under the caption “other investments.” Due to being held at amortized cost, the promissory note falls into the scope of ASU 2016-13. Due to immateriality, the Company does not have a current expected credit allowance against the promissory note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000 200000 <p id="xdx_840_eus-gaap--CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_zYpMcTpbZFK" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zfYw5Os3aQni">Deferred Policy Acquisition Costs</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--InsuranceContractAcquisitionCostPolicyTextBlock_zbtbvHDV8gmg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zqylhnhCESof">Funds Deposited for Benefit of Reinsured Companies</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">“Funds Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held to support our reinsurance contracts. As of September 30, 2023 and December 31, 2022, the total cash collateral posted to support all of our reinsurance treaties was approximately $<span id="xdx_90B_eus-gaap--SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral_iI_pn5n6_c20230930_zRm3q7qsWwS5" title="Cash collateral total">7.1</span> million and $<span id="xdx_90C_eus-gaap--SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral_iI_pn5n6_c20221231_zcKpqQIM23z3" title="Cash collateral total">9.3</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> 7100000 9300000 <p id="xdx_846_ecustom--LossAndLossAdjustmentExpenseReservesPolicyTextBlock_zUmaj57jLB96" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zKzjuwzWZdW6">Loss and Loss Adjustment Expense Reserves</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports the Company has received from ceding companies. The Company then uses a variety of statistical and actuarial techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures and projected ultimate premium to be written by our cedants; (2) expected loss ratios by type of business; (3) actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions. The Company also engages independent actuarial specialists, at least annually, to assist management in establishing appropriate reserves. Since reserves are estimates, the final settlement of losses may vary from the reserves established, and any adjustments to the estimates, which may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the reserves recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zSt3Q3kMEiJl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zTAknMYsoF1">Stock-Based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – <i>Stock Compensation,</i> which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period, which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which vest solely based upon the passage of time. The fair value of each RSU is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock compensation expense for expected forfeitures as of September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zkvpcevtBwA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zIAEfS5PHFS4">Fair Value of Financial Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other accrued expenses, approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_znEO5lcClRY3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zsxkyxUQozw5">Earnings (Loss) Per Common Share</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings (loss) per share if their effect is anti-dilutive.</span></p> <p id="xdx_80D_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zH2jt16vXzch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3. <span id="xdx_82B_zwNtnuqfL9gd">Recently Adopted and Issued Accounting Standards</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounting Standards Adopted</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As discussed, the Company adopted ASU 2016-13 during the first quarter of 2023 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $<span id="xdx_90F_eus-gaap--CumulativeEarningsDeficit_iI_pn5n6_c20230101_zbotR0RpCY65" title="Cumulative earnings deficit">0.1</span> million as of January 1, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 100000 <p id="xdx_808_ecustom--InvestmentsAndFairValueDisclosuresTextBlock_zRe2h41t7cKi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4. <span id="xdx_82E_zuz6gCjbxrV2">Investments and Fair Value Disclosures</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--InvestmentTableTextBlock_zk37wZcwb2pl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s equity securities held at fair value as of September 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B5_zBkL3GRuL6Fg" style="display: none">Schedule of Equity Securities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td>(in thousands)</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">As of September 30, 2023</td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gains</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Losses</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">OppFi common stock and warrants</td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zOGsDvOQpGnb" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">1,916</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zsls1FVFoOti" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">    271</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zlFXJjBzZbRc" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">         <span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zQyQmI448vUa" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">2,187</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total investments</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20230930_zNf3hjq0BHEd" style="text-align: right" title="Investments, Cost basis">1,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20230101__20230930_zxjnLASZzGI2" style="text-align: right" title="Investments, Gross Unrealized Gains">271</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20230101__20230930_ztj4cbL8Z1y1" style="text-align: right" title="Investments, Gross Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20230930_ze6CwaAhkxc8" style="text-align: right" title="Investments, Carrying Amount">2,187</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">As of December 31, 2022</td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gains</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Losses</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Hagerty common stock</td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zuzlDOEK3NUe" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">889</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20220101__20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zCthFa4yrKP" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0728">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20220101__20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_z2bdSklqNJ21" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">48</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zwJOVspMsMV3" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">841</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total investments</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20221231_zZ1AexF49Dag" style="text-align: right" title="Investments, Cost basis">889</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20220101__20221231_zQ65dXl2TrSg" style="text-align: right" title="Investments, Gross Unrealized Gains">         <span style="-sec-ix-hidden: xdx2ixbrl0734">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20220101__20221231_zrdGziofrcz9" style="text-align: right" title="Investments, Gross Unrealized Losses">      48</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20221231_zRuDzzcaFtba" style="text-align: right" title="Investments, Carrying Amount">841</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_z6mrNLMXdw9j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>OppFi Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Fund unwinding, the Company received approximately <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockMember_zL6kLQwcmqB9" title="Number of shares issued">860,000</span> shares of OppFi common stock. On the date of the distribution, the common shares had an aggregate fair value of approximately $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueOther_pn5n6_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockMember_zMGlFs9jRuaa" title="Number of shares issued, value">1.9</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hagerty Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 15, 2022, FGMP distributed <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20221214__20221215__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zF3iZtXSEoB" title="Number of shares issued, shares">99,999</span> common shares of Hagerty to the Company. On the date of distribution, the common shares had an aggregate fair value of approximately $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueOther_pid_c20221214__20221215__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_z7sC1itaLC03" title="Number of shares issued, value">889,000</span>. The Company sold the common shares during the first quarter of 2023 for a realized loss of approximately $<span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230101__20230331_zLDleXwKGKgl" title="Sale of stock number of shares sold">16,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity Method Investments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments on the Company’s consolidated balance sheets include our equity method investments in FGMP, FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On January 4, 2021, FGMP was formed as a Delaware limited partnership to co-sponsor newly formed SPACs with their founders or partners, as well as other merchant banking interests. The Company is the sole managing member of the general partner of FGMP and holds a limited partner interest of approximately <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20210104__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGSPACPartnersLPMember_zzx7oBCUnC4f" title="Equity method investments">46</span>% in FGMP directly and through its subsidiaries. FGMP participates as a co-sponsor of the SPACs launched under our SPAC Platform as well as merchant banking initiatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">For the three months ended September 30, 2023, the Company recorded equity method gains from FGMP of approximately $<span id="xdx_909_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_pn5n6_c20230701__20230930__dei--LegalEntityAxis__custom--FGMPMember_zNMYIlZGXh4b" title="Equity method investment realized gain (loss)">1.2</span> million. No capital contributions were made to FGMP during the quarter. For the nine months ended September 30, 2023, the Company contributed $<span id="xdx_902_eus-gaap--GainLossOnInvestments_pn5n6_c20230101__20230930__dei--LegalEntityAxis__custom--FGMPMember_zy6C9X5qhfr" title="Gain loss on investments">0.1</span> million into FGMP and has recorded equity method gains of approximately $<span id="xdx_901_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_pn5n6_c20230101__20230930__dei--LegalEntityAxis__custom--FGMPMember_zq9s0GPn0Y27" title="Equity method investment realized gain (loss)">4.1</span> million. The carrying value of our investment in FGMP as of September 30, 2023 was approximately $<span id="xdx_904_eus-gaap--UndistributedEarnings_pn5n6_c20230101__20230930__dei--LegalEntityAxis__custom--FGMPMember_zwTAun1Iglka" title="Undistributed earnings">9.9</span> million compared to $<span id="xdx_904_eus-gaap--UndistributedEarnings_pn5n6_c20220101__20221231__dei--LegalEntityAxis__custom--FGMPMember_ztn0MPHqVVi3" title="Undistributed earnings">5.7</span> million as of December 31, 2022. Of the $<span id="xdx_90C_eus-gaap--Investments_iI_pn5n6_c20230930__dei--LegalEntityAxis__custom--FGMPMember_zsF5RDWZFXN" title="Investments">9.9</span> million carrying value of our investment in FGMP at September 30, 2023 the Company may allocate up to approximately $<span id="xdx_908_eus-gaap--Investments_iI_pn5n6_c20230930__dei--LegalEntityAxis__custom--FGMPMember__srt--RangeAxis__srt--MaximumMember_zdEglqjUbm16" title="Investments">0.4</span> million to incentivize and compensate individuals and entities for the successful merger of SPACs launched under our platform.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity method investments previously included our investment in the Fund. However, during the first quarter of 2023, it was determined that the Fund would begin the process of winding down, and all investment holdings held in the name of the Fund would be transferred and distributed to members within the Fund based on their ownership percentage of each respective holding. Prior to the unwinding, through the Fund, the Company held underlying investments in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings LLC. The Fund, an investment company, carried each of these investments at fair value. In June 2023, all transfers were completed, resulting in the Company being transferred direct limited partner interests in FGAC Investors LLC, with a carrying value of $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230930__dei--LegalEntityAxis__custom--FGACInvestorsLLCMember_zxQL9WR8GVW7" title="Debt carry value">8.9</span> million, FG Merger Investors LLC, with a carrying value of $<span id="xdx_90F_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230930__dei--LegalEntityAxis__custom--FGMergerInvestorsLLCMember_zkGZGj2S0ADk" title="Debt carry value">3.4</span> million, and Greenfirst Forest Products Holdings, LLC, with a carrying value of $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20230930__dei--LegalEntityAxis__custom--GreenfirstForestProductsLLCMember_z4Rl5rDLGHSl" title="Debt carry value">1.4</span> million. The Company determined that it has the ability to exercise significant influence over FGAC Investors LLC, FG Merger Investors LLC and Greenfirst Forest Products Holdings LLC, and thus will account for each of these investments under the equity method of accounting. After taking into account second quarter equity pickups, <span style="background-color: white">the combined carrying value of these investments at June 30, 2023 was approximately $<span id="xdx_900_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--InvestmentFundMember_z8dDewIYWh94" title="Investment fund">11.9</span> million. For the three months ended September 30, 2023, the Company contributed $<span id="xdx_90B_eus-gaap--ProceedsFromContributedCapital_pn5n6_c20230701__20230930__dei--LegalEntityAxis__custom--FGMergerInvestorsLLCMember_zIzNtewANSj6" title="Contributed">0.5</span> million into FG Merger Investors LLC, and recorded an equity method gain of approximately $<span id="xdx_906_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_pn5n6_c20230701__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGACInvestorsLLCMember_zS2mRfn1pyCh" title="Equity method investment realized gain (loss)">2.4</span> million. The Company recorded an equity method loss from Greenfirst Forest Products Holdings LLC of approximately $<span id="xdx_907_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_pn5n6_c20230701__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FGMergerInvestorsMember_zJslzieUMf3a" title="Equity method investment realized gain (loss)">0.1</span> million and a gain of $<span id="xdx_90F_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_pn5n6_c20230701__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenfirstForestProductsHoldingsLLCMember_zSqFa23JVsYg" title="Equity method investment realized gain (loss)">0.1</span> million from FGAC Investors LLC for the three months ended September 30, 2023. The combined carrying value of these investments at September 30, 2023 was approximately $<span id="xdx_90B_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--InvestmentFundMember_zG0Dt4R52dRi" title="Investment fund">14.7</span> million.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zWbYHOjY3P7l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial information for our investments accounted for under the equity method, in the aggregate, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BD_zOmKLJen12Ra" style="display: none">Schedule of Investments Under Equity Method</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_491_20230930__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zopRpHwETiXg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of<br/> September 30, </b></span><b>2023</b></p></td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20221231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zdYYVTnyDnhe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">(in thousands)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherInvestments_iI_pn3n3_zcWNkazBouq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">Other investments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">72,585</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">35,366</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Cash_iI_pn3n3_zjdZo7MUNxH5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherAssets_iI_pn3n3_zDqiV89H1yv8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Other assets</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">177</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">165</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Assets_iI_pn3n3_zLxXDPyn6ZOg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,644</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--Liabilities_iI_pn3n3_zH4plCOeUOE6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">439</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_493_20230101__20230930__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zUyXbQhloUy4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended<br/> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p></td><td> </td><td> </td> <td colspan="2" id="xdx_49E_20220101__20220930__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zubPll4WlCR6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2022</b></span></p></td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">(in thousands)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InvestmentIncomeNet_pn3n3_zNWW8U1WMPha" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">Net investment income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">17,417</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">8,170</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherIncome_pn3n3_zaj72K2qPfE7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Other income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--GeneralAndAdministrativeExpense_iN_pn3n3_di_zBg0OU5BarIf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">General and administrative expenses</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,149</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--GrossProfit_pn3n3_zwlDDmZYgymi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Net income </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,397</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,075</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zbNQ9hNJoMCe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing equity for SPACs that have not yet closed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investments without Readily Determinable Fair Value</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to our equity method investments, other investments, as listed on our consolidated balance sheets, consist of equity we have purchased in companies for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Any profit distributions the Company receives on these investments are included in net investment income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of investments without readily determinable fair value were increased by $<span id="xdx_908_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_pn5n6_c20230101__20230930_zV4nAIlpUSd" title="Increase carrying value of investments">0.3</span> million for the nine months ended September 30, 2023, as compared to <span id="xdx_901_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_dc_c20220101__20220930_zpTvQaibuFii" title="Increase carrying value of investments">zero</span> for the nine months ended September 30, 2022. The increase was due to an observable price change in FGC during the second quarter of 2023. This amount is included in net investment income on the Company’s consolidated statements of operations. The Company did not record any changes during the three months ended September 30, 2023, and September 30, 2022. The Company’s total carrying value in investments without a readily determinable fair value was $<span id="xdx_90A_eus-gaap--Investments_iI_pn5n6_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zVYl7Jzwhg1">2.3</span> million as of September 30, 2023, compared to approximately $<span id="xdx_903_eus-gaap--Investments_iI_pn5n6_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zdaDKe5ISH3b">2.3</span> million as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments, in addition to equity method investments and investments without readily determinable fair value, include a convertible promissory note and a senior unsecured promissory note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 29, 2023, the Company invested $<span id="xdx_90D_eus-gaap--Investments_iI_c20230929__dei--LegalEntityAxis__custom--ThinkMarketsMember_zKzG9ylO2Tcj">250,000</span> in a convertible promissory note with ThinkMarkets. The promissory note has an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230929__dei--LegalEntityAxis__custom--ThinkMarketsMember_zwXKaAAuRzl1">15</span>% annually, with interest payments due monthly, and matures on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230929__20230929__dei--LegalEntityAxis__custom--ThinkMarketsMember_ziEKrNws5cg6">August 1, 2025</span>. Commencing upon the closing of the contemplated business combination, the Company has the option to convert any unpaid loan amount and all accrued and unpaid interest into fully paid shares of FGAC common stock, at a conversion price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230929__dei--LegalEntityAxis__custom--ThinkMarketsMember_z3tcRdrJCzg2" title="Shares issued price per share">5.00</span> per share. The Company evaluated the convertible promissory note’s settlement provisions and elected the fair value option to value this instrument. Under the fair value election, the convertible promissory note is measured initially and subsequently at fair value, which as of September 30, 2023, both are calculated to be $<span id="xdx_90D_eus-gaap--OtherInvestments_iI_c20230930__dei--LegalEntityAxis__custom--ThinkMarketsMember_zjLgReYfWpgf" title="Other investments">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 16, 2023, the Company invested $<span id="xdx_903_eus-gaap--UnsecuredDebt_iI_c20230316__dei--LegalEntityAxis__custom--CraveworthyMember_z7ZdFp98Sfw6" title="Senior unsecured promissory note">200,000</span> in a senior unsecured loan to Craveworthy LLC (“Craveworthy”). The loan has an interest rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230316__dei--LegalEntityAxis__custom--CraveworthyMember_z0jYCD5OL1vc" title="Debt instrument interest rate">13</span>% and a maturity of <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20230316__20230316__dei--LegalEntityAxis__custom--CraveworthyMember_zvrqgWmwX4Wj" title="Debt instrument maturity date">March 15, 2024</span>. The $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20230316__dei--LegalEntityAxis__custom--CraveworthyMember_zmBx7iqE9c39" title="Debt instrument principal amount">200,000</span> principal and any interest accrued may be prepaid voluntarily by Craveworthy but is not required to be paid until the date of maturity. As of September 30, 2023, the entire principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20230930__dei--LegalEntityAxis__custom--CraveworthyMember_zHr1l8zjz7c2" title="Debt instrument principal amount">200,000</span> as well as approximately $<span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20230930__dei--LegalEntityAxis__custom--CraveworthyMember_zu4hX8BgAgP8" title="Accrued interest">15,000</span> of accrued interest was outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 15, 2023, the Company invested $<span id="xdx_908_eus-gaap--Investments_iI_c20230315__dei--LegalEntityAxis__custom--ICoreConnectIncMember_zV1e6xkZw9Lk" title="Investments">500,000</span> in a convertible promissory note with iCore. During the third quarter, the Company elected to convert all unpaid principal and interest due from the convertible promissory note with iCore into fully paid common shares of iCore. As part of the conversion, the Company received approximately <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--ICoreConnectIncMember_zLM8G2mkt2mj" title="Number of shares issued">219,000</span> common shares of iCore. During the third quarter, the Company sold all of the common shares received from conversion for approximately $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--ICoreConnectIncMember_zOg5byVOLYJb" title="Proceeds from issuance of common stock">3.7</span> million in cash proceeds, resulting in a realized gain of approximately $<span id="xdx_908_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_pn5n6_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--ICoreConnectIncMember_zhzmWiL2jEda" title="Equity method investment realized gain (loss)">3.1</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impairment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For equity securities without readily determinable fair values, impairment is determined via a qualitative assessment which considers indicators to evaluate whether the investment is impaired. Some of these indicators include a significant deterioration in the earnings performance or asset quality of the investee, a significant adverse change in regulatory, economic or general market conditions in which the investee operates, or doubt over an investee’s ability to continue as a going concern. If the investment is deemed to be impaired after conducting this analysis, the Company would estimate the fair value of the investment to determine the amount of impairment loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For equity method investments, evidence of a loss in value might include a series of operating losses of an investee, the absence of an ability to recover the carrying amount of the investment, or a deterioration in the value of the investee’s underlying assets. If these, or other indicators lead to the conclusion that there is a decrease in the value of the investment that is other than temporary, the Company would recognize that decrease in value even though the decrease may be in excess of what would otherwise be recognized under the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The risks and uncertainties inherent in the assessment methodology used to determine impairment include, but may not be limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the opinions of professional investment managers and appraisers could be incorrect;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the past operating performance and cash flows generated from the investee’s operations may not reflect their future performance; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the estimated fair values for investment for which observable market prices are not available are inherently imprecise.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not recorded an impairment on our investments for either of the nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--InvestmentIncomeTextBlock_zWS2Iye2Thgb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment income for the three and nine months ended September 30, 2023 and 2022 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B2_zuyNdOiAqVgd" style="display: none">Schedule of Net Investment Income (Loss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20230701__20230930_zXLyUryLNmtk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20220701__20220930_zwYJJtLwd3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20230101__20230930_zfzVm00tdiod" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20220101__20220930_zE1kyrG1Z2F" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">($ in thousands)</td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Investment income:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--RealizedGainLossOnCommonStockMember_zvf0ARevS9q7" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left; padding-left: 10pt">Realized gain (loss) on common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,078</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(2,472</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,062</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(11,441</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--ChangeInUnrealizedHoldingOnCommonStockMember_zk6t4LwOr5zb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Change in unrealized holding on common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">404</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">319</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,521</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--EquityMethodEarningsMember_ztMAhayhp8c1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Equity method earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,226</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,080</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember_zoXobZSpqqnj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Increase in investments without readily determinable fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--DecreaseIncreaseInFairValueOfConvertibleNoteMember_zlSZzmGHtkb7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">(Decrease) increase in fair value of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(52</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--OtherMember_zCim85yhsVz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Other</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">71</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">324</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(46</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--NetInvestmentIncome_pn3n3_zpaln2PNYyMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,174</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,114</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A6_zisbd3YVP4Qi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value Measurements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. The FASB has issued guidance that defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal, or most advantageous market in an orderly transaction between market participants. This guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance categorizes assets and liabilities at fair value into one of three different levels depending on the observation of the inputs employed in the measurements, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets providing the most reliable measurement of fair value since it is directly observable.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – inputs to the valuation methodology which include quoted prices for similar assets or liabilities in active markets. These inputs are observable, either directly or indirectly, for substantially the full-term of the financial instrument.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – inputs to the valuation methodology which are unobservable and significant to the measurement of fair value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a variety of factors, including the type of investment, whether the investment is new and not yet established in the marketplace, the liquidity of markets and other characteristics specific to the individual investment. In some cases, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the hierarchy based on the lowest level input that is significant to the fair value measurement. When determining fair value, the Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zvlrYXIVqOK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments measured, on a recurring basis, at fair value as of September 30, 2023 and December 31, 2022 in accordance with the guidance promulgated by the FASB are as follows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B7_zoVJK5PrK90f" style="display: none">Schedule of Financial Instruments Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>(in thousands)</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold">As of September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Oppfi common stock and warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zcz4o0gXCaT3" style="width: 11%; text-align: right" title="Equity securities, common stock">2,187</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zMFWxcbcGGG2" style="width: 11%; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0887">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zooupd4ptaMi" style="width: 11%; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0889">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zg61ck2ckLbk" style="width: 11%; text-align: right" title="Equity securities, common stock">2,187</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">ThinkMarkets convertible note</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zhnFGug17l7d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0893">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zmHFlGerZPK" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0895">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zFZMS9zGyZnj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zMzUmgMEaU07" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGNBlrP835b2" style="text-align: right" title="Equity securities, common stock">2,187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z5beFKP247r8" style="text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0903">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqrWUAmjfsLg" style="text-align: right" title="Equity securities, common stock">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDS8gzDRJ7f4" style="text-align: right" title="Equity securities, common stock">2,437</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">As of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Hagerty common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zPFer3V7M0Ng" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">841</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zrnFnbxoYAsk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0911">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zU5U1nLjrmo" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0913">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zKDjHwwIXIG8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">841</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zENNNjqgeV16" style="text-align: right" title="Equity securities, common stock">841</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGtLzwtVNr4j" style="text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0919">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zyxlm1y6F056" style="text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0921">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zg4NZfXH0PHe" style="text-align: right" title="Equity securities, common stock">841</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zPscLERdPy1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 29, 2023, the Company invested $<span id="xdx_903_eus-gaap--Investments_iI_c20230929__dei--LegalEntityAxis__custom--ThinkMarketsMember_z3DAyZUgPIUd" title="Investments">250,000</span> in a convertible promissory note with ThinkMarkets. As of September 30, 2023, the Company approximates the fair value of the note to be $<span id="xdx_909_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20230929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zNPWlUpWsVC9" title="Fair value of note">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p id="xdx_891_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN8LMHrxtKm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables provide a reconciliation of the fair value of recurring Level 3 fair value measurements for the three- and nine-months ended September 30, 2023 and September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B7_z7j9UQlpjKHg" style="display: none">Schedule of Fair Value of Recurring Level 3 Fair Value Measurements</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGQQZrW9Cjqk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmldZrWddyI2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ConvertibleDebtFairValueDisclosures_iS_pn3n3_z02rN9YDEX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Beginning balance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConsiderationPaid_pn3n3_zfEz0M7YhtN2" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left; padding-left: 10pt">Consideration paid</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--IncreaseInFairValueOfConvertibleNote_pn3n3_zod8CrFdu5g3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Increase in fair value of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--TransferOut_iI_pn3n3_zqt9Pe0vyLHl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Transfer out</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iE_pn3n3_zLDHPsVZUHe6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance, September 30</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYLSGP2t4Iig" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjvXrAsLbxTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ConvertibleDebtFairValueDisclosures_iS_pn3n3_z73sZruCpjCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 10pt">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">677</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConsiderationPaid_pn3n3_zVvPX0K8zfFk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Consideration paid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--DecreaseInFairValueOfConvertibleNote_pn3n3_zSL9ggnD7OL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Decrease in fair value of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(52</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0953">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--TransferOut_iI_pn3n3_z6axCmAKPhYc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Transfer out</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(625</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iE_pn3n3_zmDm9SCBrgD5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance, September 30</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0959">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zZJEnmlrdELe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eus-gaap--InvestmentTableTextBlock_zk37wZcwb2pl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s equity securities held at fair value as of September 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B5_zBkL3GRuL6Fg" style="display: none">Schedule of Equity Securities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td>(in thousands)</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">As of September 30, 2023</td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gains</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Losses</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">OppFi common stock and warrants</td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zOGsDvOQpGnb" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">1,916</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zsls1FVFoOti" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">    271</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20230101__20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zlFXJjBzZbRc" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">         <span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20230930__us-gaap--FinancialInstrumentAxis__custom--OppFiCommonStockAndWarrantsMember_zQyQmI448vUa" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">2,187</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total investments</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20230930_zNf3hjq0BHEd" style="text-align: right" title="Investments, Cost basis">1,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20230101__20230930_zxjnLASZzGI2" style="text-align: right" title="Investments, Gross Unrealized Gains">271</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20230101__20230930_ztj4cbL8Z1y1" style="text-align: right" title="Investments, Gross Unrealized Losses"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20230930_ze6CwaAhkxc8" style="text-align: right" title="Investments, Carrying Amount">2,187</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">As of December 31, 2022</td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gains</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Losses</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Hagerty common stock</td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zuzlDOEK3NUe" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">889</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20220101__20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zCthFa4yrKP" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0728">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20220101__20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_z2bdSklqNJ21" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">48</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zwJOVspMsMV3" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">841</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total investments</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20221231_zZ1AexF49Dag" style="text-align: right" title="Investments, Cost basis">889</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DebtSecuritiesTradingUnrealizedGain_pn3n3_c20220101__20221231_zQ65dXl2TrSg" style="text-align: right" title="Investments, Gross Unrealized Gains">         <span style="-sec-ix-hidden: xdx2ixbrl0734">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtSecuritiesTradingUnrealizedLoss_pn3n3_c20220101__20221231_zrdGziofrcz9" style="text-align: right" title="Investments, Gross Unrealized Losses">      48</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--TradingSecuritiesDebt_iI_pn3n3_c20221231_zRuDzzcaFtba" style="text-align: right" title="Investments, Carrying Amount">841</td><td style="text-align: left"> </td></tr> </table> 1916000 271000 2187000 1916000 271000 2187000 889000 48000 841000 889000 48000 841000 860000 1900000 99999 889000 16000 0.46 1200000 100000 4100000 9900000 5700000 9900000 400000 8900000 3400000 1400000 11900000 500000 2400000 100000 100000 14700000 <p id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zWbYHOjY3P7l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial information for our investments accounted for under the equity method, in the aggregate, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BD_zOmKLJen12Ra" style="display: none">Schedule of Investments Under Equity Method</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_491_20230930__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zopRpHwETiXg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of<br/> September 30, </b></span><b>2023</b></p></td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20221231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zdYYVTnyDnhe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">(in thousands)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherInvestments_iI_pn3n3_zcWNkazBouq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">Other investments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">72,585</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">35,366</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Cash_iI_pn3n3_zjdZo7MUNxH5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherAssets_iI_pn3n3_zDqiV89H1yv8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Other assets</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">177</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">165</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Assets_iI_pn3n3_zLxXDPyn6ZOg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,644</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--Liabilities_iI_pn3n3_zH4plCOeUOE6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">439</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_493_20230101__20230930__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zUyXbQhloUy4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended<br/> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p></td><td> </td><td> </td> <td colspan="2" id="xdx_49E_20220101__20220930__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--EquityMethodInvestmentMember_zubPll4WlCR6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2022</b></span></p></td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">(in thousands)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InvestmentIncomeNet_pn3n3_zNWW8U1WMPha" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">Net investment income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">17,417</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">8,170</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherIncome_pn3n3_zaj72K2qPfE7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Other income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--GeneralAndAdministrativeExpense_iN_pn3n3_di_zBg0OU5BarIf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">General and administrative expenses</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,149</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--GrossProfit_pn3n3_zwlDDmZYgymi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Net income </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,397</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,075</td><td style="text-align: left"> </td></tr> </table> 72585000 35366000 275000 113000 177000 165000 73037000 35644000 439000 65000 17417000 8170000 129000 1149000 95000 16397000 8075000 300000 0 2300000 2300000 250000 0.15 2025-08-01 5.00 250000 200000 0.13 2024-03-15 200000 200000 15000 500000 219000 3700000 3100000 <p id="xdx_890_eus-gaap--InvestmentIncomeTextBlock_zWS2Iye2Thgb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment income for the three and nine months ended September 30, 2023 and 2022 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B2_zuyNdOiAqVgd" style="display: none">Schedule of Net Investment Income (Loss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20230701__20230930_zXLyUryLNmtk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20220701__20220930_zwYJJtLwd3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20230101__20230930_zfzVm00tdiod" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20220101__20220930_zE1kyrG1Z2F" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">($ in thousands)</td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Investment income:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--RealizedGainLossOnCommonStockMember_zvf0ARevS9q7" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left; padding-left: 10pt">Realized gain (loss) on common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,078</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(2,472</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,062</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(11,441</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--ChangeInUnrealizedHoldingOnCommonStockMember_zk6t4LwOr5zb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Change in unrealized holding on common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">404</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">319</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,521</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--EquityMethodEarningsMember_ztMAhayhp8c1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Equity method earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,226</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,080</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember_zoXobZSpqqnj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Increase in investments without readily determinable fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--DecreaseIncreaseInFairValueOfConvertibleNoteMember_zlSZzmGHtkb7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">(Decrease) increase in fair value of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(52</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetInvestmentIncome_pn3n3_hus-gaap--InvestmentTypeAxis__custom--OtherMember_zCim85yhsVz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Other</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">71</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">324</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(46</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--NetInvestmentIncome_pn3n3_zpaln2PNYyMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,174</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,114</td><td style="text-align: left"> </td></tr> </table> 3078000 -2472000 3062000 -11441000 404000 2448000 319000 10521000 3460000 11226000 4192000 6080000 250000 -52000 125000 71000 -28000 324000 -46000 6961000 11174000 8272000 5114000 <p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zvlrYXIVqOK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments measured, on a recurring basis, at fair value as of September 30, 2023 and December 31, 2022 in accordance with the guidance promulgated by the FASB are as follows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B7_zoVJK5PrK90f" style="display: none">Schedule of Financial Instruments Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>(in thousands)</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold">As of September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Oppfi common stock and warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zcz4o0gXCaT3" style="width: 11%; text-align: right" title="Equity securities, common stock">2,187</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zMFWxcbcGGG2" style="width: 11%; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0887">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zooupd4ptaMi" style="width: 11%; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0889">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--OpfiCommonStockAndWarrantsMember_zg61ck2ckLbk" style="width: 11%; text-align: right" title="Equity securities, common stock">2,187</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">ThinkMarkets convertible note</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zhnFGug17l7d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0893">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zmHFlGerZPK" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0895">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zFZMS9zGyZnj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--ThinkMarketsConvertibleNoteMember_zMzUmgMEaU07" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGNBlrP835b2" style="text-align: right" title="Equity securities, common stock">2,187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z5beFKP247r8" style="text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0903">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqrWUAmjfsLg" style="text-align: right" title="Equity securities, common stock">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDS8gzDRJ7f4" style="text-align: right" title="Equity securities, common stock">2,437</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">As of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Hagerty common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zPFer3V7M0Ng" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">841</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zrnFnbxoYAsk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0911">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zU5U1nLjrmo" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0913">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--HagertyCommonStockMember_zKDjHwwIXIG8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Equity securities, common stock">841</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zENNNjqgeV16" style="text-align: right" title="Equity securities, common stock">841</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGtLzwtVNr4j" style="text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0919">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zyxlm1y6F056" style="text-align: right" title="Equity securities, common stock"><span style="-sec-ix-hidden: xdx2ixbrl0921">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zg4NZfXH0PHe" style="text-align: right" title="Equity securities, common stock">841</td><td style="text-align: left"> </td></tr> </table> 2187000 2187000 250000 250000 2187000 250000 2437000 841000 841000 841000 841000 250000 250000 <p id="xdx_891_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN8LMHrxtKm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables provide a reconciliation of the fair value of recurring Level 3 fair value measurements for the three- and nine-months ended September 30, 2023 and September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B7_z7j9UQlpjKHg" style="display: none">Schedule of Fair Value of Recurring Level 3 Fair Value Measurements</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGQQZrW9Cjqk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmldZrWddyI2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ConvertibleDebtFairValueDisclosures_iS_pn3n3_z02rN9YDEX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Beginning balance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConsiderationPaid_pn3n3_zfEz0M7YhtN2" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left; padding-left: 10pt">Consideration paid</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--IncreaseInFairValueOfConvertibleNote_pn3n3_zod8CrFdu5g3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Increase in fair value of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--TransferOut_iI_pn3n3_zqt9Pe0vyLHl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Transfer out</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iE_pn3n3_zLDHPsVZUHe6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance, September 30</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYLSGP2t4Iig" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjvXrAsLbxTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ConvertibleDebtFairValueDisclosures_iS_pn3n3_z73sZruCpjCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 10pt">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">677</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConsiderationPaid_pn3n3_zVvPX0K8zfFk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Consideration paid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--DecreaseInFairValueOfConvertibleNote_pn3n3_zSL9ggnD7OL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Decrease in fair value of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(52</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0953">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--TransferOut_iI_pn3n3_z6axCmAKPhYc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Transfer out</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(625</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iE_pn3n3_zmDm9SCBrgD5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance, September 30</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0959">-</span></td><td style="text-align: left"> </td></tr> </table> 750000 125000 -625000 250000 677000 250000 -52000 -625000 250000 <p id="xdx_801_ecustom--LossAndLossAdjustmentExpenseReservesTextBlock_zFW057DPAwx" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5. <span id="xdx_827_zDn2z6yJvcJ4">Loss and Loss Adjustment Expense Reserves</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A significant degree of judgment is required to determine amounts recorded in the consolidated financial statements for the provision for loss and loss adjustment expense (“LAE”) reserves. The process for establishing this provision reflects the uncertainties and significant judgmental factors inherent in predicting future results of both known and unknown loss events. The process of establishing the provision for loss and LAE reserves relies on the judgment and opinions of many individuals, including the opinions of the Company’s management, as well as the management of ceding companies and their actuaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In estimating losses, the Company may assess any of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a review of in-force treaties that may provide coverage and incur losses;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general forecasts, catastrophe and scenario modelling analyses and results shared by cedents;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviews of industry insured loss estimates and market share analyses;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">management’s judgment; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss development factor selections, initial expected loss ratio selections, and weighting of methods used</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of certain of our quota-share agreements, and due to the nature of claims and premium reporting, a lag exists between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. The reports we receive from our cedents have pre-determined due dates. In the case of the Company’s FAL contracts, third quarter 2023 premium and loss information will not be made available to the Company until subsequent to the filing of this quarterly report. Thus, our third quarter results, including the loss and loss adjustment expense reserves presented herein, have been based upon a combination of actual results from the 2023 calendar year as well as forecasts for 2023 reported to us by the ceding companies. We have approximated third quarter 2023 results under our FAL contracts based upon this historical and forecasted information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company believes its estimate of loss and loss adjustment expense reserves are adequate as of September 30, 2023, based on available information, actual losses may ultimately differ materially from the Company’s current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information is provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_zV13b3Ayfpn4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of changes in outstanding loss and loss adjustment expense reserves for the nine months ended September 30, 2023 and 2022, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BD_zpuLbW2V4Z3d" style="display: none">Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230101__20230930_z5wj5WVXAB12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zfPIhSkDrYrg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--ReinsuranceRecoverablesGross_iS_pn3n3_zd1Abgcg8Ac3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Balance, beginning of period, net of reinsurance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,409</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,133</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IncurredRelatedToAbstract_iB_zrE7mrJHHIa5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Incurred related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ReinsuranceLossOnUncollectibleAccountsInPeriodAmount_i01_zRpV95yzyNul" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,984</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount_i01_zrw4XLZoqqH7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Prior year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">661</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">814</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--PaidRelatedToAbstract_iB_zcAObQRYdjXf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Paid related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ReinsuranceRecoverableCreditLossExpenseReversal_i01_zHILOsOkSYa9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,675</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,568</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--ReinsuranceRecoverableCreditLossExpenseReversalPriorYear_i01_zCDYkfhoF4w6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prior years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(903</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--ReinsuranceRecoverablesGross_iE_pn3n3_zqlX17aF8gij" style="vertical-align: bottom; background-color: White"> <td>Balance, September 30, net of reinsurance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,912</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,133</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_ziODMG1zJqJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_zV13b3Ayfpn4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of changes in outstanding loss and loss adjustment expense reserves for the nine months ended September 30, 2023 and 2022, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BD_zpuLbW2V4Z3d" style="display: none">Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230101__20230930_z5wj5WVXAB12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zfPIhSkDrYrg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--ReinsuranceRecoverablesGross_iS_pn3n3_zd1Abgcg8Ac3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Balance, beginning of period, net of reinsurance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,409</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,133</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IncurredRelatedToAbstract_iB_zrE7mrJHHIa5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Incurred related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ReinsuranceLossOnUncollectibleAccountsInPeriodAmount_i01_zRpV95yzyNul" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,984</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount_i01_zrw4XLZoqqH7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Prior year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">661</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">814</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--PaidRelatedToAbstract_iB_zcAObQRYdjXf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Paid related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ReinsuranceRecoverableCreditLossExpenseReversal_i01_zHILOsOkSYa9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,675</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,568</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--ReinsuranceRecoverableCreditLossExpenseReversalPriorYear_i01_zCDYkfhoF4w6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prior years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(903</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--ReinsuranceRecoverablesGross_iE_pn3n3_zqlX17aF8gij" style="vertical-align: bottom; background-color: White"> <td>Balance, September 30, net of reinsurance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,912</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,133</td><td style="text-align: left"> </td></tr> </table> 4409000 2133000 5420000 4984000 661000 814000 -3675000 -2568000 -903000 -1230000 5912000 4133000 <p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_z7R2dObEXqp3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6. <span id="xdx_820_zv93J0S43Gbl">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z8JinpHcopw8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax rates to income before income tax expense as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BF_zYcimBc7cZmd" style="display: none">Schedule of Reconciliation Effective Tax Rates</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">($ in thousands)</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Provision for taxes at U.S., statutory marginal income tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230701__20230930_zD2egGHAgQe" title="Income tax rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20220701__20220930_zl0xIzQzb2Xj" title="Income tax rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230101__20230930_zt6iaFYZWdd5" title="Income tax rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20220101__20220930_z35D1S6CDXm6" title="Income tax rate">21</span></span></span></span>%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20230701__20230930_zSwrP2ENkW0c" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">1,182</td><td style="width: 1%; text-align: left"></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20220701__20220930_zwkNFihsPVza" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">2,154</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20230101__20230930_zFfnXeKpSKNf" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">852</td><td style="width: 1%; text-align: left"></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20220101__20220930_zW0CKyCcCkPj" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">201</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Valuation allowance for deferred tax assets deemed unrealizable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20230701__20230930_zkMqGFAY9okc" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(1,200</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20220701__20220930_zJim46woxDek" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(2,168</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20230101__20230930_zMsrt9m5o3X2" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(871</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20220101__20220930_zroBrkktPD7e" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(219</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-deductible expenses associated with the Share Repurchase Transaction</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20230701__20230930_z947ef0aNQej" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction"><span style="-sec-ix-hidden: xdx2ixbrl1017">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20220701__20220930_zxYqHuzfgt3c" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20230101__20230930_zvx9snNEwXlh" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20220101__20220930_zV39vnu1qho1" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction">2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Share-based compensation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20230701__20230930_zfo9brsDX5w2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20220701__20220930_zDfIneT3qfy7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">12</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20230101__20230930_zhdjBrkFMvH7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20220101__20220930_zqjxQnmOJyja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">16</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense (benefit)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20230701__20230930_zm52FDdbc8Jk" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1033">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20220701__20220930_za8M1fLx1Zcd" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1035">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20230101__20230930_z50yhUSdfq62" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1037">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20220101__20220930_z3DwjZs0Ibeh" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1039">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zCDebhqgvzb1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes as compared to the amounts used for income tax purposes. The Company’s gross deferred tax assets and liabilities are $<span id="xdx_909_eus-gaap--DeferredTaxAssetsGross_iI_pn5n6_c20230930_z3XZ3yRLEev7" title="Deferred tax assets, gross">8.0</span> million and $<span id="xdx_906_eus-gaap--DeferredTaxLiabilities_iI_pn5n6_c20230930_zXoNKvn7pnh3" title="Deferred tax liabilities">3.4</span> million as of September 30, 2023. The Company has recorded a valuation allowance against its deferred tax assets of $<span id="xdx_901_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn5n6_c20230101__20230930_zTaDlEQM5Nqi" title="Deferred tax valuation allowances">4.6</span> million, as of September 30, 2023, due to the uncertain nature surrounding our ability to realize these tax benefits in the future. Significant components of the Company’s net deferred tax assets are as follows:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zDiY3pqahWnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zAA70KXMpL35" style="display: none">Schedule of Deferred Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_499_20230930_zH3s4cSsTm7e" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20221231_zUC2uVOeoS66" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">(in thousands)</td><td> </td> <td colspan="6" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of <br/> September 30, 2023</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of <br/> December 31, 2022</b></span></p></td><td> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zZ9BH34h42y8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Deferred income tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pn3n3_maCzPrr_zfZEdkpznOHl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforward</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,670</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,171</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_i01I_pn3n3_maCzPrr_z2ocPmRsADi4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Loss and loss adjustment expense reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_i01I_pn3n3_maCzPrr_zRSe2zQPswU2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Unearned premium reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">287</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsCapitalLossCarryforwards_i01I_pn3n3_maCzPrr_zCs4ofhtQadg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Capital loss carryforward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,313</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pn3n3_maCzPrr_ztJHZtvtYi4c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">424</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">242</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsInvestments_i01I_pn3n3_maCzPrr_zFHM79hYpFag" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Investments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_i01I_pn3n3_maCzPrr_zVkquQR2ET99" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Other</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsGross_i01TI_pn3n3_mtCzPrr_maCzyTc_zet0rXHifkui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,066</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pn3n3_di_msCzyTc_zwYXGfF37cGg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Less: Valuation allowance</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,615</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,463</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_i01TI_pn3n3_mtCzyTc_maDTALNzbNe_zcQLdtplsu84" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets net of valuation allowance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,603</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zGVARscGaKL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Deferred income tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesInvestments_i01I_pn3n3_maDITLzscJ_zdIWnRiDvvQ2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Investments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,282</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_i01I_pn3n3_maDITLzscJ_zUIIe1aJ3d6l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Deferred policy acquisition costs</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">310</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">321</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredIncomeTaxLiabilities_i01TI_pn3n3_mtDITLzscJ_msDTALNzbNe_zo3Ta5z6eqg5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred income tax liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,603</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzbNe_zZIGebcDpuK7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net deferred income tax asset (liability)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1094">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">–</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A8_zDDPXDNuMez8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company had net operating loss carryforwards (“NOLs”) for federal income tax purposes of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20230930_zuruG0W9Yk3j">22.2</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, which will be available to offset future taxable income. Approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20230930__us-gaap--AwardTypeAxis__custom--ExpireOnDecemberThirtyOneTwoThousandAndThirtyNineMember_zVzRoh40voQ7">0.5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million expire on December 31, 2039, $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20230930__us-gaap--AwardTypeAxis__custom--ExpireOnDecemberThirtyOneTwoThousandAndFourtyMember_zuXsSkzUnIL4">0.1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million expire on December 31, 2040, and $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20230930__us-gaap--AwardTypeAxis__custom--ExpireOnDecemberThirtyOneTwoThousandAndFourtyOneMember_z1hT1Md1UOZ6">1.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the Company’s NOLs will expire on December 31, 2041. The remaining $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20230930__us-gaap--AwardTypeAxis__custom--NotExpireUnderCurrentTaxLawMember_zgSwexG5mOHc">20.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the Company’s NOLs do not expire under current tax law. Additionally, the Company has approximately $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20230930__us-gaap--AwardTypeAxis__custom--ExpireOnDecemberTwoThousandAndTwentySixMember_z4Mf2zJwdOvf">11.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of capital loss carryforward that can only be used to offset capital gains and which will expire in December 2026 if not used prior.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company had no unrecognized tax benefits. The Company analyzed its tax positions in accordance with the provisions of Accounting Standards Codification Topic 740, <i>Income Taxes</i>, and has determined that there are currently no uncertain tax positions. The Company generally recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z8JinpHcopw8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax rates to income before income tax expense as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BF_zYcimBc7cZmd" style="display: none">Schedule of Reconciliation Effective Tax Rates</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">($ in thousands)</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Provision for taxes at U.S., statutory marginal income tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230701__20230930_zD2egGHAgQe" title="Income tax rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20220701__20220930_zl0xIzQzb2Xj" title="Income tax rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230101__20230930_zt6iaFYZWdd5" title="Income tax rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlY29uY2lsaWF0aW9uIEVmZmVjdGl2ZSBUYXggUmF0ZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20220101__20220930_z35D1S6CDXm6" title="Income tax rate">21</span></span></span></span>%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20230701__20230930_zSwrP2ENkW0c" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">1,182</td><td style="width: 1%; text-align: left"></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20220701__20220930_zwkNFihsPVza" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">2,154</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20230101__20230930_zFfnXeKpSKNf" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">852</td><td style="width: 1%; text-align: left"></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_c20220101__20220930_zW0CKyCcCkPj" style="width: 11%; text-align: right" title="Provision for taxes at U.S. statutory marginal income tax rate of 21%">201</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Valuation allowance for deferred tax assets deemed unrealizable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20230701__20230930_zkMqGFAY9okc" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(1,200</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20220701__20220930_zJim46woxDek" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(2,168</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20230101__20230930_zMsrt9m5o3X2" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(871</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_c20220101__20220930_zroBrkktPD7e" style="text-align: right" title="Valuation allowance for deferred tax assets deemed unrealizable">(219</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-deductible expenses associated with the Share Repurchase Transaction</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20230701__20230930_z947ef0aNQej" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction"><span style="-sec-ix-hidden: xdx2ixbrl1017">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20220701__20220930_zxYqHuzfgt3c" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20230101__20230930_zvx9snNEwXlh" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pn3n3_c20220101__20220930_zV39vnu1qho1" style="text-align: right" title="Non-deductible expenses associated with the Share Repurchase Transaction">2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Share-based compensation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20230701__20230930_zfo9brsDX5w2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20220701__20220930_zDfIneT3qfy7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">12</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20230101__20230930_zhdjBrkFMvH7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_c20220101__20220930_zqjxQnmOJyja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Share-based compensation">16</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense (benefit)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20230701__20230930_zm52FDdbc8Jk" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1033">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20220701__20220930_za8M1fLx1Zcd" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1035">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20230101__20230930_z50yhUSdfq62" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1037">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations_pn3n3_c20220101__20220930_z3DwjZs0Ibeh" style="text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1039">-</span></td><td style="text-align: left"> </td></tr> </table> 0.21 0.21 0.21 0.21 1182000 2154000 852000 201000 -1200000 -2168000 -871000 -219000 2000 1000 2000 18000 12000 18000 16000 8000000.0 3400000 4600000 <p id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zDiY3pqahWnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zAA70KXMpL35" style="display: none">Schedule of Deferred Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_499_20230930_zH3s4cSsTm7e" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20221231_zUC2uVOeoS66" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">(in thousands)</td><td> </td> <td colspan="6" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of <br/> September 30, 2023</b></span></p></td><td> </td><td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of <br/> December 31, 2022</b></span></p></td><td> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zZ9BH34h42y8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Deferred income tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pn3n3_maCzPrr_zfZEdkpznOHl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforward</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,670</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,171</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_i01I_pn3n3_maCzPrr_z2ocPmRsADi4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Loss and loss adjustment expense reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_i01I_pn3n3_maCzPrr_zRSe2zQPswU2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Unearned premium reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">287</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsCapitalLossCarryforwards_i01I_pn3n3_maCzPrr_zCs4ofhtQadg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Capital loss carryforward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,313</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pn3n3_maCzPrr_ztJHZtvtYi4c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">424</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">242</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsInvestments_i01I_pn3n3_maCzPrr_zFHM79hYpFag" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Investments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_i01I_pn3n3_maCzPrr_zVkquQR2ET99" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Other</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsGross_i01TI_pn3n3_mtCzPrr_maCzyTc_zet0rXHifkui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,066</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pn3n3_di_msCzyTc_zwYXGfF37cGg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Less: Valuation allowance</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,615</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,463</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_i01TI_pn3n3_mtCzyTc_maDTALNzbNe_zcQLdtplsu84" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets net of valuation allowance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,603</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zGVARscGaKL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Deferred income tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesInvestments_i01I_pn3n3_maDITLzscJ_zdIWnRiDvvQ2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Investments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,282</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_i01I_pn3n3_maDITLzscJ_zUIIe1aJ3d6l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Deferred policy acquisition costs</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">310</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">321</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredIncomeTaxLiabilities_i01TI_pn3n3_mtDITLzscJ_msDTALNzbNe_zo3Ta5z6eqg5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred income tax liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,603</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzbNe_zZIGebcDpuK7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net deferred income tax asset (liability)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1094">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">–</span></td><td style="text-align: left"> </td></tr> </table> 4670000 4171000 52000 39000 395000 287000 2491000 4313000 424000 242000 10000 5000 8000 9000 8050000 9066000 4615000 5463000 3435000 3603000 3125000 3282000 310000 321000 3435000 3603000 22200000 500000 100000 1600000 20000000.0 11900000 <p id="xdx_805_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zar3zZOu1qS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7. <span id="xdx_821_zGUqupGgAbRh">Equity Incentive Plan Grants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 15, 2021, our shareholders approved the FG Financial Group, Inc. 2021 Equity Incentive Plan (the “2021 Plan”). The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (or “SARs”), restricted shares, restricted share units, and other share-based awards, and provides for a maximum of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20211215__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_ziRj1HwqiSZ3" title="Number of share available for issuance">1,500,000</span> shares available for issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 24, 2023, the Company’s board of directors approved an amendment to the 2021 Plan to increase the number of shares available for issuance from <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230324__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneIncentivePlanMember_z1SiKi6Tt0Ph" title="Number of share available for issuance">1,500,000</span> to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230324__us-gaap--PlanNameAxis__custom--AmendmentTwoThousandAndTwentyOneIncentivePlanMember_zftFeAdw3Y6c" title="Number of share available for issuance">2,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, on March 24, 2023, <span id="xdx_90A_ecustom--EmployeeStockPurchasePlanDescription_iI_c20230324_zIQKViiVv7Ok" title="ESPP Plan, description">the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>RSUs Outstanding</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zkyoBzWrZUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes RSU activity for the nine months ended September 30, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8B6_zYi82uSZyEp2" style="display: none">Schedule of Restricted Stock Units Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Restricted Stock Units</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Grant Date Fair Value</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Non-vested units, January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zY2RqvQZ5LVa" style="width: 16%; text-align: right" title="Number of Non-vested Units, Beginning balance">256,382</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJ03KBspDn3d" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning balance">2.57</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDRhsIh2JxUi" style="text-align: right" title="Number of Non-vested Units, Granted">821,974</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1cKRCIjnXab" style="text-align: right" title="Weighted Average Grant Date Fair Value, Granted">2.76</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyqHVUUp01cj" style="text-align: right" title="Number of Non-vested Units, Vested">(227,301</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDEp_zLsbJ7E6c0R9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Vested">2.71</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUdpYyV8knGj" style="text-align: right" title="Number of Non-vested Units, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1127">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcjmDPQZ5Nb2" style="text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1129">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-vested units, September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhKOjyP1BiN6" style="text-align: right" title="Number of Non-vested Units, Ending balance">851,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3gbITWkRAq2" style="text-align: right" title="Weighted Average Grant Date Fair Value, Ending balance">1.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-vested units, January 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znpOg4pYuQD8" style="text-align: right" title="Number of Non-vested Units, Beginning balance">164,655</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9H5OTnAoFSb" style="text-align: right" title="Weighted Average Grant Date Fair Value, Beginning balance">4.35</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkYDX8VIZ8Ca" style="text-align: right" title="Number of Non-vested Units, Granted">158,225</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL25rQzhNYh5" style="text-align: right" title="Weighted Average Grant Date Fair Value, Granted">1.58</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpVvAOXYFd82" style="text-align: right" title="Number of Non-vested Units, Vested">(50,065</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDEp_znnZAPAhql4k" style="text-align: right" title="Weighted Average Grant Date Fair Value, Vested">4.81</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5SEJrPCmBa3" style="text-align: right" title="Number of Non-vested Units, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1147">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIfxWTj6dfj" style="text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1149">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-vested units, September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9W1okSlKVm5" style="text-align: right" title="Number of Non-vested Units, Ending balance">272,815</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zB4b2zborRM9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Ending balance">2.66</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A2_zB9eUAKQ3X6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 19, 2022, we issued a total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20220818__20220819__srt--TitleOfIndividualAxis__custom--NonEmployeeDirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2tJQ5TXWT0h" title="Number of restricted stock issued">158,225</span> RSUs to our non-employee directors. The RSUs vest in five equal annual installments, beginning with the first anniversary of the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 17, 2023, we granted a total of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230216__20230217__srt--TitleOfIndividualAxis__srt--ManagementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvAA1GvvEpai" title="Number of restricted units granted">415,000</span> RSUs to various members of the Company’s management. The RSUs vest in three equal annual installments, beginning with the date the shares were granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the third quarter of 2023, we granted a total of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--NonExecutiveMembersMember_z078VeoXqJ61" title="Number of restricted units granted">36,974</span> RSUs to non-executive members of our Company’s board of directors. The RSU’s vest immediately.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2021, the Company entered into an Equity Award Letter Agreement (the “Letter Agreement”) with Mr. Swets, pursuant to which the Company clarified its intention to grant an additional <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210117__20210118__srt--TitleOfIndividualAxis__custom--LarryGSwetsJrMember__us-gaap--TypeOfArrangementAxis__custom--EquityAwardLetterAgreementMember_zyipbvp5Eyo2" title="Grant an additional stock options">370,000</span> stock options, restricted shares or restricted stock units pursuant to a future award, subject to the approval of an amended and/or new equity plan, among other conditions. On February 17, 2023, in satisfaction of the obligations in the letter agreement, the Company granted <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230216__20230217__srt--TitleOfIndividualAxis__custom--MrSwetsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9LyAcyi0Del" title="Number of restricted units granted">370,000</span> RSUs to Mr. Swets that will vest on the first anniversary of the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 31, 2022, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220731__20220731__srt--TitleOfIndividualAxis__custom--EmployeeDirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwentyTwentyOneEquityIncentivePlanMember_zuAWI5gU5qVi" title="Number of shares issued">25,000</span> restricted shares under the 2021 Equity Incentive Plan to an employee of the Company. The restriction was lifted on the first anniversary of the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Options Outstanding</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 12, 2021, in connection with Larry G. Swets, Jr.’s appointment as Chief Executive Officer, the Company entered into a Stock Option Agreement (the “Stock Option”) with Mr. Swets. The Stock Option entitles Mr. Swets to purchase up to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210112__20210112__srt--TitleOfIndividualAxis__custom--LarryGSwetsJrMember__us-gaap--TypeOfArrangementAxis__custom--StockOptionAgreementMember_zLMWUPBEef34" title="Grant an additional stock options">130,000</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210112__20210112__srt--TitleOfIndividualAxis__custom--LarryGSwetsJrMember__us-gaap--TypeOfArrangementAxis__custom--StockOptionAgreementMember_z6maOrmW1Ugh" title="Exercise price of shares">3.38</span> per share. <span id="xdx_90A_ecustom--StockOptiondescription_c20210112__20210112__srt--TitleOfIndividualAxis__custom--LarryGSwetsJrMember__us-gaap--TypeOfArrangementAxis__custom--StockOptionAgreementMember_zLmNlKvRBz7g" title="Stock option,description">The Stock Option becomes vested and fully exercisable in 20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through each applicable vesting date and that the Company’s book value per share has increased by 15% or more as compared to the Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Stock Option contains performance and service conditions that affect vesting. Pursuant to ASC Topic 718- <i>Stock Compensation,</i> these conditions have not been reflected in estimating the fair value of the award upon its grant date; however, the Company employed a Monte-Carlo model to estimate the likelihood of satisfaction of the required performance and service conditions. This resulted in a derived service period of approximately <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--StockOptionAgreementMember__srt--TitleOfIndividualAxis__custom--LarryGSwetsJrMember_zO38EJO8xSDd" title="Stock option service period">3.3</span> years under the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In estimating the fair value of the Stock Option, the Company estimated volatility based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the Stock Option. The expected life of the Stock Option is assumed to be equivalent to its contractual term. The dividend rate is based on our historical rate, which the Company anticipates will remain at zero. The following assumptions were used to determine the estimated fair value of the Stock Option:</span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zuVoiTm8II3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B2_zbKlhidcnbkh" style="display: none">Schedule of Fair Value of Stock Options</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Expected volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930_zw65YuZdv3o7" title="Expected volatility">45.60</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930_zkJu6whN4guj" title="Expected life (years)">10.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930_zwMDSyfAwCW1" title="Risk-free interest rate">5.15</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230101__20230930_zlFc64lkvrW2" title="Dividend yield">0.00</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A8_ztkbDXfV71Ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zfq9FmQI6MO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes activity for stock options issued for the nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zwufVsxrkj" style="display: none">Schedule of Stock Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Common Stock Options</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Ave<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Ave<br/> Remaining<br/> Contractual<br/> Term (yrs)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Ave<br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify">Outstanding, January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWyQCrdSHs26" style="width: 9%; text-align: right" title="Shares, Outstanding, Beginning balance">130,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z6JcuBXKeQf2" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">3.38</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zb4K5wxomrq3" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance">8.04</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z9dpikjHgwh2" style="width: 9%; text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance">1.88</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zsAetON355ii" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercisable, January 1, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zLE13NjyHot8" style="text-align: right" title="Shares, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1197">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zflkHWFvsS0i" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1199">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zrWiWg5UDFsk" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1201">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z0mI32jbsd95" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1203">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zbmQ3THK1pwc" style="text-align: right" title="Shares, Granted"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zakJjA3LVBNl" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zqSZvtDZAj9l" style="text-align: right" title="Weighted Average Grant date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1209">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zU5jlNVSFiD2" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1211">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zLuLeW7aYHq9" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1213">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zJpHuRI4dJp4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1215">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z3Ds1gg3m6ci" style="text-align: right" title="Weighted Average Grant date Fair Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1217">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zXkIT57f1OXj" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1219">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z3DrId6uDwfe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1221">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zca0St3fLQif" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1223">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zLKruDJbHWN6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant date Fair Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1225">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zvYF5PS6iWX5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1227">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Outstanding, September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z4MIxUNRp4w1" style="text-align: right" title="Shares, Outstanding, Ending balance">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWHuOVVmeYaj" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance">3.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zVyUHZgtkKVl" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance">7.29</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zJsJhitlJId" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Ending balance">1.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z6OC5dwyQIZe" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1237">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercisable, September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zDUIUTUbPg1i" style="text-align: right" title="Shares, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1239">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zAN4E88ztV51" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1241">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zBCCtvTsgss" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1243">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zEJhw7aui12d" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1245">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Outstanding, January 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zMTsOvqweklb" style="text-align: right" title="Shares, Outstanding, Beginning balance">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zNoKwJtFrDD4" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">3.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zs0NfocfEsoa" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance">9.04</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zRkFJk0nu72l" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance">1.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zwc8qI5MQhAf" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Beginning balance">49,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercisable, January 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zyNtvLd70hxg" style="text-align: right" title="Shares, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1257">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zsP1vOBk9h8i" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1259">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zbaO0UPMbSU9" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1261">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWYOuUscnOMj" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1263">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z1ldIGlgF1v9" style="text-align: right" title="Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1265">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_ztaau7qXMRT9" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1267">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zqG75L1Vax23" style="text-align: right" title="Weighted Average Grant date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1269">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWVi8cx9ntY8" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1271">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zKGbw5yNvlp4" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1273">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zrUkiRsDIk7" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1275">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zJzOOBDVqpQ5" style="text-align: right" title="Weighted Average Grant date Fair Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1277">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zcS4UoNWLmd9" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1279">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zcJs0YaMEHU6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1281">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zp7TQ49VoyOe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1283">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zaJUG6f1X3T8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant date Fair Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1285">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zpyf6abAyQIg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1287">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Outstanding, September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zzdxqUoSiE3k" style="text-align: right" title="Shares, Outstanding, Ending balance">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zrfpYvCBwux7" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance">3.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z8570CDadie2" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance">8.29</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z4iENgImxwAb" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Ending balance">1.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_za3Jmrh9d7ba" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1297">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercisable, September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z6UCyT0SJ70e" style="text-align: right" title="Shares, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1299">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zqI7eSOd2t4g" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1301">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_znnLiGX6TvX3" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1303">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zzkHqn6mg0Dj" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1305">–</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zIesyb3hNm6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total stock-based compensation expense for the nine months ended September 30, 2023 and 2022 was approximately $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930_zn7xVHvvu9G5" title="Share-based payment arrangement, expense">1.5</span> million and $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220101__20220930_zTi4GdyTld7e" title="Share-based payment arrangement, expense">180,000</span>, respectively. As of September 30, 2023, total unrecognized stock compensation expense of approximately $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn5n6_c20230930_zzaHt6opzSM2" title="Unrecognized stock based compensation expense">1.8</span> million remains, which will be recognized through December 31, 2026. Stock compensation expense has been reflected in the Company’s financial statements as part of general and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No warrants were granted or exercised during the nine months ended September 30, 2023 and 2022. On February 24, 2022, <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220224__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJXsud5npifg" title="Warrants outstanding">1,500,000</span> warrants with an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220224__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbUDAtbc9b8l" title="Exercise price of warrants">15.00</span> expired. As of September 30, 2023, the Company did not have any warrants outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1500000 1500000 2000000 the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment. <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zkyoBzWrZUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes RSU activity for the nine months ended September 30, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8B6_zYi82uSZyEp2" style="display: none">Schedule of Restricted Stock Units Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Restricted Stock Units</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Grant Date Fair Value</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Non-vested units, January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zY2RqvQZ5LVa" style="width: 16%; text-align: right" title="Number of Non-vested Units, Beginning balance">256,382</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJ03KBspDn3d" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning balance">2.57</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDRhsIh2JxUi" style="text-align: right" title="Number of Non-vested Units, Granted">821,974</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1cKRCIjnXab" style="text-align: right" title="Weighted Average Grant Date Fair Value, Granted">2.76</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyqHVUUp01cj" style="text-align: right" title="Number of Non-vested Units, Vested">(227,301</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDEp_zLsbJ7E6c0R9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Vested">2.71</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUdpYyV8knGj" style="text-align: right" title="Number of Non-vested Units, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1127">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcjmDPQZ5Nb2" style="text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1129">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-vested units, September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhKOjyP1BiN6" style="text-align: right" title="Number of Non-vested Units, Ending balance">851,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3gbITWkRAq2" style="text-align: right" title="Weighted Average Grant Date Fair Value, Ending balance">1.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-vested units, January 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znpOg4pYuQD8" style="text-align: right" title="Number of Non-vested Units, Beginning balance">164,655</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9H5OTnAoFSb" style="text-align: right" title="Weighted Average Grant Date Fair Value, Beginning balance">4.35</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkYDX8VIZ8Ca" style="text-align: right" title="Number of Non-vested Units, Granted">158,225</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL25rQzhNYh5" style="text-align: right" title="Weighted Average Grant Date Fair Value, Granted">1.58</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpVvAOXYFd82" style="text-align: right" title="Number of Non-vested Units, Vested">(50,065</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDEp_znnZAPAhql4k" style="text-align: right" title="Weighted Average Grant Date Fair Value, Vested">4.81</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5SEJrPCmBa3" style="text-align: right" title="Number of Non-vested Units, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1147">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIfxWTj6dfj" style="text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1149">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-vested units, September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9W1okSlKVm5" style="text-align: right" title="Number of Non-vested Units, Ending balance">272,815</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zB4b2zborRM9" style="text-align: right" title="Weighted Average Grant Date Fair Value, Ending balance">2.66</td><td style="text-align: left"> </td></tr> </table> 256382 2.57 821974 2.76 227301 2.71 851055 1.40 164655 4.35 158225 1.58 50065 4.81 272815 2.66 158225 415000 36974 370000 370000 25000 130000 3.38 The Stock Option becomes vested and fully exercisable in 20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through each applicable vesting date and that the Company’s book value per share has increased by 15% or more as compared to the Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031. P3Y3M18D <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zuVoiTm8II3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B2_zbKlhidcnbkh" style="display: none">Schedule of Fair Value of Stock Options</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Expected volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930_zw65YuZdv3o7" title="Expected volatility">45.60</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930_zkJu6whN4guj" title="Expected life (years)">10.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930_zwMDSyfAwCW1" title="Risk-free interest rate">5.15</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230101__20230930_zlFc64lkvrW2" title="Dividend yield">0.00</span></td><td style="text-align: left">%</td></tr> </table> 0.4560 P10Y 0.0515 0.00 <p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zfq9FmQI6MO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes activity for stock options issued for the nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zwufVsxrkj" style="display: none">Schedule of Stock Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Common Stock Options</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Ave<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Ave<br/> Remaining<br/> Contractual<br/> Term (yrs)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Ave<br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify">Outstanding, January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWyQCrdSHs26" style="width: 9%; text-align: right" title="Shares, Outstanding, Beginning balance">130,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z6JcuBXKeQf2" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">3.38</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zb4K5wxomrq3" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance">8.04</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z9dpikjHgwh2" style="width: 9%; text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance">1.88</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zsAetON355ii" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercisable, January 1, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zLE13NjyHot8" style="text-align: right" title="Shares, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1197">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zflkHWFvsS0i" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1199">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zrWiWg5UDFsk" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1201">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z0mI32jbsd95" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1203">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zbmQ3THK1pwc" style="text-align: right" title="Shares, Granted"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zakJjA3LVBNl" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zqSZvtDZAj9l" style="text-align: right" title="Weighted Average Grant date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1209">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zU5jlNVSFiD2" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1211">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zLuLeW7aYHq9" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1213">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zJpHuRI4dJp4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1215">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z3Ds1gg3m6ci" style="text-align: right" title="Weighted Average Grant date Fair Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1217">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zXkIT57f1OXj" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1219">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z3DrId6uDwfe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1221">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zca0St3fLQif" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1223">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zLKruDJbHWN6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant date Fair Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1225">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zvYF5PS6iWX5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1227">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Outstanding, September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z4MIxUNRp4w1" style="text-align: right" title="Shares, Outstanding, Ending balance">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWHuOVVmeYaj" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance">3.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zVyUHZgtkKVl" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance">7.29</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zJsJhitlJId" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Ending balance">1.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z6OC5dwyQIZe" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1237">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercisable, September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zDUIUTUbPg1i" style="text-align: right" title="Shares, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1239">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zAN4E88ztV51" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1241">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zBCCtvTsgss" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1243">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zEJhw7aui12d" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1245">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Outstanding, January 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zMTsOvqweklb" style="text-align: right" title="Shares, Outstanding, Beginning balance">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zNoKwJtFrDD4" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance">3.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zs0NfocfEsoa" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance">9.04</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zRkFJk0nu72l" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance">1.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zwc8qI5MQhAf" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Beginning balance">49,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercisable, January 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zyNtvLd70hxg" style="text-align: right" title="Shares, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1257">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zsP1vOBk9h8i" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1259">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iS_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zbaO0UPMbSU9" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1261">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWYOuUscnOMj" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1263">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z1ldIGlgF1v9" style="text-align: right" title="Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1265">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_ztaau7qXMRT9" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1267">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zqG75L1Vax23" style="text-align: right" title="Weighted Average Grant date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1269">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zWVi8cx9ntY8" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1271">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zKGbw5yNvlp4" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1273">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zrUkiRsDIk7" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1275">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zJzOOBDVqpQ5" style="text-align: right" title="Weighted Average Grant date Fair Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1277">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zcS4UoNWLmd9" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1279">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zcJs0YaMEHU6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1281">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zp7TQ49VoyOe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1283">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zaJUG6f1X3T8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant date Fair Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1285">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zpyf6abAyQIg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1287">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Outstanding, September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zzdxqUoSiE3k" style="text-align: right" title="Shares, Outstanding, Ending balance">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zrfpYvCBwux7" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance">3.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z8570CDadie2" title="Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance">8.29</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z4iENgImxwAb" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Outstanding, Ending balance">1.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_za3Jmrh9d7ba" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1297">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercisable, September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_z6UCyT0SJ70e" style="text-align: right" title="Shares, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1299">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zqI7eSOd2t4g" style="text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1301">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_iE_pid_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_znnLiGX6TvX3" style="text-align: right" title="Weighted Ave Grant Date Fair Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1303">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenEquityIncentivePlanMember_zzkHqn6mg0Dj" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1305">–</span></td><td style="text-align: left"> </td></tr> </table> 130000 3.38 P8Y14D 1.88 130000 3.38 P7Y3M14D 1.88 130000 3.38 P9Y14D 1.88 49400 130000 3.38 P8Y3M14D 1.88 1500000 180000 1800000 1500000 15.00 <p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z615w1Ct7Ws3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8. <span id="xdx_82C_z1PF7sCd8ma4">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party transactions are carried out in the normal course of operations and are measured in part by the amount of consideration paid or received, as established and agreed by the parties. Management believes that consideration paid for such services in each case approximates fair value. Except where disclosed elsewhere in these consolidated financial statements, the following is a summary of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Joint Venture Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2020, the Company entered into the Limited Liability Company Agreement of Fundamental Global Asset Management, LLC (“FGAM”), a joint venture owned <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200331__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FundamentalGlobalAssetManagementMember_zWt7HjarPDXj" title="Investment ownership percentage">50</span>% by each of the Company and FG. The purpose of FGAM is to sponsor, capitalize and provide strategic advice to investment managers in connection with the launch and/or growth of their asset management businesses and the investment products they sponsor (each, a “Sponsored Fund”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FGAM is governed by a Board of Managers consisting of four managers, two of which have been appointed by each Member. The Company has appointed two of its independent directors to the Board of Managers of FGAM. Certain major actions, including any decision to sponsor a new investment manager, require the prior consent of both Members.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>FG Special Situations Fund</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company participated as a limited partner in the Fund. The general partner of the Fund, and the investment advisor of the Fund, was ultimately controlled by Mr. Cerminara, the Chairman of the Company’s Board of Directors. Portions of the Company’s investment into the Fund were used to sponsor the launch of SPACs affiliated with certain of our officers and directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund began the process of winding down in the first quarter of 2023 and completed the process in the second quarter of 2023. As a result of the winddown, the Company now holds direct limited partner interests in FGAC Investors LLC, FG Merger Investors LLC, and Greenfirst Forest Products Holdings, LLC. Mr. Cerminara, Mr. Swets and Mr. Baqar, our Executive Vice President and Chief Financial Officer, serve as managers of FGAC Investors LLC and FG Merger Investors LLC, while Mr. Cerminara ultimately controls Greenfirst Forest Products Holdings, LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>FG Merchant Partners</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FGMP was formed to co-sponsor newly formed SPACs with their founders or partners. Certain of our directors and officers also hold limited partner interests in FGMP. Mr. Swets holds a limited partner interest through Itasca Financial LLC, an advisory and investment firm for which Mr. Swets is managing member. Mr. Baqar also holds a limited partner interest through Sequoia Financial LLC, an advisory firm for which Mr. Baqar is managing member. Mr. Cerminara also holds a limited partner interest through Fundamental Global, LLC, a holding company for which Mr. Cerminara is the manager and one of the members.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FGMP has invested in the founder shares and warrants of Aldel, FG Merger Corp, FG Acquisition Corp, FGC and Craveworthy. Certain of our directors and officers are affiliated with these entities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>FG Communities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October of 2022, the Company directly invested $<span id="xdx_906_eus-gaap--Investments_iI_pn5n6_c20221031__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_znnXf568ABQc" title="Investments">2.0</span> million into FGC. The Company also holds an interest through its ownership in FGMP. FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC. Mr. Cerminara is the President and a director of FGC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Craveworthy</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 16, 2023, the Company invested $<span id="xdx_901_eus-gaap--UnsecuredDebt_iI_c20230316__dei--LegalEntityAxis__custom--CraveworthyMember_zvMNi37OFCY6" title="Senior unsecured promissory note">200,000</span> in a senior unsecured loan to Craveworthy. Mr. Swets has an indirect interest in Craveworthy, independent from the interests held by the Company through its ownership in FGMP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Think Markets</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 29, 2023, the Company invested $<span id="xdx_90E_eus-gaap--Investments_iI_c20230929__dei--LegalEntityAxis__custom--ThinkMaketsMember_zGNnJc7o0Ibc" title="Investments">250,000</span> in a convertible promissory note to support the business combination of Think Markets and FG Acquisition Corp. Mr. Swets and Mr. Baqar are executive officers of FG Acquisition Corp.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shared Services Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2020, the Company entered into a Shared Services Agreement (the “Shared Services Agreement”) with Fundamental Global Management, LLC (“FGM”), an affiliate of FG, pursuant to which FGM provides the Company with certain services related to the day-to-day management of the Company, including assisting with regulatory compliance, evaluating the Company’s financial and operational performance, providing a management team to supplement the executive officers of the Company, and such other services consistent with those customarily performed by executive officers and employees of a public company. In exchange for these services, the Company pays FGM a fee of $<span id="xdx_90C_ecustom--SharedServicesFee_c20200331__20200331__us-gaap--TypeOfArrangementAxis__custom--SharedServicesAgreementMember__dei--LegalEntityAxis__custom--FundamentalGlobalManagementLLCMember_ze7A7B7GgQE3" title="Shared services fee">456,000</span> per quarter (the “Shared Services Fee”), plus reimbursement of expenses incurred by FGM in connection with the performance of the Services, subject to certain limitations approved by the Company’s Board of Directors or Compensation Committee from time to time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Shared Services Agreement has an initial term of three years, and thereafter renews automatically for successive one-year terms unless terminated in accordance with its terms. The Shared Services Agreement may be terminated by FGM or by the Company, by a vote of the Company’s independent directors, at the end of the initial or automatic renewal term upon 120 days’ notice, subject to payment by the Company of certain costs incurred by FGM to wind down the provision of services and, in the case of a termination by the Company without cause, payment of a termination fee equal to the Shared Services Fee paid for the two quarters preceding termination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company paid $<span id="xdx_905_ecustom--SharedServicesFee_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--SharedServicesAgreementMember__dei--LegalEntityAxis__custom--FundamentalGlobalManagementLLCMember_zg3nhVKbeKZh" title="Shared services fee">1,368,000</span> and $<span id="xdx_90A_ecustom--SharedServicesFee_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--SharedServicesAgreementMember__dei--LegalEntityAxis__custom--FundamentalGlobalManagementLLCMember_zDWE2WNBv9of" title="Shared services fee">1,368,000</span> to FGM under the Shared Services Agreement for each of the nine months ended September 30, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.50 2000000.0 200000 250000 456000 1368000 1368000 <p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zWrNwhjNNoNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9. <span id="xdx_823_zNunGFCGVHu5">Net Earnings Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net earnings per share is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding during the periods presented. In calculating diluted earnings per share, those potential common shares that are found to be anti-dilutive are excluded from the calculation. The table below provides a summary of the numerators and denominators used in determining basic and diluted earnings per share for the three and nine months ended September 30, 2023 and 2022.</span></p> <p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zybEQCltruX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B6_zKlwQA8wAHJl" style="display: none">Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zMZ4IbVqi7V2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220701__20220930_zVp81EOSTaGj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230930_zFte2cKAGml1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20220930_zujc84QDJETg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">($ in thousands)</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_zq6K3Vvb7xZh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Net income from continuing operations</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,628</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">10,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,055</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">955</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_pn3n3_di_zZjvVU0jTPX1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Dividends declared on Series A Preferred Shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,339</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,342</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_zwEWUL7ERHP6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,181</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,716</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(387</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zmXndUdpXqCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average common shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,303,739</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,333,709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,813,438</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,564,017</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_zmJAGWYCx6W4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (loss) per common share from continuing operations</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--WeightedAverageCommonSharesOutstandingContinuingOperations_pid_zCvgLH0El4xc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,303,739</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,333,709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,813,438</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,564,017</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zxaY965gKNV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zDCqGD1k7cZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities outstanding as of September 30, 2023 and 2022 have been excluded from the computation of diluted weighted-average shares outstanding as their effect would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B5_zQvwvSKPJkkb" style="display: none">Schedule of Potentially Dilutive Securities Excluded from Calculation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zHmb2f5J9x3a" style="width: 14%; text-align: right" title="Potentially dilutive securities outstanding">130,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zCTyV1VRk41k" style="width: 14%; text-align: right" title="Potentially dilutive securities outstanding">130,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Restricted stock units</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFRbfIW1RaJj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities outstanding">851,055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_znfUNVlKtDKk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities outstanding">297,815</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20230930_zQgybWElsi5i" style="text-align: right" title="Potentially dilutive securities outstanding">981,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220930_zMNWfj7K9LN6" style="text-align: right" title="Potentially dilutive securities outstanding">427,815</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zfnR42yhmKI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zybEQCltruX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B6_zKlwQA8wAHJl" style="display: none">Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zMZ4IbVqi7V2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220701__20220930_zVp81EOSTaGj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230930_zFte2cKAGml1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20220930_zujc84QDJETg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">($ in thousands)</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_zq6K3Vvb7xZh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Net income from continuing operations</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,628</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">10,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,055</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">955</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_pn3n3_di_zZjvVU0jTPX1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Dividends declared on Series A Preferred Shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,339</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,342</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_zwEWUL7ERHP6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,181</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,716</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(387</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zmXndUdpXqCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average common shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,303,739</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,333,709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,813,438</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,564,017</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_zmJAGWYCx6W4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (loss) per common share from continuing operations</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--WeightedAverageCommonSharesOutstandingContinuingOperations_pid_zCvgLH0El4xc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,303,739</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,333,709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,813,438</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,564,017</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 5628000 10255000 4055000 955000 447000 447000 1339000 1342000 5181000 9808000 2716000 -387000 10303739 9333709 9813438 7564017 0.50 1.05 0.28 -0.05 10303739 9333709 9813438 7564017 <p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zDCqGD1k7cZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities outstanding as of September 30, 2023 and 2022 have been excluded from the computation of diluted weighted-average shares outstanding as their effect would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B5_zQvwvSKPJkkb" style="display: none">Schedule of Potentially Dilutive Securities Excluded from Calculation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zHmb2f5J9x3a" style="width: 14%; text-align: right" title="Potentially dilutive securities outstanding">130,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zCTyV1VRk41k" style="width: 14%; text-align: right" title="Potentially dilutive securities outstanding">130,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Restricted stock units</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFRbfIW1RaJj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities outstanding">851,055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_znfUNVlKtDKk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities outstanding">297,815</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20230930_zQgybWElsi5i" style="text-align: right" title="Potentially dilutive securities outstanding">981,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220930_zMNWfj7K9LN6" style="text-align: right" title="Potentially dilutive securities outstanding">427,815</td><td style="text-align: left"> </td></tr> </table> 130000 130000 851055 297815 981055 427815 <p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zoPFhDvj6K9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10. <span id="xdx_82A_zZ9HQTe0NTS9">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legal Proceedings:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the <span style="background-color: white">Company was not aware of any material claims or actions pending or threatened against us</span>. From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. Currently, it is not possible to predict legal outcomes and their impact on the future development of claims. Any such development will be affected by future court decisions and interpretations. Because of these uncertainties, additional liabilities may arise for amounts in excess of the Company’s current reserves.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating Lease Commitments:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2021, the Company entered into a lease agreement for office space in St. Petersburg, FL. The lease had a term of 12 months and was not renewed upon expiration. Total minimum rent over the <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20210731__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zEhQqbp9W2ag" title="Lease term">12</span>-month term was approximately $<span id="xdx_900_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20210731__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_z6Nwz4wzhzsc" title="Payments for rent">17,000</span>. Due to the short-term nature of the lease, the Company recognized lease expense on a straight-line basis over the term of the lease, with any variable lease payments recognized in the period in which the obligation for the payment occurred. Rent expense related to the St. Petersburg office was <span id="xdx_909_eus-gaap--PaymentsForRent_pip0_dc_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zUa0ZhU1p4ai" title="Payments for rent">zero</span> and approximately $<span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_z95S2pawK3nk" title="Payments for rent">10,000</span> for the nine months ended September 30, 2023 and September 30, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2022, the Company entered into a lease agreement for office space in Itasca, IL. The lease has a term of <span id="xdx_906_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtM_c20220430__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zILofVbDDUSd" title="Lease term">44</span> months beginning on May 1, 2022. Total minimum rent over the term of the lease is expected to be approximately $<span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20220430__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zdK0GZwTcOQ3" title="Payments for rent">77,000</span>. The Company has accounted for the lease under ASC 842, Leases. The annual discount rate used for the Itasca office was <span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_dp_uPure_c20230930_zz1DL54UHWvi" title="Lessee discount rate">8</span>%. As of September 30, 2023, the right of use asset and lease liability are approximately $<span id="xdx_901_ecustom--OperatingAssetAndLeaseLiability_iI_c20230930_zSG9OkSuJJyc" title="Operating asset and lease liability">44,000</span>, each, and held in “Other assets” and “Other liabilities” on the balance sheet, respectively. Rent expense related to the Itasca office was approximately $<span id="xdx_902_eus-gaap--PaymentsForRent_pp0p0_c20230101__20230930_z7JKorQUAaGf" title="Rent expense">16,000</span> and $<span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_c20220101__20220930_zhqt8ZGH29Ug" title="Rent expense">8,800</span> for the nine months ended September 30, 2023 and September 30, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> P12M 17000 0 10000 P44M 77000 0.08 44000 16000 8800 <p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_znLKVHP0agC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11. <span id="xdx_82F_zXzY1MLc8sZ7">Segment Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has <span id="xdx_90C_eus-gaap--NumberOfOperatingSegments_pp0p0_dc_uSegment_c20230101__20230930_zJB9RsoVDYfc" title="Number of operating segments">two</span> operating segments—insurance and asset management. The chief operating decision maker (“CODM”) is the Company’s Chief Executive Officer. The measure of profit or loss used by the CODM to identify and measure the Company’s reportable segments is income before income tax. Our insurance segment consists of the operations of our Cayman Islands-based reinsurance subsidiary, FGRe, as well as the returns associated with the investments made by our reinsurance operations. Our asset management segment includes our investments made outside of reinsurance operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the financial information for each segment that is specifically identifiable or based on allocations using internal methodology as of and for the three and nine months ended September 30, 2023 and 2022. The ‘other’ category in the table below consists largely of corporate general and administrative expenses which have not been allocated to a specific segment. Segment assets for the “other” category primarily consist of unrestricted cash in the amounts of $<span id="xdx_904_eus-gaap--Cash_iI_pn5n6_c20230930__us-gaap--CashAndCashEquivalentsAxis__custom--UnrestrictedCashMember_zCz2yQEiK3e2" title="Unrestricted cash">3.8</span> million and $<span id="xdx_902_eus-gaap--Cash_iI_pn5n6_c20220930__us-gaap--CashAndCashEquivalentsAxis__custom--UnrestrictedCashMember_zIigP8dzUPH1" title="Unrestricted cash">8.7</span> million as of September 30, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zpIG2Qn70nV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BD_zrnVqaG2evl6" style="display: none">Summary of Segment Reporting</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended September 30, 2023</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Insurance</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Asset Management</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Net premiums earned</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z4r58wYotvO9" style="width: 11%; text-align: right" title="Net premiums earned">4,192</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zZpVIyk48Jbc" style="width: 11%; text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1415">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zOl0NyheUUok" style="width: 11%; text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1417">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930_z1UGXarUWVPj" style="width: 11%; text-align: right" title="Net premiums earned">4,192</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zGcbHab96Z3c" style="text-align: right" title="Net investment income (loss)">5,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zv85CwHEKtQ1" style="text-align: right" title="Net investment income (loss)">1,922</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zLv90BJU4Jca" style="text-align: right" title="Net investment income (loss)">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930_zAQESMEYkuXe" style="text-align: right" title="Net investment income (loss)">6,961</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zxrPGBby3E8c" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--OtherIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_ze4TS3TS7Jrf" style="text-align: right" title="Other income">24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OtherIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zqTWxdgK5VTc" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OtherIncome_pn3n3_c20230701__20230930_z3f4hHTakVmh" style="text-align: right" title="Other income">24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z1mupaomRsC1" style="text-align: right" title="Total revenue">9,224</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zeZOQGO407Jh" style="text-align: right" title="Total revenue">1,946</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zyffyQ8VnuK4" style="text-align: right" title="Total revenue">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930_zKx158349cY7" style="text-align: right" title="Total revenue">11,177</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z6luEXWPXGWg" style="text-align: right" title="Income (loss) before income tax">5,465</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zuiL733uVvG7" style="text-align: right" title="Income (loss) before income tax">1,946</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zM2wK7Q0r9x3" style="text-align: right" title="Income (loss) before income tax">(1,783</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930_zAtMVae6uY79" style="text-align: right" title="Income (loss) before income tax">5,628</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">For the nine months ended September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net premiums earned</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zZYMHEgbYSB3" style="text-align: right" title="Net premiums earned">11,534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zoQMsnNRole1" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1455">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zsA2jGk6fYMi" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1457">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930_zskvsug0HmJ3" style="text-align: right" title="Net premiums earned">11,534</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zusROqu1k3T" style="text-align: right" title="Net investment income (loss)">8,108</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zJcQUfRPquE" style="text-align: right" title="Net investment income (loss)">150</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zWUSgMVkhvh6" style="text-align: right" title="Net investment income (loss)">14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930_zvYinkZd7Lm7" style="text-align: right" title="Net investment income (loss)">8,272</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OtherIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zOMwMYoH15Mc" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1469">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OtherIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zBvAYGcPgnlc" style="text-align: right" title="Other income">84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_z6Yj07advbJb" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1473">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--OtherIncome_pn3n3_c20230101__20230930_zWHgbBl5Lkkf" style="text-align: right" title="Other income">84</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zlPLR0bx2VD5" style="text-align: right" title="Total revenue">19,642</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zVJbkisdKnB7" style="text-align: right" title="Total revenue">234</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zs9QqJ0Sysfb" style="text-align: right" title="Total revenue">14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930_znjUnxKH77l7" style="text-align: right" title="Total revenue">19,890</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zwvOqbY2OIni" style="text-align: right" title="Income (loss) before income tax">9,366</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zck21bKPD006" style="text-align: right" title="Income (loss) before income tax">234</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zUZZiaWEizka" style="text-align: right" title="Income (loss) before income tax">(5,545</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930_zWSy85B8lOkd" style="text-align: right" title="Income (loss) before income tax">4,055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">As of September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Segment assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z81yaI5LdDu6" style="text-align: right" title="Segment assets">35,776</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zfblFNMrU0sl" style="text-align: right" title="Segment assets">18,436</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zjnSO5yAfMwj" style="text-align: right" title="Segment assets">4,616</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20230930_z0j0RMzccWSb" style="text-align: right" title="Segment assets">58,828</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">For the three months ended September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net premiums earned</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zXb7TF5aU8fj" style="text-align: right" title="Net premiums earned">4,383</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_za8UqnS9yOE8" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1503">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_z4xcZrSa9pA" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1505">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930_zwbn86cYcFjd" style="text-align: right" title="Net premiums earned">4,383</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zd26XoGogGo7" style="text-align: right" title="Net investment income (loss)">2,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zDQt6xMokYw9" style="text-align: right" title="Net investment income (loss)">8,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zmCG6z1R9B4j" style="text-align: right" title="Net investment income (loss)"><span style="-sec-ix-hidden: xdx2ixbrl1513">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930_zQsnPOyfig1l" style="text-align: right" title="Net investment income (loss)">11,174</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OtherIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zC4galYcOZS7" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1517">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zb4xmXeU4bad" style="text-align: right" title="Other income">89</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OtherIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zpdpX04KM26j" style="text-align: right" title="Other income">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OtherIncome_pn3n3_c20220701__20220930_ztSJQlG3xaod" style="text-align: right" title="Other income">214</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zva5r8YOToV7" style="text-align: right" title="Total revenue">6,851</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zk4q6ZoBncp5" style="text-align: right" title="Total revenue">8,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zC8lTEoBnHql" style="text-align: right" title="Total revenue">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930_z7mo4NMfENni" style="text-align: right" title="Total revenue">15,771</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zxquB4yJd7nl" style="text-align: right" title="Income (loss) before income tax">3,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_znmhBk9mGtB7" style="text-align: right" title="Income (loss) before income tax">8,798</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zGgy3ZTnkwkf" style="text-align: right" title="Income (loss) before income tax">(1,817</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930_z9aAiqeVwydh" style="text-align: right" title="Income (loss) before income tax">10,255</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">For the nine months ended September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net premiums earned</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zUphTP0NjAyk" style="text-align: right" title="Net premiums earned">9,809</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zkDVVYwqedw3" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1543">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zzYjwbZFSYSj" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1545">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930_zsADVz7PxRAi" style="text-align: right" title="Net premiums earned">9,809</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zGKAm6Q1IXNg" style="text-align: right" title="Net investment income (loss)">1,562</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zUWXLd97AmBi" style="text-align: right" title="Net investment income (loss)">3,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zhTgS5FDZ7s6" style="text-align: right" title="Net investment income (loss)"><span style="-sec-ix-hidden: xdx2ixbrl1553">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930_zXWgFbluEZfb" style="text-align: right" title="Net investment income (loss)">5,114</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z4UZg4ygW8O7" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1557">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zhVjrM2YJ24f" style="text-align: right" title="Other income">141</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zy3Ga6BOnOzd" style="text-align: right" title="Other income">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherIncome_pn3n3_c20220101__20220930_zTRs1ANLWlA3" style="text-align: right" title="Other income">266</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zQOKvfUzSFd2" style="text-align: right" title="Total revenue">11,371</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_z0oUKPWembb5" style="text-align: right" title="Total revenue">3,693</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zE79A8oDrB95" style="text-align: right" title="Total revenue">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930_zZXzpC4EZ5sc" style="text-align: right" title="Total revenue">15,189</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zrTFxrhcgjl7" style="text-align: right" title="Income (loss) before income tax">2,728</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zBhwAYC5LjZc" style="text-align: right" title="Income (loss) before income tax">3,680</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zPjVtmj6EJS4" style="text-align: right" title="Income (loss) before income tax">(5,453</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930_ziXKxOTvnjpb" style="text-align: right" title="Income (loss) before income tax">955</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">As of September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_pn3n3_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zd1BuEU6T9g5" style="text-align: right" title="Segment assets">21,662</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zCIYad0JeJg1" style="text-align: right" title="Segment assets">17,777</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zHfpxpJ1kK55" style="text-align: right" title="Segment assets">9,484</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20220930_z6NYaWyyV87i" style="text-align: right" title="Segment assets">48,923</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AE_zlPzZTEVlPK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2 3800000 8700000 <p id="xdx_892_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zpIG2Qn70nV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BD_zrnVqaG2evl6" style="display: none">Summary of Segment Reporting</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended September 30, 2023</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Insurance</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Asset Management</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Net premiums earned</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z4r58wYotvO9" style="width: 11%; text-align: right" title="Net premiums earned">4,192</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zZpVIyk48Jbc" style="width: 11%; text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1415">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zOl0NyheUUok" style="width: 11%; text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1417">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PremiumsEarnedNet_pn3n3_c20230701__20230930_z1UGXarUWVPj" style="width: 11%; text-align: right" title="Net premiums earned">4,192</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zGcbHab96Z3c" style="text-align: right" title="Net investment income (loss)">5,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zv85CwHEKtQ1" style="text-align: right" title="Net investment income (loss)">1,922</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zLv90BJU4Jca" style="text-align: right" title="Net investment income (loss)">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NetInvestmentIncome_pn3n3_c20230701__20230930_zAQESMEYkuXe" style="text-align: right" title="Net investment income (loss)">6,961</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zxrPGBby3E8c" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--OtherIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_ze4TS3TS7Jrf" style="text-align: right" title="Other income">24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OtherIncome_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zqTWxdgK5VTc" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OtherIncome_pn3n3_c20230701__20230930_z3f4hHTakVmh" style="text-align: right" title="Other income">24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z1mupaomRsC1" style="text-align: right" title="Total revenue">9,224</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zeZOQGO407Jh" style="text-align: right" title="Total revenue">1,946</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zyffyQ8VnuK4" style="text-align: right" title="Total revenue">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230701__20230930_zKx158349cY7" style="text-align: right" title="Total revenue">11,177</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z6luEXWPXGWg" style="text-align: right" title="Income (loss) before income tax">5,465</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zuiL733uVvG7" style="text-align: right" title="Income (loss) before income tax">1,946</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zM2wK7Q0r9x3" style="text-align: right" title="Income (loss) before income tax">(1,783</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20230930_zAtMVae6uY79" style="text-align: right" title="Income (loss) before income tax">5,628</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">For the nine months ended September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net premiums earned</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zZYMHEgbYSB3" style="text-align: right" title="Net premiums earned">11,534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zoQMsnNRole1" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1455">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zsA2jGk6fYMi" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1457">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20230930_zskvsug0HmJ3" style="text-align: right" title="Net premiums earned">11,534</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zusROqu1k3T" style="text-align: right" title="Net investment income (loss)">8,108</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zJcQUfRPquE" style="text-align: right" title="Net investment income (loss)">150</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zWUSgMVkhvh6" style="text-align: right" title="Net investment income (loss)">14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetInvestmentIncome_pn3n3_c20230101__20230930_zvYinkZd7Lm7" style="text-align: right" title="Net investment income (loss)">8,272</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OtherIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zOMwMYoH15Mc" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1469">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OtherIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zBvAYGcPgnlc" style="text-align: right" title="Other income">84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_z6Yj07advbJb" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1473">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--OtherIncome_pn3n3_c20230101__20230930_zWHgbBl5Lkkf" style="text-align: right" title="Other income">84</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zlPLR0bx2VD5" style="text-align: right" title="Total revenue">19,642</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zVJbkisdKnB7" style="text-align: right" title="Total revenue">234</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zs9QqJ0Sysfb" style="text-align: right" title="Total revenue">14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230930_znjUnxKH77l7" style="text-align: right" title="Total revenue">19,890</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zwvOqbY2OIni" style="text-align: right" title="Income (loss) before income tax">9,366</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zck21bKPD006" style="text-align: right" title="Income (loss) before income tax">234</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zUZZiaWEizka" style="text-align: right" title="Income (loss) before income tax">(5,545</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230930_zWSy85B8lOkd" style="text-align: right" title="Income (loss) before income tax">4,055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">As of September 30, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Segment assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20230930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z81yaI5LdDu6" style="text-align: right" title="Segment assets">35,776</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zfblFNMrU0sl" style="text-align: right" title="Segment assets">18,436</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zjnSO5yAfMwj" style="text-align: right" title="Segment assets">4,616</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20230930_z0j0RMzccWSb" style="text-align: right" title="Segment assets">58,828</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">For the three months ended September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net premiums earned</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zXb7TF5aU8fj" style="text-align: right" title="Net premiums earned">4,383</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_za8UqnS9yOE8" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1503">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_z4xcZrSa9pA" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1505">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PremiumsEarnedNet_pn3n3_c20220701__20220930_zwbn86cYcFjd" style="text-align: right" title="Net premiums earned">4,383</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zd26XoGogGo7" style="text-align: right" title="Net investment income (loss)">2,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zDQt6xMokYw9" style="text-align: right" title="Net investment income (loss)">8,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zmCG6z1R9B4j" style="text-align: right" title="Net investment income (loss)"><span style="-sec-ix-hidden: xdx2ixbrl1513">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NetInvestmentIncome_pn3n3_c20220701__20220930_zQsnPOyfig1l" style="text-align: right" title="Net investment income (loss)">11,174</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OtherIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zC4galYcOZS7" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1517">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zb4xmXeU4bad" style="text-align: right" title="Other income">89</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OtherIncome_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zpdpX04KM26j" style="text-align: right" title="Other income">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OtherIncome_pn3n3_c20220701__20220930_ztSJQlG3xaod" style="text-align: right" title="Other income">214</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zva5r8YOToV7" style="text-align: right" title="Total revenue">6,851</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zk4q6ZoBncp5" style="text-align: right" title="Total revenue">8,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zC8lTEoBnHql" style="text-align: right" title="Total revenue">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220701__20220930_z7mo4NMfENni" style="text-align: right" title="Total revenue">15,771</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zxquB4yJd7nl" style="text-align: right" title="Income (loss) before income tax">3,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_znmhBk9mGtB7" style="text-align: right" title="Income (loss) before income tax">8,798</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zGgy3ZTnkwkf" style="text-align: right" title="Income (loss) before income tax">(1,817</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20220930_z9aAiqeVwydh" style="text-align: right" title="Income (loss) before income tax">10,255</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">For the nine months ended September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net premiums earned</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zUphTP0NjAyk" style="text-align: right" title="Net premiums earned">9,809</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zkDVVYwqedw3" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1543">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zzYjwbZFSYSj" style="text-align: right" title="Net premiums earned"><span style="-sec-ix-hidden: xdx2ixbrl1545">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20220930_zsADVz7PxRAi" style="text-align: right" title="Net premiums earned">9,809</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net investment income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zGKAm6Q1IXNg" style="text-align: right" title="Net investment income (loss)">1,562</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zUWXLd97AmBi" style="text-align: right" title="Net investment income (loss)">3,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zhTgS5FDZ7s6" style="text-align: right" title="Net investment income (loss)"><span style="-sec-ix-hidden: xdx2ixbrl1553">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NetInvestmentIncome_pn3n3_c20220101__20220930_zXWgFbluEZfb" style="text-align: right" title="Net investment income (loss)">5,114</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_z4UZg4ygW8O7" style="text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1557">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zhVjrM2YJ24f" style="text-align: right" title="Other income">141</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherIncome_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zy3Ga6BOnOzd" style="text-align: right" title="Other income">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherIncome_pn3n3_c20220101__20220930_zTRs1ANLWlA3" style="text-align: right" title="Other income">266</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zQOKvfUzSFd2" style="text-align: right" title="Total revenue">11,371</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_z0oUKPWembb5" style="text-align: right" title="Total revenue">3,693</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zE79A8oDrB95" style="text-align: right" title="Total revenue">125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220930_zZXzpC4EZ5sc" style="text-align: right" title="Total revenue">15,189</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) before income tax</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zrTFxrhcgjl7" style="text-align: right" title="Income (loss) before income tax">2,728</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zBhwAYC5LjZc" style="text-align: right" title="Income (loss) before income tax">3,680</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zPjVtmj6EJS4" style="text-align: right" title="Income (loss) before income tax">(5,453</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220101__20220930_ziXKxOTvnjpb" style="text-align: right" title="Income (loss) before income tax">955</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">As of September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_pn3n3_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--InsuranceMember_zd1BuEU6T9g5" style="text-align: right" title="Segment assets">21,662</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--AssetManagementMember_zCIYad0JeJg1" style="text-align: right" title="Segment assets">17,777</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20220930__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zHfpxpJ1kK55" style="text-align: right" title="Segment assets">9,484</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20220930_z6NYaWyyV87i" style="text-align: right" title="Segment assets">48,923</td><td style="text-align: left"> </td></tr> </table> 4192000 4192000 5032000 1922000 7000 6961000 24000 24000 9224000 1946000 7000 11177000 5465000 1946000 -1783000 5628000 11534000 11534000 8108000 150000 14000 8272000 84000 84000 19642000 234000 14000 19890000 9366000 234000 -5545000 4055000 35776000 18436000 4616000 58828000 4383000 4383000 2468000 8706000 11174000 89000 125000 214000 6851000 8795000 125000 15771000 3274000 8798000 -1817000 10255000 9809000 9809000 1562000 3552000 5114000 141000 125000 266000 11371000 3693000 125000 15189000 2728000 3680000 -5453000 955000 21662000 17777000 9484000 48923000 <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zKulq9jvNvPc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12. <span id="xdx_82D_zLb3cAtNRYNg">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Corporation has evaluated subsequent events through the filing date of the financial statements and determined that there have been no events that have occurred that would require additional disclosures.</span></p> EXCEL 62 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

T.V7?@ 0 *&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #@6E7@(3XG< ! '@ $P M @ $\8 $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .@ Z + ,T/ M8@$ ! end XML 63 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 244 275 1 false 76 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://fgfinancial.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://fgfinancial.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://fgfinancial.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://fgfinancial.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) Sheet http://fgfinancial.com/role/StatementsOfShareholdersEquity Consolidated Statements of Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) Sheet http://fgfinancial.com/role/StatementsOfShareholdersEquityParenthetical Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statement of Cash Flows (Unaudited) Sheet http://fgfinancial.com/role/StatementOfCashFlows Consolidated Statement of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Nature of Business Sheet http://fgfinancial.com/role/NatureOfBusiness Nature of Business Notes 8 false false R9.htm 00000009 - Disclosure - Significant Accounting Policies Sheet http://fgfinancial.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Recently Adopted and Issued Accounting Standards Sheet http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandards Recently Adopted and Issued Accounting Standards Notes 10 false false R11.htm 00000011 - Disclosure - Investments and Fair Value Disclosures Sheet http://fgfinancial.com/role/InvestmentsAndFairValueDisclosures Investments and Fair Value Disclosures Notes 11 false false R12.htm 00000012 - Disclosure - Loss and Loss Adjustment Expense Reserves Sheet http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReserves Loss and Loss Adjustment Expense Reserves Notes 12 false false R13.htm 00000013 - Disclosure - Income Taxes Sheet http://fgfinancial.com/role/IncomeTaxes Income Taxes Notes 13 false false R14.htm 00000014 - Disclosure - Equity Incentive Plan Grants Sheet http://fgfinancial.com/role/EquityIncentivePlanGrants Equity Incentive Plan Grants Notes 14 false false R15.htm 00000015 - Disclosure - Related Party Transactions Sheet http://fgfinancial.com/role/RelatedPartyTransactions Related Party Transactions Notes 15 false false R16.htm 00000016 - Disclosure - Net Earnings Per Share Sheet http://fgfinancial.com/role/NetEarningsPerShare Net Earnings Per Share Notes 16 false false R17.htm 00000017 - Disclosure - Commitments and Contingencies Sheet http://fgfinancial.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 00000018 - Disclosure - Segment Reporting Sheet http://fgfinancial.com/role/SegmentReporting Segment Reporting Notes 18 false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://fgfinancial.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://fgfinancial.com/role/SignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Investments and Fair Value Disclosures (Tables) Sheet http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables Investments and Fair Value Disclosures (Tables) Tables http://fgfinancial.com/role/InvestmentsAndFairValueDisclosures 21 false false R22.htm 00000022 - Disclosure - Loss and Loss Adjustment Expense Reserves (Tables) Sheet http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReservesTables Loss and Loss Adjustment Expense Reserves (Tables) Tables http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReserves 22 false false R23.htm 00000023 - Disclosure - Income Taxes (Tables) Sheet http://fgfinancial.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://fgfinancial.com/role/IncomeTaxes 23 false false R24.htm 00000024 - Disclosure - Equity Incentive Plan Grants (Tables) Sheet http://fgfinancial.com/role/EquityIncentivePlanGrantsTables Equity Incentive Plan Grants (Tables) Tables http://fgfinancial.com/role/EquityIncentivePlanGrants 24 false false R25.htm 00000025 - Disclosure - Net Earnings Per Share (Tables) Sheet http://fgfinancial.com/role/NetEarningsPerShareTables Net Earnings Per Share (Tables) Tables http://fgfinancial.com/role/NetEarningsPerShare 25 false false R26.htm 00000026 - Disclosure - Segment Reporting (Tables) Sheet http://fgfinancial.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://fgfinancial.com/role/SegmentReporting 26 false false R27.htm 00000027 - Disclosure - Nature of Business (Details Narrative) Sheet http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative Nature of Business (Details Narrative) Details http://fgfinancial.com/role/NatureOfBusiness 27 false false R28.htm 00000028 - Disclosure - Significant Accounting Policies (Details Narrative) Sheet http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative Significant Accounting Policies (Details Narrative) Details http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies 28 false false R29.htm 00000029 - Disclosure - Recently Adopted and Issued Accounting Standards (Details Narrative) Sheet http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandardsDetailsNarrative Recently Adopted and Issued Accounting Standards (Details Narrative) Details http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandards 29 false false R30.htm 00000030 - Disclosure - Schedule of Equity Securities (Details) Sheet http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails Schedule of Equity Securities (Details) Details 30 false false R31.htm 00000031 - Disclosure - Schedule of Investments Under Equity Method (Details) Sheet http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails Schedule of Investments Under Equity Method (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Net Investment Income (Loss) (Details) Sheet http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails Schedule of Net Investment Income (Loss) (Details) Details 32 false false R33.htm 00000033 - Disclosure - Schedule of Financial Instruments Measured at Fair Value (Details) Sheet http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails Schedule of Financial Instruments Measured at Fair Value (Details) Details 33 false false R34.htm 00000034 - Disclosure - Schedule of Fair Value of Recurring Level 3 Fair Value Measurements (Details) Sheet http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails Schedule of Fair Value of Recurring Level 3 Fair Value Measurements (Details) Details 34 false false R35.htm 00000035 - Disclosure - Investments and Fair Value Disclosures (Details Narrative) Sheet http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative Investments and Fair Value Disclosures (Details Narrative) Details http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables 35 false false R36.htm 00000036 - Disclosure - Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves (Details) Sheet http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves (Details) Details 36 false false R37.htm 00000037 - Disclosure - Schedule of Reconciliation Effective Tax Rates (Details) (Parenthetical) Sheet http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetailsParenthetical Schedule of Reconciliation Effective Tax Rates (Details) (Parenthetical) Details 37 false false R38.htm 00000038 - Disclosure - Schedule of Reconciliation Effective Tax Rates (Details) Sheet http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails Schedule of Reconciliation Effective Tax Rates (Details) Details 38 false false R39.htm 00000039 - Disclosure - Schedule of Deferred Income Taxes (Details) Sheet http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails Schedule of Deferred Income Taxes (Details) Details 39 false false R40.htm 00000040 - Disclosure - Income Taxes (Details Narrative) Sheet http://fgfinancial.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://fgfinancial.com/role/IncomeTaxesTables 40 false false R41.htm 00000041 - Disclosure - Schedule of Restricted Stock Units Activity (Details) Sheet http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails Schedule of Restricted Stock Units Activity (Details) Details 41 false false R42.htm 00000042 - Disclosure - Schedule of Fair Value of Stock Options (Details) Sheet http://fgfinancial.com/role/ScheduleOfFairValueOfStockOptionsDetails Schedule of Fair Value of Stock Options (Details) Details 42 false false R43.htm 00000043 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Equity Incentive Plan Grants (Details Narrative) Sheet http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative Equity Incentive Plan Grants (Details Narrative) Details http://fgfinancial.com/role/EquityIncentivePlanGrantsTables 44 false false R45.htm 00000045 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://fgfinancial.com/role/RelatedPartyTransactions 45 false false R46.htm 00000046 - Disclosure - Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share (Details) Sheet http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share (Details) Details 46 false false R47.htm 00000047 - Disclosure - Schedule of Potentially Dilutive Securities Excluded from Calculation (Details) Sheet http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails Schedule of Potentially Dilutive Securities Excluded from Calculation (Details) Details 47 false false R48.htm 00000048 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://fgfinancial.com/role/CommitmentsAndContingencies 48 false false R49.htm 00000049 - Disclosure - Summary of Segment Reporting (Details) Sheet http://fgfinancial.com/role/SummaryOfSegmentReportingDetails Summary of Segment Reporting (Details) Details 49 false false R50.htm 00000050 - Disclosure - Segment Reporting (Details Narrative) Sheet http://fgfinancial.com/role/SegmentReportingDetailsNarrative Segment Reporting (Details Narrative) Details http://fgfinancial.com/role/SegmentReportingTables 50 false false All Reports Book All Reports fgf-20230930.xsd fgf-20230930_cal.xml fgf-20230930_def.xml fgf-20230930_lab.xml fgf-20230930_pre.xml form10-q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 67 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "FGF", "nsuri": "http://fgfinancial.com/20230930", "dts": { "schema": { "local": [ "fgf-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "fgf-20230930_cal.xml" ] }, "definitionLink": { "local": [ "fgf-20230930_def.xml" ] }, "labelLink": { "local": [ "fgf-20230930_lab.xml" ] }, "presentationLink": { "local": [ "fgf-20230930_pre.xml" ] }, "inline": { "local": [ "form10-q.htm" ] } }, "keyStandard": 243, "keyCustom": 32, "axisStandard": 20, "axisCustom": 0, "memberStandard": 16, "memberCustom": 56, "hidden": { "total": 172, "http://fasb.org/us-gaap/2023": 129, "http://xbrl.sec.gov/dei/2023": 4, "http://fgfinancial.com/20230930": 39 }, "contextCount": 244, "entityCount": 1, "segmentCount": 76, "elementCount": 470, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 796, "http://xbrl.sec.gov/dei/2023": 33 }, "report": { "R1": { "role": "http://fgfinancial.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://fgfinancial.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:EquitySecuritiesFvNi", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:EquitySecuritiesFvNi", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://fgfinancial.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://fgfinancial.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations (Unaudited)", "shortName": "Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:PremiumsEarnedNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "FGF:RevenuesFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://fgfinancial.com/role/StatementsOfShareholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited)", "shortName": "Consolidated Statements of Shareholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-03-31_us-gaap_CommonStockMember", "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R6": { "role": "http://fgfinancial.com/role/StatementsOfShareholdersEquityParenthetical", "longName": "00000006 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical)", "shortName": "Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:PreferredStockDividendsPerShareCashPaid", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:PreferredStockDividendsPerShareCashPaid", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R7": { "role": "http://fgfinancial.com/role/StatementOfCashFlows", "longName": "00000007 - Statement - Consolidated Statement of Cash Flows (Unaudited)", "shortName": "Consolidated Statement of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:UnrealizedGainLossOnInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R8": { "role": "http://fgfinancial.com/role/NatureOfBusiness", "longName": "00000008 - Disclosure - Nature of Business", "shortName": "Nature of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://fgfinancial.com/role/SignificantAccountingPolicies", "longName": "00000009 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandards", "longName": "00000010 - Disclosure - Recently Adopted and Issued Accounting Standards", "shortName": "Recently Adopted and Issued Accounting Standards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosures", "longName": "00000011 - Disclosure - Investments and Fair Value Disclosures", "shortName": "Investments and Fair Value Disclosures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReserves", "longName": "00000012 - Disclosure - Loss and Loss Adjustment Expense Reserves", "shortName": "Loss and Loss Adjustment Expense Reserves", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "FGF:LossAndLossAdjustmentExpenseReservesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "FGF:LossAndLossAdjustmentExpenseReservesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://fgfinancial.com/role/IncomeTaxes", "longName": "00000013 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://fgfinancial.com/role/EquityIncentivePlanGrants", "longName": "00000014 - Disclosure - Equity Incentive Plan Grants", "shortName": "Equity Incentive Plan Grants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://fgfinancial.com/role/RelatedPartyTransactions", "longName": "00000015 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://fgfinancial.com/role/NetEarningsPerShare", "longName": "00000016 - Disclosure - Net Earnings Per Share", "shortName": "Net Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://fgfinancial.com/role/CommitmentsAndContingencies", "longName": "00000017 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://fgfinancial.com/role/SegmentReporting", "longName": "00000018 - Disclosure - Segment Reporting", "shortName": "Segment Reporting", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://fgfinancial.com/role/SubsequentEvents", "longName": "00000019 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies", "longName": "00000020 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables", "longName": "00000021 - Disclosure - Investments and Fair Value Disclosures (Tables)", "shortName": "Investments and Fair Value Disclosures (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReservesTables", "longName": "00000022 - Disclosure - Loss and Loss Adjustment Expense Reserves (Tables)", "shortName": "Loss and Loss Adjustment Expense Reserves (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "FGF:LossAndLossAdjustmentExpenseReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "FGF:LossAndLossAdjustmentExpenseReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://fgfinancial.com/role/IncomeTaxesTables", "longName": "00000023 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://fgfinancial.com/role/EquityIncentivePlanGrantsTables", "longName": "00000024 - Disclosure - Equity Incentive Plan Grants (Tables)", "shortName": "Equity Incentive Plan Grants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://fgfinancial.com/role/NetEarningsPerShareTables", "longName": "00000025 - Disclosure - Net Earnings Per Share (Tables)", "shortName": "Net Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://fgfinancial.com/role/SegmentReportingTables", "longName": "00000026 - Disclosure - Segment Reporting (Tables)", "shortName": "Segment Reporting (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "longName": "00000027 - Disclosure - Nature of Business (Details Narrative)", "shortName": "Nature of Business (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "FGF:NumberOfActiveReinsuranceContracts", "unitRef": "Integer", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "FGF:NumberOfActiveReinsuranceContracts", "unitRef": "Integer", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R28": { "role": "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative", "longName": "00000028 - Disclosure - Significant Accounting Policies (Details Narrative)", "shortName": "Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InvestmentInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "FGF:OtherInvestmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InvestmentInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "FGF:OtherInvestmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandardsDetailsNarrative", "longName": "00000029 - Disclosure - Recently Adopted and Issued Accounting Standards (Details Narrative)", "shortName": "Recently Adopted and Issued Accounting Standards (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2023-01-01", "name": "us-gaap:CumulativeEarningsDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "FGF:CurrentExpectedCreditLossPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails", "longName": "00000030 - Disclosure - Schedule of Equity Securities (Details)", "shortName": "Schedule of Equity Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:EquitySecuritiesFvNiCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:EquitySecuritiesFvNiCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails", "longName": "00000031 - Disclosure - Schedule of Investments Under Equity Method (Details)", "shortName": "Schedule of Investments Under Equity Method (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_EquityMethodInvestmentMember", "name": "us-gaap:OtherInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R32": { "role": "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails", "longName": "00000032 - Disclosure - Schedule of Net Investment Income (Loss) (Details)", "shortName": "Schedule of Net Investment Income (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:NetInvestmentIncome", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30_custom_RealizedGainLossOnCommonStockMember", "name": "us-gaap:NetInvestmentIncome", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentIncomeTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R33": { "role": "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails", "longName": "00000033 - Disclosure - Schedule of Financial Instruments Measured at Fair Value (Details)", "shortName": "Schedule of Financial Instruments Measured at Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-09-30_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "longName": "00000034 - Disclosure - Schedule of Fair Value of Recurring Level 3 Fair Value Measurements (Details)", "shortName": "Schedule of Fair Value of Recurring Level 3 Fair Value Measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "FGF:IncreaseInFairValueOfConvertibleNote", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member", "name": "us-gaap:ConvertibleDebtFairValueDisclosures", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R35": { "role": "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "longName": "00000035 - Disclosure - Investments and Fair Value Disclosures (Details Narrative)", "shortName": "Investments and Fair Value Disclosures (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-01-012023-03-31", "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-03-31", "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "FGF:InvestmentsAndFairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails", "longName": "00000036 - Disclosure - Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves (Details)", "shortName": "Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ReinsuranceRecoverablesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "FGF:LossAndLossAdjustmentExpenseReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ReinsuranceRecoverablesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "FGF:LossAndLossAdjustmentExpenseReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R37": { "role": "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetailsParenthetical", "longName": "00000037 - Disclosure - Schedule of Reconciliation Effective Tax Rates (Details) (Parenthetical)", "shortName": "Schedule of Reconciliation Effective Tax Rates (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R38": { "role": "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails", "longName": "00000038 - Disclosure - Schedule of Reconciliation Effective Tax Rates (Details)", "shortName": "Schedule of Reconciliation Effective Tax Rates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R39": { "role": "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails", "longName": "00000039 - Disclosure - Schedule of Deferred Income Taxes (Details)", "shortName": "Schedule of Deferred Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R40": { "role": "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative", "longName": "00000040 - Disclosure - Income Taxes (Details Narrative)", "shortName": "Income Taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R41": { "role": "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "longName": "00000041 - Disclosure - Schedule of Restricted Stock Units Activity (Details)", "shortName": "Schedule of Restricted Stock Units Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R42": { "role": "http://fgfinancial.com/role/ScheduleOfFairValueOfStockOptionsDetails", "longName": "00000042 - Disclosure - Schedule of Fair Value of Stock Options (Details)", "shortName": "Schedule of Fair Value of Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R43": { "role": "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails", "longName": "00000043 - Disclosure - Schedule of Stock Option Activity (Details)", "shortName": "Schedule of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_TwoThousandAndFourteenEquityIncentivePlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_TwoThousandAndFourteenEquityIncentivePlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R44": { "role": "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "longName": "00000044 - Disclosure - Equity Incentive Plan Grants (Details Narrative)", "shortName": "Equity Incentive Plan Grants (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-03-24", "name": "FGF:EmployeeStockPurchasePlanDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-03-24", "name": "FGF:EmployeeStockPurchasePlanDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R45": { "role": "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000045 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-03-31_custom_FGCommunitiesIncMember", "name": "us-gaap:Investments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "FGF:CurrentExpectedCreditLossPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-29_custom_ThinkMaketsMember", "name": "us-gaap:Investments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R46": { "role": "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails", "longName": "00000046 - Disclosure - Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share (Details)", "shortName": "Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R47": { "role": "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails", "longName": "00000047 - Disclosure - Schedule of Potentially Dilutive Securities Excluded from Calculation (Details)", "shortName": "Schedule of Potentially Dilutive Securities Excluded from Calculation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R48": { "role": "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "00000048 - Disclosure - Commitments and Contingencies (Details Narrative)", "shortName": "Commitments and Contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PaymentsForRent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PaymentsForRent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R49": { "role": "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails", "longName": "00000049 - Disclosure - Summary of Segment Reporting (Details)", "shortName": "Summary of Segment Reporting (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:PremiumsEarnedNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R50": { "role": "http://fgfinancial.com/role/SegmentReportingDetailsNarrative", "longName": "00000050 - Disclosure - Segment Reporting (Details Narrative)", "shortName": "Segment Reporting (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r783" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r795" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r265", "r266", "r271", "r272", "r273", "r275", "r276", "r277", "r321", "r328", "r426", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r521", "r750", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r839", "r840", "r841", "r842" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r795" ] }, "FGF_EquityMethodEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "EquityMethodEarningsMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Earnings [Member]", "documentation": "Equity Method Earnings [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsTable", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Table]", "documentation": "Disclosure of information about investments owned by investment company." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r674", "r676", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r706", "r707", "r708", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r722", "r723", "r724", "r725", "r726", "r727" ] }, "us-gaap_OtherShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermInvestments", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other investments", "documentation": "Amount of short-term investments classified as other." } } }, "auth_ref": [ "r52", "r505", "r818" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r794" ] }, "us-gaap_ScheduleOfInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsLineItems", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r674", "r676", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r722", "r723", "r724", "r725", "r726", "r727" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r794" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets", "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails", "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Total assets", "verboseLabel": "Segment assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r91", "r131", "r150", "r193", "r208", "r214", "r259", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r413", "r417", "r441", "r509", "r617", "r767", "r780", "r851", "r852", "r891" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_InvestmentInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentInterestRate", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment interest rate", "documentation": "Rate of interest on investment." } } }, "auth_ref": [ "r656", "r657", "r677", "r678", "r682", "r683", "r715", "r716", "r772", "r837", "r838" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net income from continuing operations", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r88", "r150", "r158", "r193", "r207", "r213", "r216", "r259", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r429", "r441", "r519", "r748", "r851" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r799" ] }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of dividends on preferred shares", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ReinsuranceRecoverablesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverablesGross", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, beginning of period, net of reinsurance", "periodEndLabel": "Balance, September 30, net of reinsurance", "label": "Reinsurance Recoverables, Gross", "documentation": "Amount before valuation allowance recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves." } } }, "auth_ref": [ "r114", "r271", "r502", "r516", "r543" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r791" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash deposit per institution insured by FDIC", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r798" ] }, "us-gaap_ReinsuranceRecoverablesAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverablesAllowance", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Reinsurance losses allowance", "documentation": "Amount of allowance for credit loss on reinsurance recoverable." } } }, "auth_ref": [ "r264", "r267", "r270", "r502", "r543" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://fgfinancial.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r151", "r387", "r391", "r392", "r399", "r406", "r408", "r409", "r410", "r565" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r457", "r458", "r459", "r460", "r461", "r566", "r567", "r568", "r630", "r631", "r632", "r651", "r652" ] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Rent expense", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r3" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r783" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Nonconsolidated Investee [Axis]", "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity." } } }, "auth_ref": [ "r128", "r150", "r259", "r441" ] }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity." } } }, "auth_ref": [ "r128", "r150", "r259", "r441" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r783" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized stock based compensation expense", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r882" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common stock issuance", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r58", "r59", "r83", "r571", "r648", "r733", "r779" ] }, "us-gaap_OtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestments", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other investments", "label": "Other Investments [Default Label]", "documentation": "Amount of investments classified as other." } } }, "auth_ref": [ "r816" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r138", "r388", "r389", "r392", "r393", "r398", "r400", "r559" ] }, "us-gaap_TradingSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradingSecuritiesDebt", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Investments, Carrying Amount", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading)." } } }, "auth_ref": [ "r132", "r744", "r836" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r787" ] }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtFairValueDisclosures", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Balance, September 30", "label": "Fair value of note", "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r321", "r328", "r426", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r521", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r839", "r840", "r841", "r842" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r783" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r783" ] }, "FGF_ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ConvertiblePromissoryNoteMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note [Member]", "documentation": "Convertible Promissory Note [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r788" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://fgfinancial.com/role/NatureOfBusiness" ], "lang": { "en-us": { "role": { "label": "Nature of Business", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r108", "r122" ] }, "FGF_FGACInvestorsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FGACInvestorsLLCMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FGAC Investors LLC [Member]", "documentation": "FGAC Investors LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "FGF_RevenuesFromContractWithCustomerExcludingAssessedTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails", "http://fgfinancial.com/role/StatementsOfOperations", "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r525", "r627", "r719", "r720", "r721" ] }, "us-gaap_DeferredTaxLiabilitiesInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesInvestments", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments", "label": "Deferred Tax Liabilities, Investments", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments)." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInUnearnedPremiums", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned premium reserves", "label": "Increase (Decrease) in Unearned Premiums", "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income." } } }, "auth_ref": [ "r4" ] }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r845" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation Policies", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r42", "r745" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership percentage", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "FGF_DecreaseIncreaseInFairValueOfConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "DecreaseIncreaseInFairValueOfConvertibleNoteMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Decrease (Increase) in Fair Value of Convertible Note [Member]", "documentation": "Decrease (Increase) in Fair Value of Convertible Note [Member]" } } }, "auth_ref": [] }, "us-gaap_InvestmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTableTextBlock", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Securities", "documentation": "Tabular disclosure of investment." } } }, "auth_ref": [ "r805", "r806", "r835" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "FGF_ThinkMarketsConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ThinkMarketsConvertibleNoteMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "ThinkMarkets Convertible Note [Member]", "documentation": "ThinkMarkets Convertible Note [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesTradingUnrealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesTradingUnrealizedGain", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Investments, Gross Unrealized Gains", "documentation": "Amount of unrealized gain on investment in debt security measured at fair value with change in fair value recognized in net income (trading)." } } }, "auth_ref": [ "r252" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r151", "r390", "r407" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Net unrealized holding (gain) on equity investments", "label": "Unrealized Gain (Loss) on Investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r5" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "auth_ref": [] }, "us-gaap_RealEstateInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestments", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Real estate investment", "documentation": "Amount of real estate investments, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; (7) other real estate investments; (8) real estate joint ventures; and (9) unconsolidated real estate and other joint ventures not separately presented." } } }, "auth_ref": [ "r504", "r907" ] }, "FGF_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OtherMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Other [Member]", "documentation": "Other [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails", "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "negatedLabel": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r70", "r629" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r342", "r349", "r368", "r369", "r370", "r371", "r374", "r382", "r383", "r384", "r385" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "auth_ref": [] }, "us-gaap_SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash collateral total", "documentation": "Amount, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of fund outstanding loaned in form of security resale agreement for purchase and resale of identical or substantially same security at date certain for specified price. Includes security purchased under agreement to resell not subject to master netting arrangement or similar agreement." } } }, "auth_ref": [ "r11" ] }, "FGF_ExpireOnDecemberThirtyOneTwoThousandAndThirtyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ExpireOnDecemberThirtyOneTwoThousandAndThirtyNineMember", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expire on December 31, 2039 [Member]", "documentation": "Expire on December 31, 2039 [Member]" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails", "http://fgfinancial.com/role/SegmentReportingDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash in bank", "verboseLabel": "Cash", "terseLabel": "Unrestricted cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r106", "r511", "r582", "r612", "r767", "r780", "r814" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r772" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r783" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r49" ] }, "FGF_OpfiCommonStockAndWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OpfiCommonStockAndWarrantsMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Opfi Common Stock And Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesTradingUnrealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesTradingUnrealizedLoss", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Investments, Gross Unrealized Losses", "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in net income (trading)." } } }, "auth_ref": [ "r252" ] }, "FGF_FGMergerInvestorsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FGMergerInvestorsLLCMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FG MergerInvestors LLC [Member]", "documentation": "FG MergerInvestors LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred Policy Acquisition Costs", "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs." } } }, "auth_ref": [ "r101", "r102" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common stock issuance, shares", "verboseLabel": "Number of shares issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r58", "r59", "r83", "r560", "r648", "r733" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r361" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "FGF_ChangeInUnrealizedHoldingOnCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ChangeInUnrealizedHoldingOnCommonStockMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Change in Unrealized Holding on Common Stock [Member]", "documentation": "Change in Unrealized Holding on Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value, Vested", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r362" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "verboseLabel": "Exercise price of shares", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r354" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Non-vested Units, Beginning balance", "periodEndLabel": "Number of Non-vested Units, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r358", "r359" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for rent", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r454" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r355" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Cancelled", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r356" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r59" ] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued, value", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r123", "r133", "r134", "r135", "r150", "r175", "r176", "r179", "r182", "r187", "r188", "r259", "r296", "r298", "r299", "r300", "r303", "r304", "r324", "r325", "r326", "r327", "r329", "r441", "r560", "r561", "r562", "r563", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r583", "r604", "r626", "r648", "r732", "r733", "r734", "r735", "r736", "r802", "r825", "r831" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain loss on investments", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r72", "r801" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders\u2019 equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r40", "r41", "r44", "r124", "r125", "r140", "r153", "r154", "r155", "r159", "r166", "r260", "r263", "r331", "r379", "r380", "r381", "r401", "r402", "r419", "r420", "r421", "r422", "r423", "r425", "r428", "r445", "r446", "r450", "r455", "r546", "r547", "r569", "r606", "r623", "r649", "r650", "r737", "r779", "r827", "r844", "r888", "r908" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of restricted stock issued", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r8", "r58", "r59", "r83" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Non-vested Units, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r362" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Exercisable, Beginning balance", "periodEndLabel": "Aggregate Intrinsic Value, Exercisable, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r34" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r58", "r59", "r83", "r355" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://fgfinancial.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r463", "r464" ] }, "us-gaap_InsuranceSettlementsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceSettlementsReceivableCurrent", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Reinsurance balances receivable (net of current expected losses allowance of $84 and zero, respectively)", "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r817" ] }, "us-gaap_DeferredTaxAssetsInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInvestments", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments", "label": "Deferred Tax Assets, Investments", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments)." } } }, "auth_ref": [] }, "us-gaap_ReinsuranceLossOnUncollectibleAccountsInPeriodAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceLossOnUncollectibleAccountsInPeriodAmount", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "label": "Current year", "documentation": "Amount of the write-down or write-off of a receivable from a reinsurer." } } }, "auth_ref": [ "r269" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant Date Fair Value, Beginning balance", "periodEndLabel": "Weighted Average Grant Date Fair Value, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r358", "r359" ] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Senior unsecured promissory note", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r13", "r94", "r900" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "FGF_RealizedGainLossOnCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "RealizedGainLossOnCommonStockMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Realized Gain (Loss) on Common Stock [Member]", "documentation": "Realized Gain (Loss) on Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred tax valuation allowances", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r394" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of Recurring Level 3 Fair Value Measurements", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r46", "r89" ] }, "us-gaap_CumulativeEarningsDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CumulativeEarningsDeficit", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandardsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated deficit", "label": "Cumulative earnings deficit", "documentation": "Amount of cumulative earnings (deficits) for relevant time periods." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r256", "r257", "r258" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "FGF_ThinkMarketsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ThinkMarketsMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ThinkMarkets [Member]", "documentation": "ThinkMarkets [Member]" } } }, "auth_ref": [] }, "FGF_FGSPACPartnersLPMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FGSPACPartnersLPMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FG SPAC Partners LP [Member]", "documentation": "FG SPAC Partners LP [Member]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r889" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of share available for issuance", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r34" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r6", "r12" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Provision for taxes at U.S. statutory marginal income tax rate of 21%", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r390" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r256", "r257", "r258" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other liabilities", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r17" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpense", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Non-deductible expenses associated with the Share Repurchase Transaction", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses." } } }, "auth_ref": [ "r883" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r61", "r83", "r514", "r549", "r553", "r564", "r605", "r767" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r803", "r883" ] }, "FGF_CraveworthyMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "CraveworthyMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Craveworthy [Member]", "documentation": "Craveworthy [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Exercised", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r365" ] }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "presentation": [ "http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReservesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Changes in Outstanding Loss and Loss Adjustment Expense Reserves", "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r100" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r59", "r62", "r63", "r81", "r606", "r623", "r649", "r650", "r767", "r780", "r827", "r844", "r888", "r908" ] }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Income (loss) attributable to FG Financial Group, Inc. common shareholders from continuing operations", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders." } } }, "auth_ref": [ "r173", "r182" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r411" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r411" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "FGF_InvestmentFundMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "InvestmentFundMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment Fund [Member]", "documentation": "Investment Fund [Member]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used) provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r147" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r411" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfOtherInvestments", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Net realized (gain) loss on sale of equity investments", "label": "Gain (Loss) on Sale of Other Investments", "documentation": "Amount of gain (loss) included in earnings for investments classified as other." } } }, "auth_ref": [ "r5" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided (used) by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r147" ] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r43", "r413", "r414", "r417", "r418" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity method investments", "verboseLabel": "Investment fund", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r203", "r254", "r815", "r843" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Premium Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r628", "r742", "r746" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r77", "r78", "r79" ] }, "us-gaap_PremiumsEarnedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsEarnedNet", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "FGF_RevenuesFromContractWithCustomerExcludingAssessedTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations", "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Net premiums earned", "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned." } } }, "auth_ref": [ "r119", "r120", "r537", "r554" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails", "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Non-vested Units, Granted", "verboseLabel": "Number of restricted units granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r361" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value, Forfeited", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r363" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase carrying value of investments", "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r253" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity method investment, ownership percentage", "verboseLabel": "Equity method investments", "terseLabel": "Investment ownership percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r256" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r58", "r604" ] }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]", "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r845" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Non-vested Units, Forfeited", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r363" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r58", "r324" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Loss and loss adjustment expense reserves", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from loss reserves other than estimated credit losses." } } }, "auth_ref": [ "r39", "r885" ] }, "FGF_GreenfirstForestProductsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "GreenfirstForestProductsLLCMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Green first Forest Products LLC [Member]", "documentation": "Green first Forest Products LLC [Member]" } } }, "auth_ref": [] }, "FGF_ConsiderationPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ConsiderationPaid", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Consideration paid", "documentation": "Consideration paid" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r792", "r794", "r795" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r790" ] }, "us-gaap_InsuranceContractAcquisitionCostPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceContractAcquisitionCostPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Funds Deposited for Benefit of Reinsured Companies", "documentation": "Disclosure of accounting policy for cost related directly to successful acquisition of new and renewal of insurance contract. Information includes, but is not limited to, input, judgment, assumption, and method used to determine amortization amount, and change in input, judgment, and assumption. Cost, includes but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination." } } }, "auth_ref": [ "r103", "r503", "r538", "r539", "r540" ] }, "us-gaap_ProceedsFromContributedCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromContributedCapital", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contributed", "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r793" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r330" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred income tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r56", "r57", "r93", "r395" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred income tax asset (liability)", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r884" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "FGF_EquityAwardLetterAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "EquityAwardLetterAgreementMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Award Letter Agreement [Member]", "documentation": "Equity Award Letter Agreement [Member]." } } }, "auth_ref": [] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Equity securities, common stock", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r555", "r584", "r585", "r586", "r588", "r589", "r590", "r591", "r592", "r595", "r596", "r607", "r608", "r653", "r662", "r663", "r672", "r686", "r687", "r700", "r701", "r702", "r710", "r713", "r722", "r724", "r727", "r772", "r780", "r905" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://fgfinancial.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r129" ] }, "FGF_CurrentExpectedCreditLossPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "CurrentExpectedCreditLossPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Current Expected Credit Loss", "documentation": "Current Expected Credit Loss [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r23", "r129", "r743" ] }, "FGF_LossAndLossAdjustmentExpenseReservesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "LossAndLossAdjustmentExpenseReservesPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Loss and Loss Adjustment Expense Reserves", "documentation": "Loss And Loss Adjustment Expense Reserves [Policy Text Block]", "label": "LossAndLossAdjustmentExpenseReservesPolicyTextBlock" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforward", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r39", "r885" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r796" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r24" ] }, "FGF_NumberOfActiveReinsuranceContracts": { "xbrltype": "integerItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "NumberOfActiveReinsuranceContracts", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of active reinsurance contracts", "documentation": "Number of active reinsurance contracts." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveNoncurrent", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loss and loss adjustment expense reserves", "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r819", "r847", "r848" ] }, "FGF_GreenfirstForestProductsHoldingsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "GreenfirstForestProductsHoldingsLLCMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Greenfirst Forest Products Holdings LLC [Member]", "documentation": "Greenfirst Forest Products Holdings LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "FGF_MrSwetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "MrSwetsMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr. Swets [Member]", "documentation": "Mr. Swets [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r128", "r150", "r256", "r257", "r258", "r259", "r441" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails", "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic net income (loss) per common share", "verboseLabel": "Income (loss) per common share from continuing operations", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r65", "r96", "r99", "r142", "r158", "r162", "r163", "r164", "r165", "r175", "r179", "r181", "r429", "r500", "r902" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred income tax assets net of valuation allowance", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r884" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r397" ] }, "FGF_ExpireOnDecemberThirtyOneTwoThousandAndFourtyMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ExpireOnDecemberThirtyOneTwoThousandAndFourtyMember", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expire on December 31, 2040 [Member]", "documentation": "Expire on December 31, 2040 [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsLineItems", "presentation": [ "http://fgfinancial.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "FGF_TransferOut": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "TransferOut", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Transfer out", "documentation": "Transfer out." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r150", "r256", "r257", "r258", "r259", "r441" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred income tax liabilities:" } } }, "auth_ref": [] }, "FGF_DecreaseInFairValueOfConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "DecreaseInFairValueOfConvertibleNote", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Decrease in fair value of convertible note" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://fgfinancial.com/role/NetEarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r832" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r346", "r347", "r348", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r370", "r371", "r372", "r373", "r374" ] }, "us-gaap_PreferredStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsPerShareCashPaid", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock dividends per share cash paid", "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted net income (loss) per common share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r65", "r142", "r158", "r162", "r163", "r164", "r165", "r175", "r179", "r181", "r182", "r429", "r500", "r902" ] }, "FGF_EmployeeDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "EmployeeDirectorMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employee Director [Member]", "documentation": "Employee Director [Member]" } } }, "auth_ref": [] }, "FGF_IncurredRelatedToAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "IncurredRelatedToAbstract", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "label": "Incurred related to:", "documentation": "Incurred related to [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r794" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r39", "r885" ] }, "FGF_OppFiMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OppFiMember", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Opp Fi [Member]", "documentation": "Opp Fi [Member]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsIncomeStatementImpact", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails", "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Dividends declared on Series A Preferred Shares", "negatedLabel": "Dividends declared on Series A Preferred Shares", "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders." } } }, "auth_ref": [] }, "FGF_ExpireOnDecemberThirtyOneTwoThousandAndFourtyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ExpireOnDecemberThirtyOneTwoThousandAndFourtyOneMember", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expire on December 31, 2041 [Member]", "documentation": "Expire on December 31, 2041 [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r770", "r771", "r772", "r774", "r775", "r776", "r777", "r828", "r829", "r886", "r904", "r908" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r123", "r133", "r134", "r135", "r150", "r175", "r176", "r179", "r182", "r187", "r188", "r259", "r296", "r298", "r299", "r300", "r303", "r304", "r324", "r325", "r326", "r327", "r329", "r441", "r560", "r561", "r562", "r563", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r583", "r604", "r626", "r648", "r732", "r733", "r734", "r735", "r736", "r802", "r825", "r831" ] }, "FGF_ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "label": "Prior year", "documentation": "Incurred related to: Prior years." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTable", "presentation": [ "http://fgfinancial.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Cash and Cash Equivalents [Table]", "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_DeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredPolicyAcquisitionCosts", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred policy acquisition costs", "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force." } } }, "auth_ref": [ "r105", "r517", "r541", "r542", "r548", "r768" ] }, "FGF_PaidRelatedToAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "PaidRelatedToAbstract", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "label": "Paid related to:", "documentation": "Paid related to [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r794" ] }, "FGF_CommonStock0.001ParValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "CommonStock0.001ParValuePerShareMember", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.001 par value per share" } } }, "auth_ref": [] }, "FGF_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Ave Grant Date Fair Value, Outstanding, Beginning balance", "periodEndLabel": "Weighted Ave Grant Date Fair Value, Outstanding, Ending balance", "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average grant date fair value.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r783" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r781" ] }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Capital loss carryforward", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards." } } }, "auth_ref": [ "r39", "r885" ] }, "us-gaap_EquityMethodInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsTextBlock", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments Under Equity Method", "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information." } } }, "auth_ref": [ "r255" ] }, "FGF_ReinsuranceRecoverableCreditLossExpenseReversalPriorYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ReinsuranceRecoverableCreditLossExpenseReversalPriorYear", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "label": "Prior years", "documentation": "Paid related to: Prior years." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred policy acquisition costs", "label": "Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost", "documentation": "The amount as of the balance sheet date of the estimated future tax effects attributable to policy acquisition costs being expensed for tax purposes but capitalized in conformity with generally accepted accounting principles, which will reverse in future periods when amortization of such capitalized costs cannot be deducted for tax purposes." } } }, "auth_ref": [ "r39", "r885" ] }, "FGF_AmendmentTwoThousandAndTwentyOneIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "AmendmentTwoThousandAndTwentyOneIncentivePlanMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amendment 2021 Incentive Plan [Member]", "documentation": "Amendment 2021 Incentive Plan [Member]" } } }, "auth_ref": [] }, "FGF_IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Income tax benefit", "documentation": "Income tax expense benefit from continuing and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://fgfinancial.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r129" ] }, "FGF_NonEmployeeDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "NonEmployeeDirectorMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non Employee Director [Member]", "documentation": "Non Employee Director [Member]" } } }, "auth_ref": [] }, "FGF_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Ave Remaining Contractual Term (Years), Outstanding, Beginning balance", "documentation": "Sharebased Compensation Arrangement years." } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r834", "r890" ] }, "FGF_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Ave Grant Date Fair Value, Exercisable, Beginning balance", "periodEndLabel": "Weighted Ave Grant Date Fair Value, Exercisable, Ending balance", "documentation": "Weighted ave grant date fair value, exercisable.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" } } }, "auth_ref": [] }, "FGF_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Granted", "documentation": "Aggregate Intrinsic Value, Granted." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://fgfinancial.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "label": "Segment Reporting", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r189", "r190", "r191", "r192", "r193", "r205", "r210", "r214", "r215", "r216", "r217", "r218", "r219", "r221" ] }, "FGF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant date Fair Value, Exercised", "documentation": "Weighted Average Grant date Fair Value, Exercised." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred policy acquisition costs", "label": "Increase (Decrease) in Deferred Policy Acquisition Costs", "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers." } } }, "auth_ref": [ "r4" ] }, "FGF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant date Fair Value, Cancelled", "documentation": "Share based compensation arrangement by share based payment award options cancelled in period weighted average grant date fair value." } } }, "auth_ref": [] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r585", "r587", "r588", "r590", "r592", "r653", "r662", "r679", "r687", "r700", "r704", "r705", "r724", "r728", "r729", "r730", "r731", "r772" ] }, "FGF_EmployeeStockPurchasePlanDescription": { "xbrltype": "stringItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "EmployeeStockPurchasePlanDescription", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ESPP Plan, description", "documentation": "Employee stock purchase plan description." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r37", "r884" ] }, "FGF_Sec8.00CumulativePreferredStockSeries25.00ParValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "Sec8.00CumulativePreferredStockSeries25.00ParValuePerShareMember", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r38" ] }, "FGF_StockOptiondescription": { "xbrltype": "stringItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "StockOptiondescription", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option,description", "documentation": "Stock option, description." } } }, "auth_ref": [] }, "FGF_FundamentalGlobalInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FundamentalGlobalInvestorMember", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fundamental Global GP, LLC [Member]", "documentation": "Fundamental Global Investor [Member]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNetAbstract", "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred income tax assets:" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r784" ] }, "FGF_FGCommunitiesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FGCommunitiesIncMember", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FG Communities Inc [Member]", "documentation": "FG Communities Inc [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred income tax assets", "label": "Deferred tax assets, gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r396" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://fgfinancial.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Summary of Segment Reporting", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r30", "r31", "r32", "r33" ] }, "FGF_SharedServicesFee": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "SharedServicesFee", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shared services fee", "documentation": "Shared services fee." } } }, "auth_ref": [] }, "FGF_TwoThousandAndTwentyOneIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "TwoThousandAndTwentyOneIncentivePlanMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Incentive Plan [Member]", "documentation": "2021 Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "FGF_ExpireOnDecemberTwoThousandAndTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ExpireOnDecemberTwoThousandAndTwentySixMember", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expire on December 2026 [Member]", "documentation": "Expire on December 2026 [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r30", "r31", "r32", "r33" ] }, "FGF_FundamentalGlobalAssetManagementLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FundamentalGlobalAssetManagementLLCMember", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fundamental Global Asset Management, LLC [Member]", "documentation": "Fundamental Global Asset Management, LLC [Member]." } } }, "auth_ref": [] }, "FGF_NotExpireUnderCurrentTaxLawMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "NotExpireUnderCurrentTaxLawMember", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Not Expire Under Current Tax Law [Member]", "documentation": "Not Expire Under Current Tax Law [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r39", "r885" ] }, "FGF_WeightedAverageCommonSharesOutstandingContinuingOperations": { "xbrltype": "sharesItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "WeightedAverageCommonSharesOutstandingContinuingOperations", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding", "documentation": "Weighted average common shares outstanding." } } }, "auth_ref": [] }, "FGF_OppFiCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OppFiCommonStockMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "OppFi Common Stock [Member]", "documentation": "OppFi Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDiscountRate", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee discount rate", "documentation": "Discount rate used by lessee to determine present value of operating lease payments." } } }, "auth_ref": [ "r766" ] }, "FGF_OperatingAssetAndLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OperatingAssetAndLeaseLiability", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating asset and lease liability", "documentation": "Operating asset and lease liability." } } }, "auth_ref": [] }, "FGF_NonExecutiveMembersMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "NonExecutiveMembersMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NonExecutive Members [Member]", "documentation": "NonExecutive Members [Member]" } } }, "auth_ref": [] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue:" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrants" ], "lang": { "en-us": { "role": { "label": "Equity Incentive Plan Grants", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r342", "r345", "r376", "r377", "r378", "r762" ] }, "FGF_OppFiCommonStockAndWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OppFiCommonStockAndWarrantsMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Opp Fi Common Stock And Warrants [Member]" } } }, "auth_ref": [] }, "FGF_LarryGSwetsJrMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "LarryGSwetsJrMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Larry G. Swets Jr [Member]", "documentation": "Larry G. Swets Jr [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity method investment realized gain (loss)", "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment." } } }, "auth_ref": [ "r821", "r822", "r824" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r82", "r290", "r291", "r738", "r849" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r770", "r771", "r774", "r775", "r776", "r777" ] }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingChangesAndErrorCorrectionsAbstract", "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net investment income", "label": "Investment Income, Net", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r71", "r73" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock based compensation", "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables", "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r313", "r335", "r336", "r337", "r338", "r339", "r340", "r435", "r468", "r469", "r470", "r753", "r754", "r758", "r759", "r760" ] }, "us-gaap_AmortizationOfDeferredCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDeferredCharges", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Amortization of deferred policy acquisition costs", "documentation": "The amount of amortization of deferred charges applied against earnings during the period." } } }, "auth_ref": [ "r69" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r313", "r335", "r340", "r435", "r469", "r753", "r754", "r758", "r759", "r760" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r789" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock based compensation, shares", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investments in Equity Securities", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r524", "r555", "r556", "r557", "r558", "r673", "r675" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r313", "r335", "r340", "r435", "r468", "r758", "r759", "r760" ] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity securities, at fair value (cost basis of $1,916 and $889, respectively)", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r132", "r440", "r744" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Distribution from equity method investments", "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities." } } }, "auth_ref": [ "r146", "r823" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r439" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables", "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r313", "r335", "r336", "r337", "r338", "r339", "r340", "r435", "r470", "r753", "r754", "r758", "r759", "r760" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows", "http://fgfinancial.com/role/StatementsOfOperations", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Net income", "verboseLabel": "Net income (loss)", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r128", "r136", "r137", "r145", "r150", "r158", "r167", "r168", "r193", "r207", "r213", "r216", "r259", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r412", "r415", "r416", "r429", "r441", "r501", "r520", "r570", "r625", "r646", "r647", "r748", "r764", "r765", "r779", "r820", "r851" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r506" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://fgfinancial.com/role/NetEarningsPerShare" ], "lang": { "en-us": { "role": { "label": "Net Earnings Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r171", "r183", "r184", "r185" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of equity method investments", "label": "Payments to Acquire Equity Method Investments", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r21" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails" ], "lang": { "en-us": { "role": { "label": "Potentially dilutive securities outstanding", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r183" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNiCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiCost", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Investments, Cost basis", "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r507" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfReconciliationEffectiveTaxRatesDetails" ], "lang": { "en-us": { "role": { "label": "Valuation allowance for deferred tax assets deemed unrealizable", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r883" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity securities, cost basis", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r223", "r274", "r507" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Income Taxes", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r87" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Income (loss) before income tax", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r66", "r98", "r193", "r207", "r213", "r216", "r501", "r519", "r748" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://fgfinancial.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Reconciliation Effective Tax Rates", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r86" ] }, "us-gaap_ReinsuranceRecoverableCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverableCreditLossExpenseReversal", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfChangesInOutstandingLossAndLossAdjustmentExpenseReservesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current year", "label": "Reinsurance Recoverable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on reinsurance recoverable." } } }, "auth_ref": [ "r268" ] }, "FGF_IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "IncreaseInInvestmentsWithoutReadilyDeterminableFairValueMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Increase in Investments Without Readily Determinable Fair Value [Member]", "documentation": "Increase in Investments Without Readily Determinable Fair Value [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r59" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restricted Stock Units Activity", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Granted", "verboseLabel": "Grant an additional stock options", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r354" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Financial Instruments Measured at Fair Value", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r434", "r435" ] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock number of shares sold", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding:" } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r795" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://fgfinancial.com/role/NetEarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Potentially Dilutive Securities Excluded from Calculation", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r25" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.001 par value; 100,000,000 shares authorized; 10,303,739 and 9,410,473 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r59", "r513", "r767" ] }, "us-gaap_UndistributedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarnings", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Undistributed earnings", "documentation": "The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed." } } }, "auth_ref": [ "r177", "r180" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r25" ] }, "us-gaap_IncreaseDecreaseInInsuranceSettlementsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInsuranceSettlementsReceivable", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Reinsurance balances receivable", "label": "Increase (Decrease) in Insurance Settlements Receivable", "documentation": "The increase (decrease) during the reporting period in insurance settlements receivable, which are amounts due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy. The expectation is that such reimbursement will be received within one year of the balance sheet date." } } }, "auth_ref": [ "r4" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r59", "r604" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r59", "r604", "r623", "r908", "r909" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r174", "r182" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings (Loss) Per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r25", "r26" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r9", "r10", "r35" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of Stock Options", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r85" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-Cash Investing Transactions:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNumeratorsAndDenominatorsUsedInCalculationOfBasicAndDilutedEarningsPerShareDetails", "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic", "verboseLabel": "Weighted average common shares", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r172", "r182" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price of warrants", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r330" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeTextBlock", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Net Investment Income (Loss)", "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments." } } }, "auth_ref": [ "r71", "r73", "r74", "r901" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://fgfinancial.com/role/ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromCalculationDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r25" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r800" ] }, "FGF_LossAndLossAdjustmentExpenseReservesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "LossAndLossAdjustmentExpenseReservesTextBlock", "presentation": [ "http://fgfinancial.com/role/LossAndLossAdjustmentExpenseReserves" ], "lang": { "en-us": { "role": { "label": "Loss and Loss Adjustment Expense Reserves", "documentation": "Loss And Loss Adjustment Expense Reserves [Text Block]" } } }, "auth_ref": [] }, "FGF_FGMPMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FGMPMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FGMP [Member]", "documentation": "FGMP [Member]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of furniture and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r76" ] }, "FGF_InvestmentsAndFairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "InvestmentsAndFairValueDisclosuresTextBlock", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosures" ], "lang": { "en-us": { "role": { "label": "Investments and Fair Value Disclosures", "documentation": "Investments And Fair Value Disclosures [Text Block]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r68", "r150", "r193", "r207", "r213", "r216", "r259", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r441", "r748", "r851" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r127", "r190", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r216", "r221", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r751", "r804", "r903" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r379", "r380", "r381", "r571", "r828", "r829", "r830", "r886", "r908" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://fgfinancial.com/role/Cover", "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r153", "r154", "r155", "r186", "r496", "r555", "r583", "r595", "r597", "r598", "r599", "r600", "r601", "r604", "r607", "r608", "r609", "r610", "r611", "r613", "r614", "r615", "r616", "r618", "r619", "r620", "r621", "r622", "r624", "r628", "r629", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r648", "r773" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "FGF_OtherInvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "OtherInvestmentPolicyTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Other Investments", "documentation": "Other Investment [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r585", "r587", "r588", "r590", "r592", "r653", "r662", "r679", "r687", "r700", "r704", "r705", "r724", "r728", "r729", "r730", "r731", "r772" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r77" ] }, "FGF_TwentyTwentyOneEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "TwentyTwentyOneEquityIncentivePlanMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Equity Incentive Plan [Member]", "documentation": "Twenty Twenty One Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Shares, $25.00 par and liquidation value, 1,000,000 shares authorized; 894,580 shares issued and outstanding as of September 30, 2023 and December 31, 2022", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r58", "r512", "r767" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "FGF_StockOptionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "StockOptionAgreementMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Option Agreement [Member]", "documentation": "Stock Option Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Total revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r194", "r195", "r206", "r211", "r212", "r218", "r220", "r221", "r332", "r333", "r496" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r23", "r77", "r148" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r19", "r124", "r139", "r140", "r141", "r153", "r154", "r155", "r159", "r166", "r168", "r186", "r260", "r263", "r331", "r379", "r380", "r381", "r401", "r402", "r419", "r420", "r421", "r422", "r423", "r425", "r428", "r445", "r446", "r447", "r448", "r449", "r450", "r455", "r545", "r546", "r547", "r571", "r648" ] }, "FGF_DisclosureLossAndLossAdjustmentExpenseReservesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "DisclosureLossAndLossAdjustmentExpenseReservesAbstract", "lang": { "en-us": { "role": { "label": "Loss And Loss Adjustment Expense Reserves", "verboseLabel": "Schedule Of Changes In Outstanding Loss And Loss Adjustment Expense Reserves" } } }, "auth_ref": [] }, "FGF_TwoThousandAndFourteenEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "TwoThousandAndFourteenEquityIncentivePlanMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "2014 Equity Incentive Plan [Member]", "documentation": "2014 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherInvestments", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of other investments", "label": "Payments to Acquire Other Investments", "documentation": "Amount of cash outflow to acquire investments classified as other." } } }, "auth_ref": [ "r75" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r124", "r153", "r154", "r155", "r159", "r166", "r168", "r260", "r263", "r379", "r380", "r381", "r401", "r402", "r419", "r421", "r422", "r425", "r428", "r545", "r547", "r571", "r908" ] }, "FGF_JointVentureAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "JointVentureAgreementMember", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Joint Venture Agreement [Member]", "documentation": "Joint Venture Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary." } } }, "auth_ref": [ "r7", "r45" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r13", "r54", "r55", "r92", "r94", "r152", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r451", "r752", "r753", "r754", "r755", "r756", "r826" ] }, "FGF_FundamentalGlobalAssetManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FundamentalGlobalAssetManagementMember", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fundamental Global Asset Management [Member]", "documentation": "Fundamental Global Asset Management [Member]" } } }, "auth_ref": [] }, "FGF_ThinkMaketsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ThinkMaketsMember", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Think Makets [Member]", "documentation": "Think Makets [Member]" } } }, "auth_ref": [] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r190", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r216", "r221", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r288", "r289", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r751", "r804", "r903" ] }, "FGF_FGMergerInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FGMergerInvestorsMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FG Merger Investors [Member]", "documentation": "FG Merger Investors [Member]" } } }, "auth_ref": [] }, "FGF_SharedServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "SharedServicesAgreementMember", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shared Services Agreement [Member]", "documentation": "Shared Services Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt carry value", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r13", "r94", "r322" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r124", "r139", "r140", "r141", "r153", "r154", "r155", "r159", "r166", "r168", "r186", "r260", "r263", "r331", "r379", "r380", "r381", "r401", "r402", "r419", "r420", "r421", "r422", "r423", "r425", "r428", "r445", "r446", "r447", "r448", "r449", "r450", "r455", "r545", "r546", "r547", "r571", "r648" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Cancelled", "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed." } } }, "auth_ref": [ "r36" ] }, "FGF_FundamentalGlobalManagementLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FundamentalGlobalManagementLLCMember", "presentation": [ "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fundamental Global Management, LLC [Member]", "documentation": "Fundamental Global Management, LLC [Member]" } } }, "auth_ref": [] }, "FGF_LeaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "LeaseAgreementMember", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease Agreement [Member]", "documentation": "Lease Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 10)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r18", "r51", "r510", "r603" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r53", "r111" ] }, "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of equity securities", "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity." } } }, "auth_ref": [ "r104", "r144" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Return of capital \u2013 other investments", "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy." } } }, "auth_ref": [ "r20" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://fgfinancial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r411" ] }, "FGF_UnrestrictedCashMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "UnrestrictedCashMember", "presentation": [ "http://fgfinancial.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrestricted Cash [Member]", "documentation": "Unrestricted Cash [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets", "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r90", "r130", "r508", "r780" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option service period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r763" ] }, "FGF_ICoreConnectIncMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "ICoreConnectIncMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I Core Connect Inc [Member]", "documentation": "I Core Connect Inc [Member]" } } }, "auth_ref": [] }, "FGF_DisclosureInvestmentsAndFairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "DisclosureInvestmentsAndFairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Investments And Fair Value Disclosures" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets", "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r14", "r150", "r259", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r414", "r417", "r418", "r441", "r602", "r747", "r780", "r851", "r891", "r892" ] }, "us-gaap_AllOtherSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllOtherSegmentsMember", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Other Segments [Member]", "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items." } } }, "auth_ref": [ "r190", "r206", "r207", "r208", "r209", "r210" ] }, "FGF_AssetManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "AssetManagementMember", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Asset Management [Member]", "documentation": "Asset Management [Member]" } } }, "auth_ref": [] }, "FGF_InsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "InsuranceMember", "presentation": [ "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Insurance [Member]", "documentation": "Insurance [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "The Use of Estimates in the Preparation of Consolidated Financial Statements", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r27", "r28", "r29", "r109", "r110", "r112", "r113" ] }, "srt_PlatformOperatorCryptoAssetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "PlatformOperatorCryptoAssetLineItems", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables", "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Beginning balance", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r350", "r351" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant date Fair Value, Granted", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r364" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common stock, net", "verboseLabel": "Proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r2" ] }, "srt_PlatformOperatorCryptoAssetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "PlatformOperatorCryptoAssetTable", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables", "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Table]" } } }, "auth_ref": [] }, "FGF_DividendsDeclaredOnSeriesAPreferredShares": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "DividendsDeclaredOnSeriesAPreferredShares", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Dividends declared on Series A Preferred Shares ($0.50 per share)", "documentation": "Dividends declared on Series A Preferred Shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Cancelled", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r356" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair Value, Nonrecurring [Member]", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "auth_ref": [] }, "FGF_FundsDepositedForBenefitOfReinsuredCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "FundsDepositedForBenefitOfReinsuredCompanies", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Funds deposited with reinsured companies", "documentation": "Funds deposited for benefit of reinsured companies." } } }, "auth_ref": [] }, "FGF_RevenuesFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "RevenuesFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenue", "documentation": "obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "RevenuesFromContractWithCustomerExcludingAssessedTax" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r433", "r439" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Outstanding, Beginning balance", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r34" ] }, "FGF_NetLossesAndLossAdjustmentExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "NetLossesAndLossAdjustmentExpenses", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net losses and loss adjustment expenses", "documentation": "Net Losses And Loss Adjustment Expenses." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares, Outstanding, Beginning balance", "periodEndLabel": "Shares, Outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r350", "r351" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r64", "r95", "r515", "r767", "r827", "r844", "r888" ] }, "FGF_CumulativeEffectOfAdoptionOfAccountingGuidanceForExpectedCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "CumulativeEffectOfAdoptionOfAccountingGuidanceForExpectedCreditLosses", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023", "documentation": "Cumulative effect of adoption of accounting guidance for expected credit losses." } } }, "auth_ref": [] }, "FGF_IncreaseInInvestmentWithoutReadilyDeterminableFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "IncreaseInInvestmentWithoutReadilyDeterminableFairValue", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "(Increase) in investment without a readily determinable fair value", "documentation": "Increase in investment without readily determinable fair value", "label": "IncreaseInInvestmentWithoutReadilyDeterminableFairValue" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares, Exercisable, Beginning balance", "periodEndLabel": "Shares, Exercisable, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r352" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable, accrued expenses and other liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r4" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresTables", "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r313", "r335", "r336", "r337", "r338", "r339", "r340", "r468", "r469", "r470", "r753", "r754", "r758", "r759", "r760" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r60", "r767", "r906" ] }, "FGF_IncreaseInFairValueOfConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "IncreaseInFairValueOfConvertibleNote", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfRecurringLevel3FairValueMeasurementsDetails", "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "(Increase) in fair value of convertible note", "label": "Increase in fair value of convertible note", "documentation": "Increase in fair value of convertible note." } } }, "auth_ref": [] }, "FGF_IncreaseDecreaseInFundsDepositedWithReinsuredCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "IncreaseDecreaseInFundsDepositedWithReinsuredCompanies", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Funds deposited with reinsured companies", "documentation": "Increase decrease in fundsDdeposited with reinsured companies.", "label": "IncreaseDecreaseInFundsDepositedWithReinsuredCompanies" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Exercisable, Beginning balance", "periodEndLabel": "Weighted Average Exercise Price, Exercisable, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r352" ] }, "FGF_EquitySecuritiesInOppfiReceivedInConnectionWithFgSpecialSituationsFundUnwind": { "xbrltype": "monetaryItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "EquitySecuritiesInOppfiReceivedInConnectionWithFgSpecialSituationsFundUnwind", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Equity securities in OppFi received in connection with FG Special Situations Fund unwind", "documentation": "Equity securities in oppfi received in connection with fg special situations fund unwind" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://fgfinancial.com/role/Cover", "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/RelatedPartyTransactionsDetailsNarrative", "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative", "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r153", "r154", "r155", "r186", "r496", "r555", "r583", "r595", "r597", "r598", "r599", "r600", "r601", "r604", "r607", "r608", "r609", "r610", "r611", "r613", "r614", "r615", "r616", "r618", "r619", "r620", "r621", "r622", "r624", "r628", "r629", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r648", "r773" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r58", "r604", "r623", "r908", "r909" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r373" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r47", "r48", "r305", "r451", "r753", "r754" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r152", "r413", "r414", "r417", "r418", "r462", "r739", "r850", "r853", "r854" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r372" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r371" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://fgfinancial.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r58", "r324" ] }, "us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Loss and loss adjustment expense reserves", "label": "Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve", "documentation": "Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date." } } }, "auth_ref": [ "r4" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r334", "r341", "r371", "r372", "r373", "r471", "r495", "r544", "r593", "r594", "r656", "r677", "r683", "r684", "r715", "r740", "r741", "r749", "r757", "r761", "r769", "r772", "r846", "r855", "r894", "r895", "r896", "r897", "r898" ] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://fgfinancial.com/role/NatureOfBusinessDetailsNarrative" ], "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r346", "r347", "r348", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r370", "r371", "r372", "r373", "r374" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r343", "r344", "r346", "r347", "r348", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r370", "r371", "r372", "r373", "r374" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/IncomeTaxesDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r343", "r344", "r346", "r347", "r348", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r370", "r371", "r372", "r373", "r374" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://fgfinancial.com/role/RecentlyAdoptedAndIssuedAccountingStandards" ], "lang": { "en-us": { "role": { "label": "Recently Adopted and Issued Accounting Standards", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r115", "r116", "r121", "r126", "r156", "r157", "r160", "r161", "r169", "r170", "r261", "r262", "r403", "r404", "r405", "r424", "r427", "r430", "r431", "r432", "r442", "r443", "r444", "r452", "r453", "r456", "r497", "r498", "r499", "r549", "r550", "r551", "r552", "r553" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r341", "r495", "r544", "r593", "r594", "r656", "r677", "r683", "r684", "r715", "r740", "r741", "r749", "r757", "r761", "r769", "r855", "r893", "r894", "r895", "r896", "r897", "r898" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://fgfinancial.com/role/StatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r770", "r771", "r774", "r775", "r776", "r777", "r904", "r908" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative", "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "auth_ref": [ "r292", "r293", "r294", "r295", "r334", "r341", "r371", "r372", "r373", "r471", "r495", "r544", "r593", "r594", "r656", "r677", "r683", "r684", "r715", "r740", "r741", "r749", "r757", "r761", "r769", "r772", "r846", "r855", "r894", "r895", "r896", "r897", "r898" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "FGF_EquityMethodInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "EquityMethodInvestmentMember", "presentation": [ "http://fgfinancial.com/role/ScheduleOfInvestmentsUnderEquityMethodDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment [Member]", "documentation": "Equity Method Investment [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfDeferredIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned premium reserves", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the unearned premiums reserve." } } }, "auth_ref": [ "r39", "r885" ] }, "FGF_VariableInterestEntityMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "VariableInterestEntityMember", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity [Member]", "documentation": "Variable Interest Entity [Member]" } } }, "auth_ref": [] }, "srt_ManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ManagementMember", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Management [Member]" } } }, "auth_ref": [ "r834", "r890" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) attributable to FG Financial Group, Inc. common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r143", "r162", "r163", "r164", "r165", "r172", "r173", "r178", "r182", "r193", "r207", "r213", "r216", "r748" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r50", "r899" ] }, "us-gaap_NetInvestmentIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentIncome", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": "FGF_RevenuesFromContractWithCustomerExcludingAssessedTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/ScheduleOfNetInvestmentIncomeLossDetails", "http://fgfinancial.com/role/StatementsOfOperations", "http://fgfinancial.com/role/SummaryOfSegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Net investment income", "verboseLabel": "Net investment income (loss)", "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments." } } }, "auth_ref": [ "r107", "r522", "r523", "r633", "r778" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument interest rate", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r15", "r47", "r323", "r451" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r782" ] }, "us-gaap_UnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnearnedPremiums", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://fgfinancial.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Unearned premium reserves", "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date." } } }, "auth_ref": [ "r118" ] }, "FGF_HagertyCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fgfinancial.com/20230930", "localname": "HagertyCommonStockMember", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative", "http://fgfinancial.com/role/ScheduleOfEquitySecuritiesDetails", "http://fgfinancial.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Hagerty Common Stock [Member]", "documentation": "Hagerty Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r80", "r149" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://fgfinancial.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Ave Remaining Contractual Term (Years), Outstanding, Ending balance", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r84" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://fgfinancial.com/role/EquityIncentivePlanGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-based payment arrangement, expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r375", "r386" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r117", "r752", "r887" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://fgfinancial.com/role/ScheduleOfFairValueOfStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected life (years)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r370" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "(Income) from equity method investments, net of distributions received", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r5", "r67", "r97", "r200", "r254", "r518" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r785" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://fgfinancial.com/role/StatementOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://fgfinancial.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r833" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://fgfinancial.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r786" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://fgfinancial.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://fgfinancial.com/role/InvestmentsAndFairValueDisclosuresDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r16", "r152", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r451", "r752", "r753", "r754", "r755", "r756", "r826" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://fgfinancial.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Expenses:" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://fgfinancial.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r152", "r413", "r414", "r417", "r418", "r462", "r739", "r850", "r853", "r854" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4M", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "10", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479567/321-10-45-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479408/944-825-45-1" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "220", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "SubTopic": "210", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(1))", "SubTopic": "220", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(c))", "SubTopic": "220", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-19" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "66", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-66" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-5" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479735/944-20-S99-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2A" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479616/944-310-45-5" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r801": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r802": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "SubTopic": "740", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 68 0001493152-23-040055-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-040055-xbrl.zip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�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end